C (2015-2019)

STUDIES ON CONDITIONS and RELATED ARTICLES 2015-2019

*Articles/Studies in Pre-2000 List
+Articles/Studies in 2000-2009 List
^Articles/Studies in 2010-2014 List
>Information in Another Section

CACHEXIA + (Weight Loss from Toxic Cytokines Deranging Carbohydrate, Lipid and Protein Metabolism)
CAFFEINE and the ENDOCANNABINOID SYSTEM/COFFEE +
CANCER-ADENOCARCINOMA
>CANCER–ADRENAL CORTICAL (See 2000-2009 List)
>CANCER-ANGIOSARCOMA (See News Articles 2010-2018)
CANCER–BASAL CELL CARCINOMA (See Also CANCER-SKIN)
CANCER-BLADDER/URETHRAL
CANCER-BONE+
CANCER-BREAST*+^
CANCER-CERVICAL+^
>CANCER–CHEMOTHERAPY (See CHEMOTHERAPY)
CANCER-CHOLANGIOCARCINOMA +
CANCER-COLON/COLORECTAL +
CANCER-ENDOMETRIAL +
>CANCER–EWING TUMORS (See 2000-2009 List and CANCER-PNET/PRIMITIVE NEUROECTODERMAL TUMOR+)
CANCER-GASTRIC*+
CANCER-GLIOMA/BRAIN CANCERS*+
CANCER-HEAD AND NECK+
CANCER-ID-1 GENE (This Gene Makes Several Types of Cancer [Triple Negative Breast Cancer, Glioblastomas, some Colon and Salivary Cancers] More Aggressive so They Spread Faster. CBD Deactivates the ID-1 Gene)
CANCER-KAPOSI’S SARCOMA+
CANCER-KIDNEY+
CANCER-LEUKEMIA*+
CANCER-LIVER+
CANCER-LUNG*+
CANCER-LYMPHOMA*+
CANCER-MELANOMA*+
>CANCER–MESOTHELIOMA (See News Articles)
CANCER-MYELOMA*+
CANCER-NASOPHARYNGEAL (See 2010-2014 List)
CANCER-NEUROBLASTOMA*+
CANCER-ORAL*+
CANCER-OVARIAN+
CANCER-PANCREATIC +
CANCER-PITUITARY ADENOMA (See 2010-2014 List)
>CANCER-PNET/PRIMITIVE NEUROECTODERMAL TUMOR + (See News Articles 2010-2016)
CANCER-PROSTATE*+
CANCER-RHABDOMYOSARCOMA+ (See 2010-2014 List)
CANCER–SALIVARY GLAND
CANCER-SKIN +
CANCER-SQUAMOUS CELL CARCINOMA +
CANCER-TESTICULAR
top
CANCER-THYROID +
CANCER-VARIOUS/UNNAMED +
CANCER-VULVAR
CANNABINOID HYPEREMESIS SYNDROME + (Vomiting Due To Purported Cannabinoid ‘Overdose’ [Azadirachtin and/or PGR Poisoning])
>CARDIOVASCULAR (See HEART DISEASE)
CARPAL TUNNEL SYNDROME +
CATALEPSY (Bodily Condition Marked by Sudden Rigidity and Fixation of Posture)
CATATONIA
CELIAC DISEASE +
CEREBRAL PALSY*+
CHAGAS DISEASE/AMERICAN TRYPANOSOMIASIS
>CHARCOT-MARIE-TOOTH DISEASE (Inherited Neurological Disorder – See News Articles 2010-2016)
CHEMICAL COMPOSITION*+
CHEMICAL INTOLERANCE/CHEMICAL SENSITIVITY
CHEMOTHERAPY*+
CHEST PAIN-NON CARDIAC
CHILD ABUSE/NEGLECT/BULLYING
>CHILDHOOD IMMUNE THROMBOCYTOPENIA (See IMMUNE THROMBOCYTOPENIA)
CHILDREN*+ (2 to 12 Years Old, or Equivalent in Animals) NOTE: Children Do Not Always React to Cannabis Like Adults; They Can Experience Breathing Trouble and Other Serious Problems, Especially with High-Doses (Some Edibles, Hash, etc. See Also ADOLESCENTS and INFANTS)
CHOLERA*+ (See 2010-2014 List)
CHOLESTEROL*+
CHRONIC CEREBRAL HYPOPERFUSION (Long-Term Lack of Blood Getting to the Brain)
CHRONIC FATIGUE SYNDROME/MYALGIC ENCEPHALOMYELITIS*
CHRONIC MOUNTAIN SICKNESS
CHRONIC TRAUMATIC ENCEPHALOPATHY/CTE (See Also BRAIN TRAUMA)
CIDS/CNS INJURY-INDUCED IMMUNODEFICIENCY SYNDROME
CIRCADIAN RHYTHM/CIRCANNUAL RHYTHM/BIORHYTHMS
CLINICAL ENDOCANNABINOID DEFICIENCY THEORY
CNS/CENTRAL NERVOUS SYSTEM
COCAINE and the ENDOCANNABINOID SYSTEM
>COGNITIVE EFFECTS (See IQ)
COHORT/LARGE STUDIES
COLITIS*+ (See Also BOWEL DISORDERS)
CONCUSSIONS (See also CHRONIC TRAUMATIC ENCEPHALOPATHY, BRAIN TRAUMA)
CONSTIPATION
COPD/CHRONIC OBSTRUCTIVE PULMONARY DISEASE*+
CORNEAL KERATITIS (Painful Sores or Ulcers on the Cornea of the Eye)
COUGH +
COWPOX (See Also SMALL POX)
CREATIVITY and CANNABIS
CRIME and CANNABIS
CROHN’S DISEASE*+ (See Also BOWEL DISORDERS)
CRPS/RSD-COMPLEX REGIONAL PAIN SYNDROME/REFLEX SYMPATHETIC DYSTROPHY/CAUSALGIA +
>CRUETZFELDT-JACOB DISEASE (See MAD COW DISEASE)
>CT-3 (See AJULMIC ACID in the SYNTHETICS Section)
CULTIVATION + (Not a ‘Grow Guide’, Just Interesting Stuff Found About Growing! [No Date Restriction])
CUSHING’S SYNDROME (See 2010-2014 List)
CYCLIC VOMITING SYNDROME (See also NAUSEA and CANNABINOID HYPEREMESIS)
CYSTIC FIBROSIS*+
CYSTITIS +
top


CACHEXIA 
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015)
http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Cannabis – therapy for the future? (abst in English–2015) http://www.ncbi.nlm.nih.gov/pubmed/26375695  (abst in Czech) https://www.prolekare.cz/casopisy/vnitrni-lekarstvi/2015-7-8/konopi-lecba-budoucnosti-55723?hl=cs
Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats (full–2016) http://link.springer.com/article/10.1007%2Fs00213-016-4397-4
Sex Differences in Cannabinoid-Regulated Biology: A Focus on Energy Homeostasis  (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091302216300036
Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome (abst–2016) http://link.springer.com/article/10.1007%2Fs40262-015-0363-2
Clinical Evidence for Utilizing Cannabinoids in the Elderly (link to PDF–2017)  https://www.ima.org.il/imaj/viewarticle.aspx?year=2017&month=02&page=71
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications  (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4043
A cannabigerol-rich Cannabis sativa extract, devoid of [INCREMENT]9-tetrahydrocannabinol, elicits hyperphagia in rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28125508
Are cannabinoids an alternative for cachexia-anorexia syndrome in patients with  advanced cancer? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29286357
Cannabinoid therapy in practice (abst in German & English-2018)
https://link.springer.com/article/10.1007%2Fs00120-018-0636-0

The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial (abst–2018)
https://link.springer.com/article/10.1007%2Fs00520-018-4154-9
Health-related quality of life across cancer cachexia stages (full–2019) http://apm.amegroups.com/article/view/21116/22353
Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol (full–2019) https://onlinelibrary.wiley.com/doi/full/10.1002/jcsm.12426
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice (full–2019) https://www.ebiomedicine.com/article/S2352-3964(19)30356-1/fulltextMedical Cannabinoids for Cancer Cachexia: A Systematic Review and Meta-Analysis (full–2019) https://www.hindawi.com/journals/bmri/2019/2864384/
Progress in cannabis research from a pharmaceutical chemist’s point of view. (Germany) (abst in English & German–2019) https://link.springer.com/article/10.1007%2Fs00103-019-02964-4


CAFFEINE and the ENDOCANNABINOID SYSTEM/COFFEE+
Management of non-alcoholic fatty liver disease in 2015 (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691699/
Effects of cannabidiol on contractions and calcium signaling in rat ventricular myocytes (link to PDF–2015) http://www.ncbi.nlm.nih.gov/pubmed/25711828
Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26099242
Connecting the dots, genome-wide association studies in substance use (article–2016) https://www.researchgate.net/publication/298422234_Connecting_the_dots_genome-wide_association_studies_in_substance_use
Caffeine and Cannabis Effects on Vital Neurotransmitters and Enzymes in the Brain  Tissue of Juvenile Experimental Rats (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448447/
Chronic and acute adenosine A2A receptor blockade prevents long-term episodic  memory disruption caused by acute cannabinoid CB1 receptor activation (abst–2017) http://www.sciencedirect.com/science/article/pii/S0028390817300758
Pharmacological challenge studies with acute psychosocial stress (abst–2017)  http://www.psyneuen-journal.com/article/S0306-4530(17)30544-9/fulltext
Insomnia and Regulation of Sleep-Wake Cycle With Drugs Among Adolescent Risky Drinkers (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30176972
A fully automated approach for the analysis of 37 psychoactive substances in raw wastewater based on on-line solid phase extraction-liquid chromatography-tandem mass spectrometry (abst–2018) https://www.sciencedirect.com/science/article/pii/S0021967318311890?via%3Dihub
Investigating causal associations between use of nicotine, alcohol, caffeine, and cannabis: A two-sample bidirectional Mendelian randomization study (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29334416


CANCER-ADENOCARCINOMA
Effect of anandamide on endometrial adenocarcinoma (Ishikawa) cell numbers: implications for endometrial cancer therapy (link to download–2015) https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60335-X/fulltext
Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells (full–2016) http://www.sciencedirect.com/science/article/pii/S2213231716301252
Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10564&path%5B%5D=33384
Value of CNRIP1 promoter methylation in colorectal cancer screening and prognosis assessment and its influence on the activity of cancer cells (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701694/
Endocannabinoids modulate apoptosis in endometriosis and adenomyosis (abst–2017) https://www.semanticscholar.org/paper/Endocannabinoids-modulate-apoptosis-in-and-Bilgi%C3%A7-Guzel/3ad9640d75b58af9ff66007d177feaa3292663b5
Serum endocannabinoids in assessing pain in patients with chronic pancreatitis and in those with pancreatic ductal adenocarcinoma (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28631495
Enhancing the Therapeutic Efficacy of Cancer Treatment With Cannabinoids (full–2018) https://www.frontiersin.org/articles/10.3389/fonc.2018.00114/full
Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer (full–2018) https://www.frontiersin.org/articles/10.3389/fphar.2018.00889/full
Striking lung cancer response to self-administration of cannabidiol: A case report and literature review (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385325/


CANCER–BASAL CELL CARCINOMA
Medical Marijuana Treatment for vismodegib-related muscle spasm (full-2017) https://www.jaadcasereports.org/article/S2352-5126(17)30124-8/pdf
Cannabis for vismodegib-related muscle cramps in a patient with advanced basal cell carcinoma (abst–2018) http://www.jpsmjournal.com/article/S0885-3924(18)30070-8/fulltext


CANCER-BLADDER/URETHRAL +
Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the California Men’s Health Study (full–2015) https://www.semanticscholar.org/paper/Association-between-cannabis-use-and-the-risk-of-ThomasWallner/9e5d7262609e10c514dad0ce457e7521b8deb50c
top

Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance (full–2016) https://www.dovepress.com/endocannabinoid-system-as-a-regulator-of-tumor-cell-malignancy-ndash-bpeer-reviewed-fulltext-article-OTT
Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated
modifications of sphingolipids metabolism (full–2017)  http://www.nature.com/articles/srep42157
Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434502/
Development of new inhibitors for N-acylethanolamine-hydrolyzing acid amidase as promising tool against bladder cancer (abst–2017) http://www.sciencedirect.com/science/article/pii/S0968089616314961


CANCER-BONE +
Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2 (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580018/
The secreted protein acidic and rich in cysteine is a critical mediator of cell death program induced by WIN/TRAIL combined treatment in osteosarcoma cells (full–2015) https://www.spandidos-publications.com/ijo/48/3/1039
Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord (abst–2015) http://link.springer.com/article/10.1007/s10753-015-0168-3
A Single Intrathecal or Intraperitoneal Injection of CB2 Receptor Agonist Attenuates Bone Cancer Pain and Induces a Time-Dependent Modification of GRK2 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26935064 
Inhibition of autophagy and enhancement of endoplasmic reticulum stress increase sensitivity of osteosarcoma Saos-2 cells to cannabinoid receptor agonist WIN55,212-2 (abst–2016) https://www.semanticscholar.org/paper/Inhibition-of-autophagy-and-enhancement-of-stress-ZhangBi/cb61b9c8b50355a776a461ca04b1cf3b8f4ad9a1
The role of mifamurtide in chemotherapy-induced osteoporosis of children with osteosarcoma (abst–2016) http://www.eurekaselect.com/148390/article
Anti-proliferative, pro-apoptotic and anti-invasive effect of EC/EV system in human
osteosarcoma (full–2017) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=17089&path%5B%5D=54691
Recent advances in understanding and managing cancer pain (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482325/
Anti-proliferative, pro-apoptotic and anti-invasive effect of EC/EV system in human
osteosarcoma (full–2017) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589594/
A peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer induced bone pain (link to download–2017) http://www.dol.inf.br/Html/Edicao/PDF/Alerta10.pdf
Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral 
type 2 cannabinoid receptor (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1043661816313809
Morin Suppresses Astrocyte Activation and Regulates Cytokine Release in Bone Cancer Pain Rat Models (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28618070
Bufalin attenuates cancer-induced pain and bone destruction in a model of bone cancer  (abst–2017) https://link.springer.com/article/10.1007%2Fs00210-017-1419-7
Anti-Tumorigenic Properties of Omega-3 Endocannabinoid Epoxides (abst–2018)
https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00243
Bortezomib And Endocannabinoid/Endovanilloid System: A Synergism In Osteosarcoma (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S1043661818310387
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice (full–2019) https://www.ebiomedicine.com/article/S2352-3964(19)30356-1/fulltext
The Endocannabinoid/Endovanilloid System in Bone: From Osteoporosis to Osteosarcoma (full–2019) https://www.mdpi.com/1422-0067/20/8/1919/htm


CANCER-BREAST*+
Bone cell-autonomous contribution of type 2 cannabinoid receptor to breast cancer induced osteolysis (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571957/
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470774/
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer (full–2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387115/

The therapeutic potential of orphan GPCRs, GPR35 and GPR55 (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397721/
The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer (full–2015)
http://ar.iiarjournals.org/content/35/9/4707.long
Selective, Nontoxic CB2 Cannabinoid o-Quinone with in Vivo Activity against TripleNegative Breast Cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25671648

Curcumin sensitizes human U-87 glioblastoma and MCF-7 breast cancer cells to the endocannabinoid reuptake inhibitor OMDM-2 (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1565733
Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent
Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in
Spinal Cord (abst–2015) http://link.springer.com/article/10.1007/s10753-015-0168-3
Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent (full–2016) https://www.dovepress.com/modulation-of-breast-cancer-cell-viability-by-a-cannabinoid-receptor-2-peerreviewed-fulltext-article-BCTT
Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path[]=9408&path[]=29962

TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path%5B%5D=9663&path%5B%5D=30267
Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10206&path%5B%5D=32116
Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00503/full

Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/
Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0167240
Effect of endocannabinoid degradation on pain: role of FAAH polymorphisms in experimental and postoperative pain in women treated for breast cancer (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26808012
Delineating the molecular mechanisms of tamoxifen’s oncolytic actions in estrogen receptor-negative cancers (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27083550
Cannabidiolic acid-mediated selective down-regulation of c-fos in highly aggressive breast cancer MDA-MB-231 cells: possible involvement of its down-regulation in the abrogation of aggressiveness (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27530354
Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27633508
top

Polyunsaturated Fatty Acids Differentially Modulate Cell Proliferation and
Endocannabinoid System in Two Human Cancer Lines (full–2017)  http://www.arcmedres.com/article/S0188-4409(17)30026-7/fulltext
Regulation of Id-1 Gene Expression in Aggressive Breast Cancer and Glioblastoma Cells Using Cannabinoid Compounds (link to PDF–2017) http://gssrr.org/index.php?journal=JournalOfBasicAndApplied&page=article&op=view&path%5B%5D=7621
Anti-invasion Effects of Cannabinoids Agonist and Antagonist on Human Breast Cancer Stem Cells (full–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843309/
Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer (full–2018) https://www.frontiersin.org/articles/10.3389/fphar.2018.00889/fullCannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304621/
Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol (full–2018) http://ar.iiarjournals.org/content/38/10/5831.long
Prospective analysis of safety and efficacy of medical cannabis in large unselected
population of patients with cancer (Israel) (click “researchgate” for download
2018) https://scholar.google.com/scholar?cluster=325327779336056220&hl=en&as_sdt=0,5

The tamoxifen derivative ridaifen-B is a high affinity selective CB2 receptor inverse
agonist exhibiting anti-inflammatory and anti-osteoclastogenic effects (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0041008X18302679
Appraising the “entourage effect”: antitumor action of a pure cannabinoid versus a
botanical drug preparation in preclinical models of breast cancer (abst–2018)
https://www.sciencedirect.com/science/article/abs/pii/S0006295218302387
Development of thiazole-5-carboxylate derivatives as selective inhibition of
monoacylglycerol lipase as a target in Cancer (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29962341
Novel mechanism of cannabidiol-induced apoptosis in breast cancer cell lines (abst–2018) https://www.thebreastonline.com/article/S0960-9776(18)30121-8/fulltext
Combined CB2 Receptor Agonist and Photodynamic Therapy Synergistically Inhibit Tumor Growth in Triple Negative Breast Cancer (abst–2018) https://www.sciencedirect.com/science/article/pii/S1572100018301571?via%3Dihub
The onus of cannabinoids in interrupting the molecular odyssey of breast cancer: A critical perspective on UPRER and beyond (full–2019) https://www.sciencedirect.com/science/article/pii/S1319016419300064?via%3Dihub
Future Aspects for Cannabinoids in Breast Cancer Therapy (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479799/
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet? (full–2019) https://www.frontiersin.org/articles/10.3389/fphar.2019.00339/full
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice (full–2019) https://www.ebiomedicine.com/article/S2352-3964(19)30356-1/fulltext


CANCER-CERVICAL +
The evolving role of the endocannabinoid system in gynaecological cancer (full–2015) http://humupd.oxfordjournals.org/content/21/4/517.long
Over-expression of cannabinoid receptor 2 induces the apoptosis of cervical carcinoma Caski cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26062417
Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells (full–2016) http://bmccomplementalternmed.biomedcentral.com/articles/10.1186/s12906-016-1280-0


CANCER-CHOLANGIOCARCINOMA+
The therapeutic potential of orphan GPCRs, GPR35 and GPR55 (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397721/


CANCER-COLON/COLORECTAL +
Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381706/
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470774/
Endocannabinoid and ceramide levels are altered in patients with colorectal cancer (full–2015) https://www.spandidos-publications.com/or/34/1/447
Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by
CB1 Receptor in Human Colon Cancer Cell Lines (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25893829
Endocannabinoids and the Digestive Tract and Bladder in Health and Disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408170
CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=11968&path%5B%5D=37882
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives (full–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26817719
Endocannabinoids in the gastrointestinal tract (full–2016)  http://ajpgi.physiology.org/content/311/4/G655.long
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/
The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130148/
Docosahexaenoyl Serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23–IL-17 signalling in macrophages (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116302499
Phytochemicals as adjunctive with conventional anticancer therapies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262332
Dietary ω-3 Polyunsaturated Fatty Acids Inhibit Tumor Growth in Transgenic ApcMin/+ Mice, Correlating with CB1 Receptor Up-Regulation (full–2017)  http://www.mdpi.com/1422-0067/18/3/485/htm
Targeting cannabinoid receptors in gastrointestinal cancers for therapeutic uses: current status and future perspectives (full–2017)  http://www.tandfonline.com/doi/full/10.1080/17474124.2017.1367663
Value of CNRIP1 promoter methylation in colorectal cancer screening and prognosis
assessment and its influence on the activity of cancer cells (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701694/
Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by
Rimonabant: a therapeutic target for colon cancer (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601949/
Fatty acid amide hydrolase (FAAH) inhibitor PF-3845 reduces viability, migration and

invasiveness of human colon adenocarcinoma Colo-205 cell line: an in vitro study (click “ABP” icon for download–2017) https://www.ncbi.nlm.nih.gov/pubmed/28850633
Pharmacological inhibition of MAGL lipase attenuates experimental colon  carcinogenesis (abst–2017)  http://www.sciencedirect.com/science/article/pii/S104366181630932X
Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in
addition to FOBT (abst–2017) http://link.springer.com/article/10.1007%2Fs11739-017-1610-3
Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and
Therapeutic Relevance (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28161834
G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1 (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28875496
Cannabidiol and Palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon (abst–2017) https://www.semanticscholar.org/paper/Cannabidiol-and-palmitoylethanolamide-are-in-the-CouchTasker/813bc07599af55cdbd40b8c8630897d8a6c6d24d
Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758598/
Identification of Synergistic Interaction Between Cannabis-Derived Compounds for
Cytotoxic Activity in Colorectal Cancer Cell Lines and Colon Polyps That Induces
Apoptosis-Related Cell Death and Distinct Gene Expression (full–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038055/
Synthetic Cannabinoid Activity Against Colorectal Cancer Cells (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340378/

Interferon γ treatment increases endocannabinoid and related N-acylethanolamine levels in T84 human colon carcinoma cells (abst–2018) https://www.semanticscholar.org/paper/Interferon-%CE%B3-treatment-increases-endocannabinoid-in-AlhouayekRankin/fcea05dcfc2fefab39e03ba42e3d3a775af61a9d
Cannabinoid Receptor-1 Up-regulation in Azoxymethane (AOM)-treated Mice After
Dietary Treatment with Quercetin (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/30061214
Cannabinoid pharmacology and therapy in gut disorders (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303186
Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer (full–2019) https://www.mdpi.com/2072-6694/11/5/642/htm
Cannabidiol Overcomes Oxaliplatin Resistance by Enhancing NOS3- and SOD2-Induced Autophagy in Human Colorectal Cancer Cells (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627455/
Cannabidiol-induced apoptosis is mediated by activation of Noxa in human colorectal cancer cells (full–2019) https://www.sciencedirect.com/science/article/pii/S0304383519300230?via%3Dihub
Down-Regulation of Cannabinoid Type 1 (CB1) Receptor and its Downstream Signaling Pathways in Metastatic Colorectal Cancer (full–2019) https://www.mdpi.com/2072-6694/11/5/708/htm
In-hospital outcomes of inflammatory bowel disease in cannabis users: a nationwide propensity-matched analysis in the United States (full–2019) http://atm.amegroups.com/article/view/25637/24217
Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer (full–2019) https://www.nature.com/articles/s41598-019-38865-4
The Important Role of the Endocannabinoid System and the Endocannabinoidome in Gut Health (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31202201


CANCER-ENDOMETRIAL+
Effect of anandamide on endometrial adenocarcinoma (Ishikawa) cell numbers: implications for endometrial cancer therapy (link to download–2015) https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60335-X/fulltext
Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=10564&path%5B%5D=33384
∆9-tetrahydrocannabinol inhibits epithelial-mesenchymal transition and metastasis by targeting matrix metalloproteinase-9 in endometrial cancer (full–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950514/
Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1  receptors in apoptosis (link to PDF-2018)  https://www.researchgate.net/publication/323158392_Cannabinoidinduced_cell_death_in_endometrial_cancer_cells_involvement_of_TRPV1_receptors_in_apoptosis
Identification of Novel Predictive Biomarkers for Endometrial Malignancies: N-Acylethanolamines (full-2019) https://www.frontiersin.org/articles/10.3389/fonc.2019.00430/ful


CANCER-GASTRIC*+
WIN 55,212-2 Inhibits the Epithelial Mesenchymal Transition of Gastric Cancer Cells via COX-2 Signals (full–2016) http://www.karger.com/Article/FullText/447910
Comparing the effects of endogenous and synthetic cannabinoid receptor agonists on survival of gastric cancer cells (abst–2016) http://www.sciencedirect.com/science/article/pii/S0024320516305677
Phytochemicals as adjunctive with conventional anticancer therapies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262332
Targeting cannabinoid receptors in gastrointestinal cancers for therapeutic uses: current status and future perspectives (full–2017)  http://www.tandfonline.com/doi/full/10.1080/17474124.2017.1367663
Cannabidiol Induces Cell Cycle Arrest and Cell Apoptosis in Human Gastric Cancer SGC-7901 Cells (full–2019) https://www.mdpi.com/2218-273X/9/8/302/htm


CANCER-GLIOMA/BRAIN CANCERS*+
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients’ cells (full–2015) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=3895&path%5B%5D=8966
Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma (full–2015) http://www.nature.com/cddis/journal/v6/n1/full/cddis2014566a.html
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids (full–2015) http://tinyurl.com/ozojefv
Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stemlike cells proliferation by inducing autophagy in a TRPV2-dependent manner (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/ijc.29573/full
The therapeutic potential of orphan GPCRs, GPR35 and GPR55 (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397721/
Anti-carcinogenic activity of anandamide on human glioma in vitro and in vivo (full–2015) http://www.spandidos-publications.com/10.3892/mmr.2015.4721
Co-mutated pathways analysis highlights the coordination mechanism in glioblastoma multiforme (link to download–2015) http://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=3797&category_id=109&keyword=cannabinoid&option=com_virtuemart&Itemid=1
On the effects of CP 55-940 and other cannabinoid receptor agonists in C6 and U373 cell lines (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26255146
Curcumin sensitizes human U-87 glioblastoma and MCF-7 breast cancer cells to the endocannabinoid reuptake inhibitor OMDM-2 (abst–2015) http://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1565733
Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance (full–2016) https://www.dovepress.com/endocannabinoid-system-as-a-regulator-of-tumor-cell-malignancy-ndash-bpeer-reviewed-fulltext-article-OTT
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via
autolysosome destabilization (full–2016)  http://www.tandfonline.com/doi/full/10.1080/15548627.2016.1213927
Influence of Biomechanical Properties and Cannabinoids on Tumor Invasion (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308229/
Anticancer mechanisms of cannabinoids (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791144/
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/
Quantitative analyses of synergistic responses between cannabidiol and DNA-damaging agents on the proliferation and viability of glioblastoma and neural progenitor cells in culture (full–2016)
http://jpet.aspetjournals.org/content/360/1/215.long
Letter to the editor re Sredni et al.: spontaneous involution of pediatric low-grade

gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system (2016) (letter–2016)  http://link.springer.com/article/10.1007%2Fs00381-016-3333-6
Spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system (abst–2016)  http://link.springer.com/article/10.1007%2Fs00381-016-3243-7
Polyunsaturated Fatty Acids Differentially Modulate Cell Proliferation and
Endocannabinoid System in Two Human Cancer Lines (full–2017)  http://www.arcmedres.com/article/S0188-4409(17)30026-7/fulltext
Regulation of human glioblastoma cell death by combined treatment of cannabidiol,
γ-radiation and small molecule inhibitors of cell signaling pathways (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650324/
Regulation of Id-1 Gene Expression in Aggressive Breast Cancer and Glioblastoma Cells Using Cannabinoid Compounds (link to PDF–2017) http://gssrr.org/index.php?journal=JournalOfBasicAndApplied&page=article&op=view&path%5B%5D=7621
Hypoxia-induced inhibition of the endocannabinoid system in glioblastoma cells (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29130103
Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs (full–2018)
https://www.frontiersin.org/articles/10.3389/fnmol.2018.00159/full
Cannabis Therapeutics and the Future of Neurology (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200872/
Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol (full–2018) http://ar.iiarjournals.org/content/38/10/5831.long
Current natural therapies in the treatment against glioblastoma (link to PDF–2018) https://www.researchgate.net/publication/327037112_Current_natural_therapies_in_the_treatment_against_glioblastoma
(±)-Sativamides A and B, Two Pairs of Racemic Nor-Lignanamide Enantiomers from the Fruits of Cannabis sativa (abst–2018)  https://pubs.acs.org/doi/10.1021/acs.joc.7b02765
Optimization Of A Preclinical Therapy Of Cannabinoids In Combination With Temozolomide Against Glioma (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303496
Targeting Glioma Initiating Cells With A Combined Therapy Of Cannabinoids And Temozolomide (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303897
Lipid nanocapsules decorated and loaded with cannabidiol as targeted prolonged release carriers for glioma therapy: In vitro screening of critical parameters (full–2019) https://www.sciencedirect.com/science/article/pii/S0939641118311366?via%3Dihub
Case Report: Clinical Outcome and Image Response of Two Patients With Secondary High-Grade Glioma Treated With Chemoradiation, PCV, and Cannabidiol (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345719/
Medical Cannabis Certification in a Large Pediatric Oncology Center (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617193/
The use of cannabis in supportive care and treatment of brain tumor (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6655483/
Medical Cannabis Use in Glioma Patients Treated at a Comprehensive Cancer Center in Florida (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31081711
Corticosterone inhibits the expression of cannabinoid receptor-1 and cannabinoid receptor agonist-induced decrease in cell viability in glioblastoma cells (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31423223


CANCER-HEAD AND NECK+
Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue  squamous cell carcinoma: associations with clinicopathological parameters and patients’ survival (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26459312
Head and neck cancer among marijuana users: A meta-analysis of matched case-control studies (abst–2015) http://www.aobjournal.com/article/S0003-9969%2815%2930041-8/abstract
top
5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanineinduced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells (full–2016) http://bmccancer.biomedcentral.com/articles/10.1186/s12885-016-2499-3
Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27005465
Overexpression of cannabinoid receptor 1 in esophageal squamous cell carcinoma is
correlated with metastasis to lymph nodes and distant organs, and poor prognosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27976824
Review: The Role of Cannabinoids on Esophageal Function—What We Know Thus Far  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665514/
Therapeutic Cannabis and Endocannabinoid Signaling System Modulator Use in Otolaryngology Patients (full-2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057224/
Marijuana and head and neck cancer: an epidemiological review (full-2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249858/
Association of Marijuana Use With Psychosocial and Quality of Life Outcomes Among Patients With Head and Neck Cancer (download–2018) https://www.sativaisticated.com/wp-content/uploads/2018/08/Association-of-Marijuana-Use-With-Psychosocial-and-Quality-of-Life-Outcomes-Among-Patients-With-Head-and-Neck-Cancer-Medical-Cannabis-Medical-Marijuana-Research-Study-for-Head-and-Neck-Cancer.pdf
Cannabinoid Hyperemesis Syndrome: A Case Report of a Confounding Entity in Oncology Care (1st page–2018) http://ascopubs.org/doi/full/10.1200/JOP.17.00106
Altered mRNA Expression of Genes Involved in Endocannabinoid Signalling in Squamous Cell Carcinoma of the Oral Tongue (full–2019) https://www.tandfonline.com/doi/full/10.1080/07357907.2019.1638394
Assessment of quality and consistency of monoclonal antibodies for CB1 and CB2 in head and neck squamous cell carcinoma (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31037797
What is the evidence for cannabis use in otolaryngology?: A narrative review (abst–2019) https://www.sciencedirect.com/science/article/abs/pii/S0196070919304685?via%3Dihub


CANCER-ID-1 GENE
Suppression of invasion and metastasis in aggressive salivary cancer cells through
targeted inhibition of ID1 gene expression (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883028/
Regulation of Id-1 Gene Expression in Aggressive Breast Cancer and Glioblastoma Cells Using Cannabinoid Compounds (link to PDF–2017) http://gssrr.org/index.php?journal=JournalOfBasicAndApplied&page=article&op=view&path%5B%5D=7621


CANCER-KAPOSI’S SARCOMA+
Cannabinoids in dermatology: a scoping review (full–2018)  https://escholarship.org/uc/item/7pn8c0sb


CANCER-KIDNEY 
The therapeutic aspects of the endocannabinoid system (ECS) for cancer and their development: from nature to laboratory (link to PDF–2015)  http://www.eurekaselect.com/137770/article
Overexpression of cannabinoid receptor 1 promotes renal cell carcinoma progression (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27757850
Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434502/
Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression (abst–2017)  https://link.springer.com/article/10.1007%2Fs00432-017-2527-y
Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212–2 in renal cell carcinoma  (full–2018) https://bmccancer.biomedcentral.com/articles/10.1186/s12885-018-4496-1


CANCER-LEUKEMIA*+
Cannabidiol for the Prevention of Graft-Versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study (full–2015) http://www.bbmt.org/article/S1083-8791(15)00375-4/fulltext
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476410/
Downstream effects of endocannabinoid on blood cells: implications for health and disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25957591
Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns (full–2016)
http://bmccancer.biomedcentral.com/articles/10.1186/s12885-015-2029-8
Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156693
Endocannabinoid system: a promising therapeutic target for the treatment of haematological malignancies? (abst in English–2016) http://www.ncbi.nlm.nih.gov/pubmed/27237820  (abst in Chinese) http://www.eurekaselect.com/142651/article
top
Phytochemicals as adjunctive with conventional anticancer therapies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262332
Cannabidiol Reduces Leukemic Cell Size – But Is It Important? (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28392768
Metabolic gatekeeper function of B-lymphoid transcription factors (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621518/
Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration (abst–2017)
https://www.spandidos-publications.com/10.3892/ijo.2017.4022
Effects of CB2 and TRPV1 receptors’ stimulation in pediatric acute T-lymphoblastic
leukemia (full–2018) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940388/
Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective
Cannabinoid Receptor Agonist in Jurkat Leukemia Cells (full–2018) 
http://www.mdpi.com/1422-0067/19/7/1958/htm
Assessment of Cannabinoids Agonist and Antagonist in Invasion Potential of K562
Cancer Cells 
(link to PDF–2018) https://www.researchgate.net/publication/325671277_Assessment_of_Cannabinoids_Agonist_and_Antagonist_in_Invasion_Potential_of_K562_Cancer_Cells
Medical Cannabis Certification in a Large Pediatric Oncology Center (full–2019)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617193/


CANCER-LIVER +
Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells (full–2015) http://www.spandidos-publications.com/10.3892/mmr.2015.4477
[Corrigendum] Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells (correction–2015) http://www.spandidos-publications.com/mmr/13/1/1054
top

Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path[]=7950&path[]=23319
Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979564/
Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis (full–2016) http://gut.bmj.com/content/65/10/1721.long
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/
Cannabinoid WIN55, 212-2 inhibits proliferation, invasion and migration of human
SMMC-7721 hepatocellular carcinoma cells (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27126940
Phytochemicals as adjunctive with conventional anticancer therapies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262332
Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer (full–2018) https://www.frontiersin.org/articles/10.3389/fphar.2018.00889/full
Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis (full–2018) https://www.hindawi.com/journals/cjgh/2018/9430953/
Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29341392
Endocannabinoid system and the expression of endogenous ceramides in human hepatocellular carcinoma (abst-2019) https://www.ncbi.nlm.nih.gov/pubmed/31423220


CANCER-LUNG*+
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup (full–2015)  http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men (full–2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586320/

The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids (full–2015) http://tinyurl.com/ozojefv
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387115/
Human lung-resident macrophages express CB1 and CB2 receptors whose activation
inhibits the release of angiogenic and lymphangiogenic factors (full–2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4787289/
How beneficial is vaping cannabis to respiratory health compared to smoking? (article–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13075/full
Genotoxic properties of XLR-11, a widely consumed synthetic cannabinoid, and of the benzoyl indole RCS-4 (full–2016) http://link.springer.com/article/10.1007/s00204-016-1664-4/fulltext.html
Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path[]=7592&path[]=21964
Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance (full–2016) https://www.dovepress.com/endocannabinoid-system-as-a-regulator-of-tumor-cell-malignancy-ndash-bpeer-reviewed-fulltext-article-OTT
Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells (full–2016) http://www.sciencedirect.com/science/article/pii/S2213231716301252
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/
Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26741322
A Guide to the National Academy of Science Report on Cannabis: An Exclusive
Discussion with Panel Members (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569624/
Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609560/
The Fatty Acid Amide Hydrolase Inhibitor URB937 Ameliorates Radiation-Induced
Lung Injury in a Mouse Model (abst–2017)  http://link.springer.com/article/10.1007%2Fs10753-017-0568-7
The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29061818
Enhancing the Therapeutic Efficacy of Cancer Treatment With Cannabinoids (full–2018) https://www.frontiersin.org/articles/10.3389/fonc.2018.00114/full
Marijuana and the lung: hysteria or cause for concern? (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118880/
Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer. (Israel) (click “researchgate” for download–2018) https://scholar.google.com/scholar?cluster=325327779336056220&hl=en&as_sdt=0,5
Monoacylglycerol lipase inhibitors reverse paclitaxel-induced nociceptive behavior and proinflammatory markers in a mouse model of chemotherapy-induced neuropathy (link to PDF–2018) http://jpet.aspetjournals.org/content/early/2018/03/14/jpet.117.245704
Cannabis Use, Lung Cancer, and Related Issues (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29374567
The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial (abst–2018)
https://link.springer.com/article/10.1007%2Fs00520-018-4154-9
Anti-Tumorigenic Properties of Omega-3 Endocannabinoid Epoxides (abst–2018)
https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00243
Development of thiazole-5-carboxylate derivatives as selective inhibition of
monoacylglycerol lipase as a target in Cancer (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29962341
Striking lung cancer response to self-administration of cannabidiol: A case report and literature review (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385325/


CANCER-LYMPHOMA*+
Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278325/
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476410/
Influence of rimonabant treatment on peripheral blood mononuclear cells; flow cytometry analysis and gene expression profiling (full–2015)  https://peerj.com/articles/1056/
top

The potential relevance of the endocannabinoid, 2-arachidonoylglycerol, in diffuse large B-cell lymphoma (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751914/
High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana (full–2016) https://www.hindawi.com/journals/crit/2016/4028492/

Phytochemicals as adjunctive with conventional anticancer therapies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262332
Cannabis Use and Bleomycin: An Overview and Case Study of Pulmonary Toxicity  (abst–2018) https://cjon.ons.org/cjon/22/4/cannabis-use-and-bleomycin-overview-and-case-study-pulmonary-toxicity
Medical Cannabis Use by Hodgkin Lymphoma Patients: Experience of a Single Center (abst–2018) https://www.karger.com/Article/Abstract/493567
Medical Cannabis Certification in a Large Pediatric Oncology Center (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617193/


CANCER-MELANOMA*+
Exploiting Cannabinoid-Induced Cytotoxic Autophagy to Drive Melanoma Cell Death (full–2015) http://www.nature.com/jid/journal/v135/n6/pdf/jid201545a.pdf
Differential role of cannabinoids in the pathogenesis of skin cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25921771
AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25974027
Melanoma research in Hungary: promising results in a previously orphan tumor (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26665186
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/
Standardized Cannabis sativa extract attenuates tau and stathmin gene expression in the melanoma cell line (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673704/
Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28601556
Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells (abst–2017) http://www.sciencedirect.com/science/article/pii/S0887233317300188
The Therapeutic Potential of Cannabinoids in Dermatology (full–2018) http://www.skintherapyletter.com/dermatology/cannabinoids-potential/
The role of lipid signaling in the progression of malignant melanoma (abst–2018) https://www.semanticscholar.org/paper/The-role-of-lipid-signaling-in-the-progression-of-T%C3%ADm%C3%A1rHeged%C3%BCs/24686e1f84c70ffbfc9d09c957a66495735a3e0
Review of Common Alternative Herbal “Remedies” for Skin Cancer (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30096105
Dermatology-Related Uses of Medical Cannabis Promoted by Dispensaries in Canada, Europe, and the United States (abst–2018) http://journals.sagepub.com/doi/abs/10.1177/1203475418808761?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=cmsa
Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System (full–2019) https://www.mdpi.com/1420-3049/24/5/918/htmCannabinoids as a Potential New and Novel Treatment for Melanoma: A Pilot Study in a Murine Model (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30691796


CANCER-MYELOMA
Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504841/
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476410/
Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns (full–2016)
http://bmccancer.biomedcentral.com/articles/10.1186/s12885-015-2029-8
top
Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path%5B%5D=12721&path%5B%5D=40316
Endocannabinoid system: a promising therapeutic target for the treatment of haematological malignancies? (abst in English–2016) http://www.ncbi.nlm.nih.gov/pubmed/27237820  (abst in Chinese) http://www.eurekaselect.com/142651/article

Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo (full–2017) https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.30483
Assessment of Cannabinoids Agonist and Antagonist in Invasion Potential of K562
Cancer Cells
(link to PDF–2018)  https://www.researchgate.net/publication/325671277_Assessment_of_Cannabinoids_Agonist_and_Antagonist_in_Invasion_Potential_of_K562_Cancer_Cells


CANCER-NEUROBLASTOMA*+
THC exerts neuroprotective effect in glutamate affected murine primary mesencephalic cultures and neuroblastoma N18TG2 cells (abst–2015)
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1565754
In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791143/
JWH-133, a Selective Cannabinoid CB2 Receptor Agonist, Exerts Toxic Effects on Neuroblastoma SH-SY5Y Cells (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26842917
Toxicological impact of JWH-018 and its phase I metabolite N-(3-hydroxypentyl) on human cell lines (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27054591
Cannabinoids in Pediatrics (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473390/
Ceramide binding to anandamide increases its half-life and potentiates its cytotoxicity in human neuroblastoma cells (abst–2017) https://www.semanticscholar.org/paper/Ceramide-binding-to-anandamide-increases-its-and-in-ScalaMazzarino/1543d98e3ba90a1c0a790c32b9649c89844ec5c8
The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29061818
Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343753/


CANCER-ORAL*+
Review of Various Herbal Supplements as Complementary Treatments for Oral Cancer (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26863913
top


CANCER-OVARIAN+
The therapeutic potential of orphan GPCRs, GPR35 and GPR55 (full–2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397721/
The evolving role of the endocannabinoid system in gynaecological cancer (full–2015) http://humupd.oxfordjournals.org/content/21/4/517.long
The G-protein coupled receptor 55-agonist L-α-lysophosphatidylinositol mediates ovarian carcinoma cell induced angiogenesis (link to download–2015) http://www.actaps.com.cn/qikan/manage/wenzhang/2014-3-10.pdf

Why I chose to use cannabis (article–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791147/
Phytochemicals as adjunctive with conventional anticancer therapies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262332
Cannabinoid Disposition After Human Intraperitoneal Use: An Insight Into
Intraperitoneal Pharmacokinetic Properties in Metastatic Cancer (full–2018)  http://www.clinicaltherapeutics.com/article/S0149-2918(17)31114-1/fulltext


CANCER-PANCREATIC+
The therapeutic potential of orphan GPCRs, GPR35 and GPR55 (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397721/
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/
Serum endocannabinoids in assessing pain in patients with chronic pancreatitis and in those with pancreatic ductal adenocarcinoma (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28631495
Enhancing the Therapeutic Efficacy of Cancer Treatment With Cannabinoids (full–2018) https://www.frontiersin.org/articles/10.3389/fonc.2018.00114/full
Prospective analysis of safety and efficacy of medical cannabis in large unselected
population of patients with cancer 
(Israel) (click “researchgate” for download–2018) https://scholar.google.com/scholar?cluster=325327779336056220&hl=en&as_sdt=0,5
Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352507/
Nabilone administration in refractory chronic diarrhea: a case series (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593541/
Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer (full–2019) https://www.frontiersin.org/articles/10.3389/fonc.2019.00660/full


CANCER-PROSTATE*+
Proapoptotic effect of endocannabinoids in prostate cancer cells (full–2015)
http://www.spandidos-publications.com/or/33/4/1599

The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids (full–2015) http://tinyurl.com/nlaavnr
Co-Localization of Alpha1-Adrenoceptors and GPR55: A Novel Prostate Cancer Paradigm? (full–2015) http://file.scirp.org/Html/2-2500616_55349.htm
The therapeutic potential of orphan GPCRs, GPR35 and GPR55 (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397721/
The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer (full–2015)
http://ar.iiarjournals.org/content/35/9/4707.long
The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer (full–2015)
http://ar.iiarjournals.org/content/35/9/4707.long
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor

agonists with anticancer and immuno-modulatory activity (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0223523415002937
The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells (full–2016) http://www.nature.com/pcan/journal/vaop/ncurrent/full/pcan201619a.html
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/ 
Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the
treatment of breast and prostate carcinomas (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27633508
A quantitative study on splice variants of N-acylethanolamine acid amidase in human prostate cancer cells and other cells (abst–2016)  http://www.sciencedirect.com/science/article/pii/S1388198116302645
Phytochemicals as adjunctive with conventional anticancer therapies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262332
Effects of tumour necrosis factor α upon the metabolism of the endocannabinoid
anandamide in prostate cancer cells (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599064/
Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434502/
Epigenetic Control of Endocannabinoid Function (full–2017) https://www.ukessays.com/essays/sciences/epigenetic-control-endocannabinoid-2047.php
Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer (full–2018) https://www.frontiersin.org/articles/10.3389/fphar.2018.00889/full
Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol (full–2018) http://ar.iiarjournals.org/content/38/10/5831.long
Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid receptor 2 dependent manner (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30242861
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice (full–2019) https://www.ebiomedicine.com/article/S2352-3964(19)30356-1/fulltext


CANCER–SALIVARY GLAND
Suppression of invasion and metastasis in aggressive salivary cancer cells through targeted inhibition of ID1 gene expression (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883028/


CANCER-SKIN+
The therapeutic potential of orphan GPCRs, GPR35 and GPR55 (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397721/
Arachidonoyl-ethanolamide activates endoplasmic reticulum stress-apoptosis in tumorigenic keratinocytes: Role of cyclooxygenase-2 and novel J-series prostamides (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/mc.22257/full
Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: Receptor-independent endocannabinoid signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26513129
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/
The cross-talk between electrophiles, antioxidant defence and the endocannabinoid system in fibroblasts and keratinocytes after UVA and UVB irradiation (abs–2016) http://www.sciencedirect.com/science/article/pii/S0923181115300761
The Risks and Benefits of Cannabis in the Dermatology Clinic (abst–2017)
http://journals.sagepub.com/doi/full/10.1177/1203475417738971
Cannabinoids in dermatology: a scoping review (full–2018) https://escholarship.org/uc/item/7pn8c0sb
The Therapeutic Potential of Cannabinoids in Dermatology (full–2018) http://www.skintherapyletter.com/dermatology/cannabinoids-potential/
Review of Common Alternative Herbal “Remedies” for Skin Cancer (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30096105
The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303484
Cannabinoids: Potential Role in Inflammatory and Neoplastic Skin Diseases (abst–2018) https://link.springer.com/article/10.1007%2Fs40257-018-0410-5
Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System (full–2019) https://www.mdpi.com/1420-3049/24/5/918/htm


CANCER-SQUAMOUS CELL CARCINOMA +
Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients’ survival (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26459312
top

5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanineinduced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells (full–2016) http://bmccancer.biomedcentral.com/articles/10.1186/s12885-016-2499-3
Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells (full–2016) http://www.sciencedirect.com/science/article/pii/S2213231716301252
Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27005465 Overexpression of cannabinoid receptor 1 in esophageal squamous cell carcinoma is correlated with metastasis to lymph nodes and distant organs, and poor prognosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27976824
Medical Cannabis in the Palliation of Malignant Wounds—A Case Report (full–2017) https://www.jpsmjournal.com/article/S0885-3924(16)30328-1/fulltext
Review of Common Alternative Herbal “Remedies” for Skin Cancer (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30096105
Altered mRNA Expression of Genes Involved in Endocannabinoid Signalling in Squamous Cell Carcinoma of the Oral Tongue (full–2019) https://www.tandfonline.com/doi/full/10.1080/07357907.2019.1638394


CANCER–TESTICULAR
Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642772/
Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434502/
The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29061818


CANCER-THYROID+
Clinical Significance of Cannabinoid Receptors CB1 and CB2 Expression in Human Malignant and Benign Thyroid Lesions (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619873/
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/
The effects of cannabinoids on the endocrine system (link to PDF–2018) https://journals.viamedica.pl/endokrynologia_polska/article/view/58487


CANCER-VARIOUS/UNNAMED+
Cannabis in cancer care (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/cpt.108/full
The use of cannabinoids as anticancer agents (full–2015) http://www.sciencedirect.com/science/article/pii/S0278584615001190
Plant derived substances with anti-cancer activity: from folklore to practice (full–2015) http://journal.frontiersin.org/article/10.3389/fpls.2015.00799/full
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015)
http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
top

Systematic Review of the Use of Phytochemicals for Management of Pain in Cancer Therapy (full–2015) http://www.hindawi.com/journals/bmri/2015/506327/
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids (full–2015) http://tinyurl.com/pe7eb73
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer (full–2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387115/

The evolving role of the endocannabinoid system in gynaecological cancer (full–2015) http://humupd.oxfordjournals.org/content/21/4/517.long
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience (full–2015)
http://www.jpsmjournal.com/article/S0885-3924(14)00312-1/fulltext
Δ9 Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8 (full–2015)
http://www.jleukbio.org/content/97/4/677.long

Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the
Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo (full–2015) http://www.jimmunol.org/content/194/11/5211.long
Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2 (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580018/
Anti-carcinogenic activity of anandamide on human glioma in vitro and in vivo (link to PDF–2015) http://www.spandidos-publications.com/10.3892/mmr.2015.4721
The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer (full–2015)  http://ar.iiarjournals.org/content/35/9/4707.long
Marijuana, Reconsidered: Dr. Lester Grinspoon On 45 Years Of Cannabis Science (interview-2015) http://www.mintpressnews.com/MyMPN/marijuana-reconsidered-an-interview-with-doctor-lestergrinspoon/

New insights into antimetastatic and antiangiogenic effects of cannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25619715
Arachidonoyl-ethanolamide activates endoplasmic reticulum stress-apoptosis in tumorigenic keratinocytes: Role of cyclooxygenase-2 and novel J-series prostamides (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/mc.22257/full
Simultaneous determination of endocannabinoids in murine plasma and brain substructures by surrogate-based LC-MS/MS: Application in tumor-bearing mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25863017
Downstream effects of endocannabinoid on blood cells: implications for health and disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25957591
Phytocannabinoids for Cancer Therapeutics: Recent Updates and Future Prospects (abst in English–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179998  (abst in Chinese) http://www.eurekaselect.com/133293/article
A state-of-the-art review of the management and treatment of taste and smell alterations in adult oncology patients (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26162535
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26325482
Endocannabinoids and Cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408171
Oncosuppressive functions of tribbles pseudokinase 3 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26517935
Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26720619
Cannabinoid-induced autophagy: protective or death role? (abst–2015) http://www.sciencedirect.com/science/article/pii/S109888231530023X
Delta(9)-tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25669486
top

Cannabis and cancer: reality or pipe dream? (abst–2015) http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2815%2900302-2/abstract
Use of medical cannabis to reduce pain and improve quality of life in cancer patients  (abst–2015) http://meetinglibrary.asco.org/content/155674-165
Natural product modulators of transient receptor potential (TRP) channels as potential anti-cancer agents (full–2016) http://pubs.rsc.org/en/content/articlehtml/2016/cs/c5cs00916b
Endocannabinoids as Guardians of Metastasis (full–2016) http://www.mdpi.com/1422-0067/17/2/230/htm
Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path[]=7592&path[]=21964
Cannabis and cancer: toward a new understanding (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791146/
Integrating cannabis into clinical cancer care (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/
Anticancer mechanisms of cannabinoids (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791144/
Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance (full–2016) https://www.dovepress.com/endocannabinoid-system-as-a-regulator-of-tumor-cell-malignancy-ndash-bpeer-reviewed-fulltext-article-OTT
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization (full–2016) http://www.tandfonline.com/doi/full/10.1080/15548627.2016.1213927
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/
A user’s guide to cannabinoid therapies in oncology (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00503/full
β-caryophyllene and β-caryophyllene oxide-natural compounds of anticancer and
analgesic properties (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083753/
Influence of Biomechanical Properties and Cannabinoids on Tumor Invasion (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308229/
Use of cannabinoids in cancer care: palliative care (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791145/
Storage and disposal of medical cannabis among patients with cancer: Assessing the risk of diversion and unintentional digestion (full–2016)
https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.30185
N-Arachidonoyl Dopamine Inhibits NRAS Neoplastic Transformation by Suppressing Its Plasma Membrane Translocation (full–2016)  http://mct.aacrjournals.org/content/16/1/57.long
Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine
Receptor and Cannabinoid Receptor 2 (CB2) Reveal a Mechanism for Regulation of
Tumor Progression (download–2016) 
http://www.jbc.org/content/early/2016/02/03/jbc.M115.712661.long
Cannabinoids – a new weapon against cancer? (click “Full Text Links” for download-2016) https://www.ncbi.nlm.nih.gov/pubmed/28100841
Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine

Receptor and Cannabinoid Receptor 2 (CB2) Reveal a Mechanism for Regulation of
Tumor Progression (download–2016)  http://www.jbc.org/content/early/2016/02/03/jbc.M115.712661.long
Using Medical Cannabis in an Oncology Practice (article–2016)  http://www.cancernetwork.com/oncology-journal/using-medical-cannabis-oncology-practice#sthash.CjT8fR9n.uWvEhfSG.dpuf
Cannabis and Cannabinoids (1st page–2016) http://jamanetwork.com/journals/jama/article-abstract/2592497
Cannabinoid pharmacology in cancer research: A new hope for cancer patients?  (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26852955
Ligands for cannabinoid receptors, promising anticancer agents (abst–2016) http://www.sciencedirect.com/science/article/pii/S0024320515301521

Role of the lysophosphatidylinositol/GPR55 axis in cancer (abst–2016) http://www.sciencedirect.com/science/article/pii/S2212492615300105
Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome (abst–2016) http://link.springer.com/article/10.1007%2Fs40262-015-0363-2
Antitumorigenic targets of cannabinoids – current status and implications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27070944
Delineating the molecular mechanisms of tamoxifen’s oncolytic actions in estrogen receptor-negative cancers (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27083550
The Use of Medical Marijuana in Cancer (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215434
Phytochemicals as adjunctive with conventional anticancer therapies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262332
Pediatric oncology providers and use of medical marijuana in children with cancer (abst–2016) http://meetinglibrary.asco.org/content/170798-176
Endocannabionoid System in Neurological Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27364363
Cannabinoids for Symptom Management and Cancer Therapy: The Evidence (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27407130
Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: A survey of preferences, attitudes and beliefs among patients willing to consider participation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27530738
Overlapping molecular pathways between cannabinoid receptors type 1 and 2 and estrogens/androgens on the periphery and their involvement in the pathogenesis of common diseases (Review) (abst–2016) https://www.spandidos-publications.com/10.3892/ijmm.2016.2779
Bioactive spirans and other constituents from the leaves of Cannabis sativa f. sativa (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27848262
State of the evidence: Cannabinoids and cancer pain-A systematic review (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27863159
Cannabis and Cannabinoids (PDQ®): Patient Version (full–2017)
https://www.ncbi.nlm.nih.gov/books/NBK65875/
Cannabis and Cannabinoids (PDQ®): Health Professional Version (full–2017)
https://www.ncbi.nlm.nih.gov/books/NBK65755/
Pain and Opioids in Cancer Care: Benefits, Risks, and Alternatives (full–2017)
http://meetinglibrary.asco.org/record/140727/edbook#fulltext
Polyunsaturated Fatty Acids Differentially Modulate Cell Proliferation and
Endocannabinoid System in Two Human Cancer Lines (full–2017)
http://www.arcmedres.com/article/S0188-4409(17)30026-7/fulltext
Recent advances in understanding and managing cancer pain (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482325/
Targeting cannabinoid receptors in gastrointestinal cancers for therapeutic uses: current status and future perspectives (full–2017)
http://www.tandfonline.com/doi/full/10.1080/17474124.2017.1367663
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and
Relevant Animal Studies (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/
A Guide to the National Academy of Science Report on Cannabis: An Exclusive
Discussion with Panel Members (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569624/
Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use (full–2017)  http://onlinelibrary.wiley.com/doi/10.1002/cncr.30879/full
Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434502/
Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation and Pain (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628559/
Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674070/
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges (full–2017)  https://www.frontiersin.org/articles/10.3389/fimmu.2017.01487/full
Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 ReceptorIndependent Mechanisms (full–2017)
https://www.frontiersin.org/articles/10.3389/fphar.2017.00720/full
A selective review of medical cannabis in cancer pain management (link to download–2017) http://apm.amegroups.com/article/view/16199/16359

Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications  (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4043
The Role of Cannabinoids in the Treatment of Cancer in Pediatric Patients (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4044
Medical Cannabis in the Palliation of Malignant Wounds—A Case Report (article–2017)  http://www.jpsmjournal.com/article/S0885-3924(16)30328-1/abstract
Cannabis Guidelines (article–2017) https://cjon.ons.org/cjon/21/4/cannabis-guidelines
Experts’ Perspectives on the Role of Medical Marijuana in Oncology: a semi-structured interview study (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28040884
Cannabidiol: State of the art and new challenges for therapeutic applications (abst–2017) http://www.sciencedirect.com/science/article/pii/S0163725817300657
Cannabinoids as Modulators of Cell Death: Clinical Applications and Future Directions  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28425013
Gαs signalling of the CB1 receptor and the influence of receptor number (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28516479
Analysis of Natural Product Regulation of Cannabinoid Receptors in the treatment of
Human Disease (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0163725817301511
A Review of the Therapeutic Antitumor Potential of Cannabinoids (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28799775
Cannabinoids as Anticancer Drugs (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28826542
Cannabidiol, a novel inverse agonist for GPR12 (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28888984
Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols
Oromucosal Spray as Adjunctive Therapy in Advanced Cancer Patients With Chronic
Uncontrolled Pain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28923526
Synergistic interaction of the cannabinoid and death receptor systems: A potential target for future cancer therapies? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28948607
Cannabis and Cannabinoids for Chronic Pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28983880
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017) (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29053063
Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor Independent Mechanisms (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29066974
The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29061818
Current evidence of cannabinoid-based analgesia obtained in preclinical and human
experimental settings (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29160600
Are cannabinoids an alternative for cachexia-anorexia syndrome in patients with
advanced cancer? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29286357
The current state and future perspectives of cannabinoids in cancer biology (full–2018) http://onlinelibrary.wiley.com/doi/10.1002/cam4.1312/full
Anti-invasion Effects of Cannabinoids Agonist and Antagonist on Human Breast Cancer Stem Cells (full–2018)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843309/

Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases (full–2018)
https://www.dovepress.com/pharmacotherapeutic-considerations-for-use-of-cannabinoids-to-relieve–peer-reviewed-fulltext-articleJPR
Enhancing the Therapeutic Efficacy of Cancer Treatment With Cannabinoids (full–2018) https://www.frontiersin.org/articles/10.3389/fonc.2018.00114/full
Rates of cannabis use in patients with cancer (full–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023560/
Cannabis for the Management of Cancer Symptoms: THC Version 2.0? (full–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961457/
State Prevalence and Ranks of Adolescent Substance Use: Implications for Cancer
Prevention (full–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985915/
Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896684/
Irinotecan and Δ-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary
Evaluation Using Biochemical and Genotoxicity Markers (full–2018) 
http://www.mdpi.com/1420-3049/23/6/1332/htm
Therapeutic Cannabis and Endocannabinoid Signaling System Modulator Use in
Otolaryngology Patients (full-2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057224/
Evidence for THC versus CBD in cannabinoids (full-2018)
http://www.cfp.ca/content/64/7/519.long
Medical Cannabis: The Oncology Nurse’s Role in Patient Education About the Effects of Marijuana on Cancer Palliation (full–2018) https://cjon.ons.org/cjon/22/1/medical-cannabis-oncology-nurse-s-role-patient-education-about-effects-marijuana-cancer

Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer (full–2018) https://www.frontiersin.org/articles/10.3389/fphar.2018.00889/full

The role of cannabinoids in pain control: the good, the bad, and the ugly (full–2018) https://www.minervamedica.it/en/journals/minervaanestesiologica/article.php?cod=R02Y2018N08A0955&html=1&htmlID=20H%2FJ%2FzJfllWbTQgG%2Bvg0sefo5GdruhwhCHuDxoDpD61KdeBk12dKITvfl98aZhJ6Y75DlKXV6PoFp9GqFlPuQ%3D%3D

Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression (full–2018) https://www.nature.com/articles/s41467-018-04999-8

Oncology Clinicians and the Minnesota Medical Cannabis Program: A Survey on Medical Cannabis Practice Patterns, Barriers to Enrollment, and Educational Needs (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225592/

Chromatographic Analyses, In Vitro Biological Activities, and Cytotoxicity of Cannabis sativa L. Essential Oil: A Multidisciplinary Study (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320915/

Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304621/

Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol (full–2018) http://ar.iiarjournals.org/content/38/10/5831.long

Medical Cannabis for Older Patients (link to PDF–2018) https://www.researchgate.net/publication/329275718_Medical_Cannabis_for_Older_Patients

Cannabinoids in cancer treatment: Therapeutic potential and legislation (link to PDF–2018) https://www.bjbms.org/ojs/index.php/bjbms/article/view/3532

Medical cannabis in the treatment of cancer pain and spastic conditions and options of drug delivery in clinical practice (link to PDF–2018) http://biomed.papers.upol.cz/artkey/bio-201801-

0003_medical_cannabis_in_the_treatment_of_cancer_pain_and_spastic_conditions_and_options_of_drug_delivery_in_clinica.php

Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis (link to PDF–2018) https://www.researchgate.net/publication/323158392_Cannabinoidinduced_cell_death_in_endometrial_cancer_cells_involvement_of_TRPV1_receptors_in_apoptosis
Practical considerations in medical cannabis administration and dosing (link to PDF–2018) https://www.researchgate.net/publication/322257368_Practical_considerations_in_medical_cannabis_administration_and_dosing
Cannabis and Anti-Cancer Drugs: Societal Usage and Expected Pharmacological
Interactions – A Review (download-2018) http://www.ch-thuir.fr/sites/default/files/Bouqui-_et_al-2018-Fundamental_%26_Clinical_Pharmacology.pdf
Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer (Israel) (click “researchgate” for download–2018) https://scholar.google.com/scholar?cluster=325327779336056220&hl=en&as_sdt=0,5

Cannabinoids in Patients with Nausea and Vomiting Associated with Malignancy and Its Treatments (1st page–2018) https://www.amjmed.com/article/S0002-9343(18)30033-0/fulltext

Targeting the endocannabinoid system as a potential anticancer approach (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29390896

INSIGHT ON THE IMPACT OF ENDOCANNABINOID SYSTEM IN CANCER: A REVIEW (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29663308

Mechanisms underlying the effects of n-3 polyunsaturated fatty acids on fear memory processing and their hypothetical effects on fear of cancer recurrence in cancer survivors (abst–2018) https://www.plefa.com/article/S0952-3278(17)30303-4/fulltext
Nutraceutical potential of hemp (Cannabis sativa L.) seeds and sprouts (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0308814618307180?via%3Dihub
Medical Oncologists’ Beliefs, Practices, and Knowledge Regarding Marijuana Used
Therapeutically: A Nationally Representative Survey Study (abst–2018)
http://ascopubs.org/doi/abs/10.1200/JCO.2017.76.1221?url_ver=Z39.88-
2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&
Is Cannabidiol a Promising Substance for New Drug Development? A Review of its
Potential Therapeutic Applications (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29773016
Effect of endocannabinoid signalling on cell fate: life, death, differentiation and proliferation of brain cells (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29797438
The tamoxifen derivative ridaifen-B is a high affinity selective CB2 receptor inverse
agonist exhibiting anti-inflammatory and anti-osteoclastogenic effects (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0041008X18302679
Appraising the “entourage effect”: antitumor action of a pure cannabinoid versus a
botanical drug preparation in preclinical models of breast cancer (abst–2018)
https://www.sciencedirect.com/science/article/abs/pii/S0006295218302387
GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and
interaction with cannabidiol (abst–2018)
https://www.nature.com/articles/s41401-018-0031-9
Development of thiazole-5-carboxylate derivatives as selective inhibition of monoacylglycerol lipase as a target in Cancer (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29962341
Anti-tumoural actions of cannabinoids (abst–2018) https://www.semanticscholar.org/paper/Anti-tumour-actions-of-cannabinoids.-HinzRamer/c54ed10f33da4b4a9cc540e7171bfb8de6594a00
Therapeutic applications of cannabinoids (abst–2018) https://www.sciencedirect.com/science/article/pii/S0009279718307373?via%3Dihub
Chronic pain and cannabinoids. Great expectations or a christmas carol (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303010

Monoacylglycerol lipase (MAGL) as a promising therapeutic target (abst–2018)
https://www.sciencedirect.com/science/article/abs/pii/S0006295218303046

Medical Marijuana Use in a Community Cancer Center (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30205775

Stilbenoids and cannabinoids from the leaves of Cannabis sativa f. sativa with potential reverse cholesterol transport activity (abst–2018) https://pubs.rsc.org/en/Content/ArticleLanding/2018/FO/C8FO01896K#!divAbstract

Cannabis-related cognitive impairment: a prospective evaluation of possible influences on patients with cancer during chemotherapy treatment as a pilot study (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30540595

Medical Marijuana in Cancer Treatment: No Standards of Care, and So Far, No Coverage (abst–2018) https://www.ajmc.com/journals/evidence-based-oncology/2018/october-2018/medical-marijuana-in-cancer-treatment-no-standards-ofcare-and-so-far-no-coverage

2019 Cannabis and Cannabinoids (PDQ®) Patient Version (full–2019) https://www.ncbi.nlm.nih.gov/books/NBK65875/

Health-related quality of life across cancer cachexia stages (full–2019) http://apm.amegroups.com/article/view/21116/22353

An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine (full–2019) https://link.springer.com/article/10.1007%2Fs40122-019-0114-4

Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Review of the Evidence (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406915/

Dronabinol for the Treatment of Paraneoplastic Night Sweats in Cancer Patients: A Report of Five Cases (full–2019) https://www.liebertpub.com/doi/full/10.1089/jpm.2018.0551?url_ver=Z39.88-2003&rfr_id=ori:rid

Spontaneous, anecdotal, retrospective, open-label study on the efficacy, safety and tolerability of cannabis galenical preparation (Bedrocan) (full–2019) https://onlinelibrary.wiley.com/doi/full/10.1111/ijpp.12514

Relationship of Cannabis Use to Patient-Reported Symptoms in Cancer Patients Seeking Supportive/Palliative Care (full–2019) https://www.liebertpub.com/doi/full/10.1089/jpm.2018.0533?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed

Patterns of Medical Cannabis Use among Cancer Patients from a Medical Cannabis Dispensary in New York State (full–2019) https://www.liebertpub.com/doi/full/10.1089/jpm.2018.0529?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed

The role of cancer in marijuana and prescription opioid use in the United States: A population-based analysis from 2005 to 2014 (full–2019) https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.32059

The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet? (full–2019) https://www.frontiersin.org/articles/10.3389/fphar.2019.00339/full
Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study (full–2019) https://www.cambridge.org/core/journals/palliative-and-supportive-care/article/cannabis-treatment-in-hospitalized-patients-using-thesyqe-inhaler-results-of-a-pilot-openlabel-study/0C1940413E704A7EADCB949F5F49603A/core-reader

Medical Cannabis Certification in a Large Pediatric Oncology Center (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617193/

The heterogeneity and complexity of Cannabis extracts as antitumor agents (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609248/
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice (full–2019) https://www.ebiomedicine.com/article/S2352-3964(19)30356-1/fulltext
Modulation of the Endocannabinoid System as a Potential Anticancer Strategy (full–2019) https://www.frontiersin.org/articles/10.3389/fphar.2019.00430/full
Medical Cannabinoids for Cancer Cachexia: A Systematic Review and Meta-Analysis (full–2019) https://www.hindawi.com/journals/bmri/2019/2864384/
Why medical cannabis is still out of patients’ reach-an essay by David Nutt. (U.K.) (click “psprings” for download–2019) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Why+medical+cannabis+is+still+out+of+patients%27+reachan+essay+by+David+Nutt.&btnG
Should Oncologists Recommend Cannabis? (article–2019) https://link.springer.com/article/10.1007%2Fs11864-019-0659-9
Strong reasons make strong actions: medical cannabis and cancer—a call for collective action (article–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588059/
Cannabis and cannabinoids in palliative care. (Germany) (abst in English & German–2019) https://link.springer.com/article/10.1007%2Fs00103-019-02967-1
Efficacy and safety of medicinal cannabis: results of the CaPRis study. (Germany) (abst in English & German–2019) https://link.springer.com/article/10.1007%2Fs00103-019-02965-3
Cannabis for cancer – illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30572744
A Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety (abst–2019) https://link.springer.com/article/10.1007%2Fs11912-019-0757-7
Cannabinoids: a new approach for pain control? (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30789867
Impact of Medical Cannabis on Patient-Reported Symptoms for Patients With Cancer Enrolled in Minnesota’s Medical Cannabis Program (abst–2019) https://ascopubs.org/doi/abs/10.1200/JOP.18.00562?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=jop
What cancer patients actually know regarding medical cannabis? A cross-sectional survey with a critical analysis of the current attitudes. (Italy) (abst–2019) https://journals.sagepub.com/doi/abs/10.1177/1078155219843161?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=oppa
Using Cannabis to Treat Cancer-Related Pain (abst–2019) https://www.sciencedirect.com/science/article/pii/S0749208119300609?via%3Dihub
Pharmacological evidence of medicinal cannabis in oncology: a systematic review (abst–2019) https://link.springer.com/article/10.1007%2Fs00520-019-04774-5
Predicting Physicians’ Intentions to Recommend Medical Cannabis (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31145978
New approaches to cancer therapy: combining Fatty Acid Amide Hydrolase (FAAH) inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) activation (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31407888
Opportunities for cannabis in supportive care in cancer (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31413731
Medical marijuana use for pediatric oncology patients: single institution experience (Israel) (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31424297


CANNABINOID HYPEREMESIS SYNDROME +
Cyclic Vomiting Presentations Following Marijuana Liberalization in Colorado (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469074/
Cannabinoid Hyperemesis Syndrome: Descriptive Overview of an Under-Recognized Diagnosis (full–2015) http://www.ima.org.il/FilesUpload/IMAJ/0/146/73215.pdf
Cannabinoid hyperemesis syndrome: Marijuana is both antiemetic and proemetic (full–2015) http://www.ccjm.org/index.php?id=107953&tx_ttnews%5Btt_news%5D=412809&cHash=0c1f8670f2fa499ee88aeff79ee2a47e
Cannabinoid Hyperemesis Syndrome: A Paradoxical Cannabis Effect (full–2015) http://www.hindawi.com/journals/crigm/2015/405238/
top

13-Year-Old Girl With Recurrent, Episodic, Persistent Vomiting: Out of the Pot and Into the Fire (full–2015)  http://pediatrics.aappublications.org/content/135/4/e1060.long
Cannabinoid Hyperemesis Syndrome: A Case Report and Literature Review (full–2015) http://www.joms.org/article/S0278-2391(15)00352-3/fulltext
Novel case of synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure (1st page–2015) http://www.ajemjournal.com/article/S0735-6757%2815%2900743-3/abstract
Cannabinoid Hyperemesis Syndrome? Bring on the Hot Sauce (article–2015)  http://journals.lww.com/em-news/blog/BreakingNews/Pages/post.aspx?PostID=183
A non-classical cannabinoid syndrome (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25567676
Cannabinoid Hyperemesis Syndrome Associated With Compulsive Showering and Acute Kidney Injury (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874760/
Cannabinoid hyperemesis syndrome as an unusual cause of cyclic vomiting (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919975/

Hypophosphatemia in Users of Cannabis (full–2016)  http://www.ajkd.org/article/S0272-6386(16)30414-0/fulltext
Cannabinoid hyperemesis syndrome and the onset of a manic episode (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854155/
Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a
Systematic Review (full–2016) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330965/
Cannabinoid Hyperemesis Syndrome: A Case Report of Cyclic Severe Hyperemesis and Abdominal Pain with Long-Term Cannabis Use (full–2016) https://www.hindawi.com/journals/crigm/2016/2815901/

Successful Treatment of Suspected Cannabinoid Hyperemesis Syndrome Using  Haloperidol in the Outpatient Setting (link to full–2016)  https://www.hindawi.com/journals/crips/2016/3614053/
An Overlooked Victim of Cannabis: Losing Several Years of Well-being and Inches of  Jejunum on the Way to Unravel Her Hyperemesis Enigma (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26757305
Cannabinoid hyperemesis syndrome masquerading as an eating disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26842268
Cannabis Hyperemesis Syndrome in the Emergency Department: How Can a Specialized Addiction Team Be Useful? A Pilot Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27485997
Novel Treatments for Cyclic Vomiting Syndrome: Beyond Ondansetron and Amitriptyline (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27757817
Synthetic cannabinoids in the kidneys (full–2017) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302017000100010&lng=en&nrm=iso&tlng=en
Cannabinoid hyperemesis and the cyclic vomiting syndrome in adults: recognition,  diagnosis, acute and long-term treatment (full–2017)  http://www.egms.de/static/en/journals/gms/2017-15/000247.shtml
Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic  nervous system? (full–2017) http://www.medical-hypotheses.com/article/S0306-9877(17)30134-2/fulltext
Running Out of Options: Rhabdomyolysis Associated with Cannabis Hyperemesis
Syndrome (full–2017) 
https://link.springer.com/article/10.1007%2Fs11606-017-4111-1
Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents: 
A Case Series (link to download–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29122973
Cannabinoid hyperemesis syndrome: a report of two cases (click “Full Text Links” for download–2017) https://www.ncbi.nlm.nih.gov/pubmed/28186319
Perspectives in the treatment for cannabinoid hyperemesis syndrome (link to PDF-2017)  http://www.adicciones.es/index.php/adicciones/article/view/875
Pharmacologic Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28370228
Diagnosis of cannabinoid hyperemesis : update on the cannabis-shower syndrome (abst in English & French–2017) https://www.ncbi.nlm.nih.gov/pubmed/28387093 (link to full in French) https://www.rmlg.ulg.ac.be/aboel.php?num_id=2847&langue=EN
Role of cannabis in digestive disorders (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/27792038
Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency  department: a case series (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/15563650.2017.1324166?journalCode=ictx20
Effects of the 2009 Medical Cannabinoid Legalization Policy on Hospital Use for  Cannabinoid Dependency and Persistent Vomiting (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28711691
Capsaicin topical in emergency department treatment of cannabinoid hyperemesis  syndrome (abst–2017) http://www.ajemjournal.com/article/S0735-6757(17)30488-6/fulltext
A case of cannabinoid hyperemesis syndrome with heliobacter pylori and pre-eclampsia during pregnancy (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28723278
Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/15563650.2017.1349910?journalCode=ictx20
Cannabinoid hyperemesis syndrome presentation to the emergency department: A two year multicentre retrospective chart review in a major urban area (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28835305
Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28953512
Emergency Department Burden of Nausea and Vomiting Associated With Cannabis Use Disorder: US Trends From 2006 to 2013 (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29095419
Cannabinoid hyperemesis syndrome: Review of the literature and of cases reported to the French addictovigilance network (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30533-1/fulltext
Cannabinoid Hyperemesis Syndrome: Public Health Implications and a Novel Model
Treatment Guideline (full–2018) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851514/
Successful Treatment of Cannabinoid Hyperemesis Syndrome with Topical Capsaicin (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758720/
Cannabinoid Hyperemesis Syndrome Masquerading as Uremia: An Educational Case Report (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109838/
Cannabinoid hyperemesis syndrome: A case report (full–2018) http://www.asianjournalofpsychiatry.com/article/S1876-2018(18)30241-7/fulltext
Coronary vasospasm complicating cannabinoid hyperemesis syndrome (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135018/
Epidemiology, Clinical Characteristics, and Associations for Rome IV Functional Nausea and Vomiting Disorders in Adults (link to PDF–2018) https://scholar.google.com/scholar?q=Epidemiology,+Clinical+Characteristics,+and+Associations+for+Rome+IV+Functional+Nausea+and+Vomiting+Disorders+in+Adults&hl=en&as_sdt=0&as_vis=1&oi=scholart
Cannabinoid Hyperemesis Syndrome: A Case Report of a Confounding Entity in Oncology Care (1st page–2018) http://ascopubs.org/doi/full/10.1200/JOP.17.00106
A Lot of Hot Steam: the Cannabinoid Hyperemesis Syndrome (Germany) (abst in English & German–2018) https://www.thieme-connect.com/DOI/DOI?10.1055/a-0599-9317
Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29310960
Cannabinoid Hyperemesis Syndrome and the Consulting Psychiatrist: A Case Study of Diagnosis and Treatment for an Emerging Disorder in Psychiatric Practice (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29320384
The Prevalence of Cannabinoid Hyperemesis Syndrome Among Regular Marijuana Smokers in an Urban Public Hospital (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29327809
Cyclic vomiting syndrome: a case series and review of the literature (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29484154
Cannabinoids and gastrointestinal motility: Pharmacology, clinical effects, and potential therapeutics in humans (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29745439
Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29768651
Points & Pearls: Cannabinoids: emerging evidence in use and abuse (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30070813
Conditioned gaping produced by high dose Δ9-tetrahydracannabinol: Dysregulation of the hypothalamic endocannabinoid system (abst–2018) https://www.sciencedirect.com/science/article/pii/S0028390818305987?via%3Dihub
Recent Trends in Cyclic Vomiting Syndrome – Associated Hospitalizations with Liberalization of Cannabis Use in the State of Colorado (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30426628
Emergency Department and Radiological Cost of Delayed Diagnosis of Cannabinoid Hyperemesis (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339733/
Pneumomediastinum in marijuana users: a retrospective review of 14 cases (full–2019) https://bmjopenrespres.bmj.com/content/6/1/e000391
Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome (full–2019) https://onlinelibrary.wiley.com/doi/full/10.1111/nmo.13606
Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic Disorders (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507278/
Hair cannabinoid concentrations in emergency patients with cannabis hyperemesis syndrome (abst in English & French–2019) https://www.cambridge.org/core/journals/canadian-journal-of-emergency-medicine/article/hair-cannabinoidconcentrations-in-emergency-patients-with-cannabis-hyperemesissyndrome/F7A3A1ED2C53EE489564905C678A712C
Cannabinoid toxicity in pediatrics (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30694824
The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30729854
Acute Illness Associated With Cannabis Use, by Route of Exposure: An Observational Study (abst–2019) https://annals.org/aim/article-abstract/2729208/acute-illness-associated-cannabis-use-route-exposure-observationalstudy?doi=10.7326%2fM18-2809
Emergency Department Visits From Edible Versus Inhalable Cannabis (abst–2019) https://annals.org/aim/article-abstract/2729210/emergency-department-visits-from-edible-versus-inhalablecannabis?doi=10.7326%2fM19-0542
Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30913155
Cannabis Hyperemesis Syndrome in Palliative Care: A Case Study and Narrative Review (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31084461
Patterns of Cannabis Use In Patients With Cyclic Vomiting Syndrome (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31352091
Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31403013


CARPAL TUNNEL SYNDROME+
Comparison of shock wave therapy and nutraceutical composed of Echinacea angustifolia, alpha lipoic acid, conjugated linoleic acid and quercetin (perinerv) in patients with carpal tunnel syndrome (full–2015) http://iji.sagepub.com/content/early/2015/04/30/0394632015584501.long
Notes from the Field: Occupational Hazards Associated with Harvesting and Processing Cannabis — Washington, 2015–2016 (full–2018)
https://www.cdc.gov/mmwr/volumes/67/wr/mm6708a7.htm?s_cid=mm6708a7_w


CATALEPSY
CB1 cannabinoid receptor-mediated anandamide signalling mechanisms of the inferior colliculus modulate the haloperidol-induced catalepsy (abst–2016) https://www.sciencedirect.com/science/article/abs/pii/S0306452216304201
GPR55: A therapeutic target for Parkinson’s disease? (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817303842
Repeated Exposure to the “Spice” Cannabinoid JWH-018 Induces Tolerance and
Enhances Responsiveness to 5-HT1A Receptor Stimulation in Male Rats (full–2018)

https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00055/full
Pharmacodynamic effects, pharmacokinetics, and metabolism of the synthetic cannabinoid AM-2201 in male rats (click “aspetjournals” for download–2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Pharmacodynamic+effects%2C+pharmacokinetics%2C+and+metabolism+of+the+synthetic+cannabinoid+AM-2201+in+male+rats&btnG


CATATONIA
Catatonia and Cannabis Withdrawal: a case report (link to PDF–2015) https://www.researchgate.net/publication/280870215_Catatonia_and_Cannabis_Withdrawal_a_case_report
Catatonia secondary to synthetic cannabinoid use in two patients with no previous psychosis (abst–2016) http://onlinelibrary.wiley.com/doi/10.1111/ajad.12318/full


CELIAC DISEASE+
Genetic Variant Q63R of Cannabinoid Receptor 2 (CB2R) Causes Differential ERK
Phosphorylation in Human Immune Cells (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29694791
Patterns of Marijuana Use Among Patients With Celiac Disease in the United States: A Population-based Analysis of the NHANES Survey (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31339867


CEREBRAL PALSY
Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders (abst–2018) http://journals.sagepub.com/doi/abs/10.1177/0883073818773028?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
top


CHAGAS DISEASE/AMERICAN TRYPANOSOMIASIS
Immunoregulatory Role of Cannabinoids during Infectious Disease (full–2017)
https://www.karger.com/Article/FullText/481824


CHEMICAL COMPOSITION*+
Levels of selected metals in leaves of Cannabis sativa L. cultivated in Ethiopia (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503701/
Minor oxygenated cannabinoids from high potency Cannabis sativa L (full–2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883105/

Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol (full–2015) http://file.scirp.org/Html/5-2500582_53912.htm
Cannabinoids Production by Hairy Root Cultures of Cannabis sativa L (full–2015) http://file.scirp.org/Html/21-2601738_58491.htm
Method for the Analysis of Cannabinoids and Terpenes in Cannabis (download–2015) https://www.researchgate.net/publication/286639823_Method_for_the_Analysis_of_Cannabinoids_and_Terpenes_in_Cannabis
Sequence heterogeneity of cannabidiolic- and tetrahydrocannabinolic acid-synthase in Cannabis sativa L. and its relationship with chemical phenotype (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25865737
Seized cannabis seeds cultivated in greenhouse: A chemical study by gas chromatography–mass spectrometry and chemometric analysis (full–2015)
http://www.scienceandjusticejournal.com/article/S1355-0306%2815%2900111-2/fulltext
Effect of induced polyploidy on some biochemical parameters in Cannabis sativa L (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25492688
Evaluation of elemental profiling methods, including laser-induced breakdown spectroscopy (LIBS), for the differentiation of Cannabis plant material grown in different nutrient solutions (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25898182
top

(1)H NMR and HPLC/DAD for Cannabis sativa L chemotype distinction, extract profiling and specification (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26048837
Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26151582
Determination of the relative percentage distribution of THCA and Δ9-THC in herbal cannabis seized in Austria – Impact of different storage temperatures on stability (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26247127
Cannabis and Endocannabinoid Signaling in Epilepsy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408165
Expression, purification and crystallization of a plant polyketide cyclase from Cannabis sativa (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666474/
Determination of 11 Cannabinoids in Biomass and Extracts of Different Varieties of Cannabis Using High-Performance Liquid Chromatography (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26651563
Size matters: evolution of large drug-secreting resin glands in elite pharmaceutical strains of Cannabis sativa (marijuana) (abst–2015) http://link.springer.com/article/10.1007/s10722-015-0254-2
Biotransformation of Tetrahydrocannabinol (abst–2015) http://link.springer.com/article/10.1007/s11101-015-9438-9
Evolution and Classification of Cannabis sativa (Marijuana, Hemp) in Relation to Human Utilization (abst–2015) http://link.springer.com/article/10.1007/s12229-015-9157-3
Expansion of female sex organs in response to prolonged virginity in Cannabis sativa (marijuana) (abst–2015) http://www.agr.gc.ca/eng/abstract/?id=35387000000564
Effect-directed analysis of cold-pressed hemp, flax and canola seed oils by planar
chromatography linked with (bio)assays and mass spectrometry (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0308814615005890
Cannabinoids for pediatric epilepsy? Up in smoke or real science? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729003/
Harvesting the biosynthetic machineries that cultivate a variety of indispensable plant natural products (full–2016) http://www.sciencedirect.com/science/article/pii/S1367593116000041
Cannabis sativa: The Plant of the Thousand and One Molecules (full–2016) http://journal.frontiersin.org/article/10.3389/fpls.2016.00019/full
Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid (full–2016) http://online.liebertpub.com/doi/10.1089/can.2015.0004
Variability in Seed Traits in a Collection of Cannabis sativa L. Genotypes (full-2016) http://journal.frontiersin.org/article/10.3389/fpls.2016.00688/full
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00309/full
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032490/
A Belated Green Revolution for Cannabis: Virtual Genetic Resources to Fast-Track Cultivar Development (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965456/
Analysis of a commerical marijuana e-cigarette formulation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867395/
Monitoring Metabolite Profiles of Cannabis sativa L. Trichomes during Flowering Period Using 1H NMR-Based Metabolomics and Real-Time PCR (full–2016)  https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0042-108058
The Name of Cannabis: A Short Guide for Nonbotanists (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531363/
Transcriptome differences between fiber-type and seed-type Cannabis sativa variety
exposed to salinity (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120038/
Compromised External Validity: Federally Produced Cannabis Does Not Reflect Legal
Markets (link to PDF–2016) http://biorxiv.org/content/early/2016/10/26/083444
Structural basis for olivetolic acid formation by a polyketide cyclase from Cannabis sativa (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26783002
The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo,
MD (interview–2016) 
https://www.liebertpub.com/doi/full/10.1089/can.2015.29003.ebr
Changes in cannabis potency over the last two decades (1995-2014) – Analysis of current data in the United States (abst–2016) http://www.sciencedirect.com/science/article/pii/S0006322316000457

Chapter 2 – Biosynthesis and Pharmacology of Phytocannabinoids and Related Chemical Constituents (abst–2016) http://www.sciencedirect.com/science/article/pii/B9780128046463000023
Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jnatprod.5b00949
The influences of cultivation setting on inflorescence lipid distributions, concentrations, and carbon isotope ratios of Cannabis sp. (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27045381
In Vitro Propagation of Cannabis sativa L. and Evaluation of Regenerated Plants for Genetic Fidelity and Cannabinoids Content for Quality Assurance (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27108324
Seed composition of ten industrial hemp cultivars approved for production in Canada (abst–2016) http://www.sciencedirect.com/science/article/pii/S088915751400194X
Seeing through the smoke: human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415303638
Near infrared spectroscopy combined with chemometrics for growth stage classification of cannabis cultivated in a greenhouse from seized seeds (abst–2016) http://www.sciencedirect.com/science/article/pii/S1386142516305583
Effects of Marijuana on ictal and interictal EEG activity in idiopathic generalized epilepsy (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27763968
Bioactive spirans and other constituents from the leaves of Cannabis sativa f. sativa (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27848262
A study of cannabis potency in France over a 25 years period (1992-2016) (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28122324
Polyphenolic Compounds and Antioxidant Activity of Cold-Pressed Seed Oil from Finola Cultivar of Cannabis sativa L. (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27076277
Quality Control of Traditional Cannabis Tinctures: Pattern, Markers, and Stability  (full–2017) http://www.mdpi.com/2218-0532/84/3/567/htm
Determination of delta-9-tetrahydrocannabinol content of cannabis seizures in Egypt  (full–2017) http://www.sciencedirect.com/science/article/pii/S1995764516304266
In silico discovery of terpenoid metabolism in Cannabis sativa (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482328/
Training and Practices of Cannabis Dispensary Staff (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531366/
Even High Doses of Oral Cannabidol Do Not Cause THC-Like Effects in Humans:
Comment on Merrick et al. Cannabis and Cannabinoid Research 2016;1(1):102–112;
DOI: 10.1089/can.2015.0004 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531368/
Conversion of Cannabidiol Following Oral Administration: Authors’ Response to
Grotenhermen et al. DOI: 10.1089/can.2016.0036 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569618/
A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510776/
Identification of Terpenoid Chemotypes Among High (−)-trans-Δ9-
Tetrahydrocannabinol-Producing Cannabis sativa L. Cultivars (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436332/
Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435777/
Terpene synthases from Cannabis sativa (full–2017)  http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0173911
Broad-Scale Genetic Diversity of Cannabis for Forensic Applications (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5249207/
Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation and Pain (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628559/
Evaluation of long-term stability of cannabinoids in standardized preparations of
cannabis flowering tops and cannabis oil by ultra-high-performance liquid
chromatography tandem mass spectrometry (full–2017)  https://www.degruyter.com/view/j/cclm.ahead-of-print/cclm-2017-0758/cclm-2017-0758.xml
Cannabidiol Does Not Convert to Δ9-Tetrahydrocannabinol in an In Vivo Animal Model  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744690/
Psychoactive constituents of cannabis and their clinical implications: a systematic review (link to download–2017)  http://adicciones.es/index.php/adicciones/article/view/858/863
Evaluation of Cannabinoid and Terpenoid Content: Cannabis Flower Compared to Supercritical CO2 Concentrate (link to 1st page–2017) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0043-119361
Phytochemistry of Cannabis sativa L. (abst–2017)  http://link.springer.com/chapter/10.1007%2F978-3-319-45541-9_1
The Bibenzyl Canniprene Inhibits the Production of Pro-Inflammatory Eicosanoids and Selectively Accumulates in Some Cannabis sativa Strains (abst–2017)  http://pubs.acs.org/doi/abs/10.1021/acs.jnatprod.6b01126
Raman spectroscopy for the characterization of different fractions of hemp essential oil extracted at 130°C using steam distillation method (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1386142517302585?via%3Dihub
Recommendation to reconsider examining cannabis subtypes together due to opposing effects on brain, cognition and behavior (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28579491
Differentiation of Cannabis subspecies by THCA synthase gene analysis using RFLP  (abst–2017) http://www.jflmjournal.org/article/S1752-928X(17)30104-X/fulltext
Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads (abst–2017) http://www.sciencedirect.com/science/article/pii/S1054358917300273?via%3Dihub
A Metabolomic Approach Applied to a Liquid Chromatography Coupled to High Resolution Tandem Mass Spectrometry Method (HPLC-ESI-HRMS/MS): Towards the
Comprehensive Evaluation of the Chemical Composition of Cannabis Medicinal
Extracts (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28915313
Pharmacological Foundations of Cannabis Chemovars (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29161743
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics
studies of cannabidiolic acid (CBDA) (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0731708517322367?via%3Dihub
A natural product from Cannabis sativa subsp. sativa inhibits homeodomain-interacting protein kinase 2 (HIPK2), attenuating MPP+-induced apoptosis in human neuroblastoma SH-SY5Y cells (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0045206816303972
Determination of Acid and Neutral Cannabinoids in Extracts of Different Strains of
Cannabis sativa Using GC-FID (abst–2017) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0043-124088
The application of plant in vitro cultures in cannabinoid production (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29249063
Exploration of Potentially Bioactive Peptides Generated from the Enzymatic Hydrolysis of Hempseed Proteins (abst–2017) http://pubs.acs.org/doi/10.1021/acs.jafc.7b03590
The crop-residue of fiber hemp cv. Futura 75: from a waste product to a source of
botanical insecticides (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29105041
Cannabinomimetric Lipids: From Natural Extract to Artificial Synthesis (full–2018)  https://link.springer.com/article/10.1007%2Fs13659-017-0151-9
The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products (full-2018)
https://www.nature.com/articles/s41598-018-22755-2
Cannabis Essential Oil: A Preliminary Study for the Evaluation of the Brain Effects
(full–2018)
https://www.hindawi.com/journals/ecam/2018/1709182/
Quality Traits of “Cannabidiol Oils”: Cannabinoids Content, Terpene Fingerprint and
Oxidation Stability of European Commercially Available Preparations (full–2018)
http://www.mdpi.com/1420-3049/23/5/1230/htm
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort (full–2018) https://link.springer.com/article/10.1186/s10194-018-0862-2
Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian
Community (full–2018) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033872/
Inadequate Regulation Contributes to Mislabeled Online Cannabidiol Products (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024459/
Chemical Profiling of Medical Cannabis Extracts (full–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044620/
Accumulation of bioactive metabolites in cultivated medical Cannabis (full–2018)
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0201119
Chemometric Analysis of Cannabinoids: Chemotaxonomy and Domestication Syndrome (full–2018) https://www.nature.com/articles/s41598-018-31120-2
Acceptance of pharmaceutical cannabis substitution by cannabis using patients with schizophrenia (full–2018) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-018-0253-7
New Methods for the Comprehensive Analysis of Bioactive Compounds in Cannabis sativa L. (hemp) (full–2018) https://www.mdpi.com/1420-3049/23/10/2639/htm
Cannabis, from Plant to Pill (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177712/
Characterization of an acidic α-galactosidase from hemp (Cannabis sativa L.) seeds and its application in removal of raffinose family oligosaccharides (RFOs) (full–2018) https://ojs.ptbioch.edu.pl/index.php/abp/article/view/1535/1495
Cannabis and the Anxiety of Fragmentation-A Systems Approach for Finding an Anxiolytic Cannabis Chemotype (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204402/
Developmental Plasticity of the Major Alkyl Cannabinoid Chemotypes in a Diverse Cannabis Genetic Resource Collection (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206272/
Chemical fingerprinting of single glandular trichomes of Cannabis sativa by Coherent anti-Stokes Raman scattering (CARS) microscopy (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233497/
Chromatographic Analyses, In Vitro Biological Activities, and Cytotoxicity of Cannabis sativa L. Essential Oil: A Multidisciplinary Study (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320915/
Hemp (Cannabis sativa L.) Seed Phenylpropionamides Composition and Effects on Memory Dysfunction and Biomarkers of Neuroinflammation Induced by Lipopolysaccharide in Mice (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288804/
Comparative Study of Chemical, Biochemical Characteristic and ATR-FTIR Analysis of Seeds, Oil and Flour of the Edible Fedora Cultivar Hemp (Cannabis sativa L.) (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337080/
A Comparative Study on Hemp (Cannabis sativa) Essential Oil Extraction Using Traditional and Advanced Techniques (link to PDF–2018) https://www.researchgate.net/publication/301542632_A_Comparative_Study_on_Hemp_Cannabis_sativa_Essential_Oil_Extraction_Using_Traditional_and_Advanced_Techniques
Ultrasound-Assisted Extraction of Cannabinoids from Cannabis Sativa L. Optimized by Response Surface Methodology (link to PDF-2018) https://www.researchgate.net/publication/323158189_UltrasoundAssisted_Extraction_of_Cannabinoids_from_Cannabis_Sativa_L_Optimized_by_Response_Surface_Methodology_Extraction_of_cannabinoids
A physical and genetic map of Cannabis sativa identifies extensive rearrangement at the THC / CBD acid synthase locus (link to PDF-2018) https://genome.cshlp.org/content/early/2018/12/05/gr.242594.118.long
Consumer perceptions of strain differences in Cannabis aroma (link to download–2018) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0192247
CMA position against separate regulations for medical cannabis draws ire and insults (article–2018) http://www.cmaj.ca/content/190/18/E574.long
Caring for the Patient Who Uses Cannabinoids (1st page–2018) https://www.jopan.org/article/S1089-9472(18)30077-7/fulltext
Detection and Quantification of Cannabinoids in Extracts of Cannabis sativa Roots Using LC-MS/MS (1st page–2018) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0044-100798
Potency of Δ9 -Tetrahydrocannabinol and Other Cannabinoids in Cannabis in England in 2016: Implications for Public Health and Pharmacology (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29441730
Cannabis for Chronic Pain: Challenges and Considerations (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29637590
Nutraceutical potential of hemp (Cannabis sativa L.) seeds and sprouts (abst–2018) https://www.sciencedirect.com/science/article/pii/S0308814618307180?via%3Dihub

Elucidation of structure-function relationship of THCA and CBDA synthase from Cannabis sativa L. (abst–2018) https://www.sciencedirect.com/science/article/pii/S0168165618305698?via%3Dihub

Iodine-mediated cyclization of cannabigerol (CBG) expands the cannabinoid biological and chemical space (abst–2018) https://www.sciencedirect.com/science/article/pii/S0968089618310630?via%3Dihub

Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus (abst–2018) https://www.sciencedirect.com/science/article/pii/S0223523418306408?via%3Dihub

Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30152161

Determination of cannabinoids in oral fluid and urine of “light cannabis” consumers: a pilot study (abst–2018) https://www.degruyter.com/view/j/cclm.ahead-of-print/cclm-2018-0566/cclm-2018-0566.xml

Distribution of Lignin, Hemicellulose, and Arabinogalactan Protein in Hemp Phloem Fibers (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30175708

Stilbenoids and cannabinoids from the leaves of Cannabis sativa f. sativa with potential reverse cholesterol transport activity (abst–2018) https://pubs.rsc.org/en/Content/ArticleLanding/2018/FO/C8FO01896K#!divAbstract

Chemical Characterization of Leaves, Male and Female Flowers from Spontaneous Cannabis (Cannabis sativa L.) Growing in Hungary (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30548994

The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No “Strain,” No Gain (full–2019) https://www.frontiersin.org/articles/10.3389/fpls.2018.01969/full

Use of 13C-qNMR Spectroscopy for the Analysis of Non-Psychoactive Cannabinoids in Fibre-Type Cannabis sativa L. (Hemp) (full–2019) https://www.mdpi.com/1420-3049/24/6/1138/htm

Inner Workings: Genomics blazes a trail to improved cannabis cultivation (full–2019) https://www.pnas.org/content/116/18/8638.long

Cannabis used in US research differs genetically to the varieties people smoke (full–2019) https://www.nature.com/articles/d41586-019-01415-z

Terpenes in Cannabis sativa – From plant genome to humans (full–2019) https://www.sciencedirect.com/science/article/pii/S0168945219301190?via%3DihubImpact of N, P, K, and Humic Acid Supplementation on the Chemical Profile of Medical Cannabis (Cannabis sativa L) (full–2019) https://www.frontiersin.org/articles/10.3389/fpls.2019.00736/full

Polyploidization for the Genetic Improvement of Cannabis sativa (full–2019) https://www.frontiersin.org/articles/10.3389/fpls.2019.00476/full

The origins of cannabis smoking: Chemical residue evidence from the first millennium BCE in the Pamirs (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561734/

Contrasting Roles of Cannabidiol as an Insecticide and Rescuing Agent for Ethanol induced Death in the Tobacco Hornworm Manduca sexta (full–2019) https://www.nature.com/articles/s41598-019-47017-7

Complex Patterns of Cannabinoid Alkyl Side-Chain Inheritance in Cannabis (full–2019) https://www.nature.com/articles/s41598-019-47812-2

Gene Networks Underlying Cannabinoid and Terpenoid Accumulation in Cannabis (link to PDF–2019) http://www.plantphysiol.org/content/early/2019/05/28/pp.18.01506.long

The Terroir of Cannabis: Terpene Metabolomics as a Tool to Understand Cannabis sativa Selections (link to 1st page–2019) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-0915-2550

Analysis of Terpenes in Cannabis sativa L. Using GC/MS: Method Development, Validation, and Application (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30646402

Promoting cannabis products to pharmaceutical drugs (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30851400

Quantitative determination of CBD and THC and their acid precursors in confiscated cannabis samples by HPLC-DAD (abst–2019) https://www.sciencedirect.com/science/article/pii/S0379073819301318?via%3Dihub

Development of a new method for the analysis of cannabinoids in honey by means of high-performance liquid chromatography coupled with electrospray ionisation-tandem mass spectrometry detection (abst–2019) https://www.sciencedirect.com/science/article/pii/S0021967319302870?via%3Dihub

Changing landscape of cannabis: novel products, formulations, and methods of administration (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31071592

Effects of long term storage on secondary metabolite profiles of cannabis resin (abst–2019) https://www.sciencedirect.com/science/article/pii/S0379073819302191?via%3Dihub

Changes in the composition of cannabis from 2000-2017 in Denmark: Analysis of confiscated samples of cannabis resin (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31219274


CHEMICAL INTOLERANCE/CHEMICAL SENSITIVITY
Levels of oxylipins, endocannabinoids and related lipids in plasma before and after low level exposure to acrolein in healthy individuals and individuals with chemical  intolerance (abst–2017) http://www.plefa.com/article/S0952-3278(16)30153-3/fulltext


CHEMOTHERAPY*+
Cannabidiol protects against doxorubicin-induced cardiomyopathy by modulating mitochondrial function and biogenesis (full–2015) http://static.smallworldlabs.com/molmedcommunity/content/pdfstore/14_261_Hao.pdf
Coadministration of indomethacin and minocycline attenuates established paclitaxel induced neuropathic thermal hyperalgesia: Involvement of cannabinoid CB1 receptors (full–2015) http://www.nature.com/srep/2015/150618/srep10541/pdf/srep10541.pdf
Cannabis and Cannabinoids–for health professionals (PDQ®) (full–2015) http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all
Cannabinoids for Medical Use A Systematic Review and Meta-analysis (full–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338251&resultClick=24
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015)
http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
top

Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience (full–2015)
http://www.jpsmjournal.com/article/S0885-3924(14)00312-1/fulltext
CB1 Knockout Mice Unveil Sustained CB2-Mediated Anti-Allodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain (full–2015) http://molpharm.aspetjournals.org/content/88/1/64.long
Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009464.pub2/full
Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2. (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580018/
Controlled release tablet formulation containing natural δ9 tetrahydrocannabinol (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098422/
Marijuana, Reconsidered: Dr. Lester Grinspoon On 45 Years Of Cannabis Science (interview–2015) http://www.mintpressnews.com/MyMPN/marijuana-reconsidered-an-interview-with-doctor-lestergrinspoon/
Medical Marijuana: Is the Cart Before the Horse? (1st page–2015)  http://jama.jamanetwork.com/article.aspx?articleid=2338230
Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26058312
Peroxisome Proliferator-Activated Receptor-α Inhibition Protects Against Doxorubicin Induced Cardiotoxicity in Mice (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26082188
Endocannabinoid Mechanisms Influencing Nausea (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26638766
TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=9663&path%5B%5D=30267
Cannabis and cancer: toward a new understanding (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791146/
Integrating cannabis into clinical cancer care (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/
Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869612/
Spontaneous Cannabinoid Receptor 2 (CB2) Expression in the Cochlea of Adult Albino Rat and Its Up-Regulation after Cisplatin Treatment (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0161954
Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path%5B%5D=12721&path%5B%5D=40316
Anticancer mechanisms of cannabinoids (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791144/
Elevation of 2-AG by monoacylglycerol lipase inhibition in the visceral insular cortex
interferes with anticipatory nausea in a rat model (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793281/
Quantitative analyses of synergistic responses between cannabidiol and DNA-damaging agents on the proliferation and viability of glioblastoma and neural progenitor cells in culture (full–2016)  http://jpet.aspetjournals.org/content/360/1/215.long
Why I chose to use cannabis (article–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791147/

Using Medical Cannabis in an Oncology Practice (article–2016) http://www.cancernetwork.com/oncology-journal/using-medical-cannabis-oncologypractice#sthash.CjT8fR9n.uWvEhfSG.dpuf
Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Cisplatin-Induced Neuropathy in Mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27214593 Phytochemicals as adjunctive with conventional anticancer therapies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262332
Pediatric oncology providers and use of medical marijuana in children with cancer (abst–2016) http://meetinglibrary.asco.org/content/170798-176
Cannabinoids for Symptom Management and Cancer Therapy: The Evidence (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27407130
Effect of combined oral doses of Δ9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea in rat models (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27438607
May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27686064
The role of mifamurtide in chemotherapy-induced osteoporosis of children with osteosarcoma (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27993113
An Overlooked Victim of Cannabis: Losing Several Years of Well-being and Inches of
Jejunum on the Way to Unravel Her Hyperemesis Enigma (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26757305
Cannabis and Cannabinoids (PDQ®): Patient Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65875/
Cannabis and Cannabinoids (PDQ®): Health Professional Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65755/
Overview of Chemotherapy-Induced Nausea and Vomiting and Evidence-Based
Therapies (full–2017) http://www.ajmc.com/journals/supplement/2017/managed-care-considerations-in-chemotherapy-induced-nausea-andvomiting/overview-of-chemotherapy-induced-nausea-and-vomiting-and-evidence-based-therapies-article/
Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674070/
Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663723/
Modulating the endocannabinoid pathway as treatment for peripheral neuropathic pain: a selected review of preclinical studies (full–2017)  http://apm.amegroups.com/article/view/16320/16484
Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo (full–2017) https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.30483
The slowly signaling G protein-biased CB2 cannabinoid receptor agonist LY2828360

suppresses neuropathic pain with sustained efficacy and attenuates morphine tolerance and dependence (link to download–2017)  http://molpharm.aspetjournals.org/content/early/2017/11/30/mol.117.109355.long
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications  (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4043
Systematic review of safeness and therapeutic efficacy of cannabis in patients with
multiple sclerosis, neuropathic pain, and in oncological patients treated with
chemotherapy (abst in English–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29119763
(full in Italian) http://www.epiprev.it/articolo_scientifico/revisione-sistematica-sull%E2%80%99efficacia-terapeutica-e-la-sicurezza-della-cannabis-
Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28235999
Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/27778331
Cannabinoids as gastrointestinal anti-inflammatory drugs (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28239924
Single and combined effects of delta9 -tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28548225
Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration (abst–2017)  https://www.spandidos-publications.com/10.3892/ijo.2017.4022
Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817303465?via%3Dihub
Cannabinoids as Anticancer Drugs (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28826542
Medical Cannabinoids in Children and Adolescents: A Systematic Review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29061872
Cannabinoids for nausea and vomiting related to chemotherapy: Overview of systematic reviews (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29168289
Cannabidiol: an alternative therapeutic agent for oral mucositis? (abst–2017) 
https://www.ncbi.nlm.nih.gov/pubmed/28191662
Are cannabinoids effective for the management of chemotherapy induced nausea and vomiting? (abst in English, link to abst in Spanish–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29286355
HU-331 and Oxidized Cannabidiol Act as Inhibitors of Human Topoisomerase IIα and β  (abst–2017) https://pubs.acs.org/doi/10.1021/acs.chemrestox.7b00302
Suppression of Cisplatin-Induced Vomiting by Cannabis sativa in Pigeons: Neurochemical Evidences (full–2018) https://www.frontiersin.org/articles/10.3389/fphar.2018.00231/full
Cannabinoids and agmatine as potential therapeutic alternatives for cisplatin-induced peripheral neuropathy (full–2018)
https://www.dovepress.com/cannabinoids-and-agmatine-as-potential-therapeutic-alternatives-for-ci-peer-reviewed-fulltext-article-JEP
Irinotecan and Δ-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary
Evaluation Using Biochemical and Genotoxicity Markers (full–2018)
http://www.mdpi.com/1420-3049/23/6/1332/htm

Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer (full–2018) https://www.frontiersin.org/articles/10.3389/fphar.2018.00889/full

The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin Induced Hearing Loss (full–2018) https://www.frontiersin.org/articles/10.3389/fncel.2018.00271/full

Medical Cannabis: The Oncology Nurse’s Role in Patient Education About the Effects of Marijuana on Cancer Palliation full–2018) https://cjon.ons.org/cjon/22/1/medical-cannabis-oncology-nurse-s-role-patient-education-about-effects-marijuana-cancer

Oncology Clinicians and the Minnesota Medical Cannabis Program: A Survey on Medical Cannabis Practice Patterns, Barriers to Enrollment, and Educational Needs (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225592/

Care After Chemotherapy: Peripheral Neuropathy, Cannabis for Symptom Control, and Mindfulness (full–2018) https://ascopubs.org/doi/full/10.1200/EDBK_209437?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed

Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy Induced Neuropathic Pain: Studies in Animal Models (link to full–2018) https://www.hindawi.com/journals/prm/2018/5234943/

Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase synergize with the opioid analgesic morphine to suppress chemotherapy-induced neuropathic nociception without enhancing effects of morphine on gastrointestinal transit (link to PDF–2018) http://jpet.aspetjournals.org/content/early/2018/10/01/jpet.118.252288.long

Cannabis and Anti-Cancer Drugs: Societal Usage and Expected Pharmacological Interactions – A Review (download–2018) http://www.ch-thuir.fr/sites/default/files/Bouqui-_et_al-2018-Fundamental_%26_Clinical_Pharmacology.pdf

Monoacylglycerol lipase inhibitors reverse paclitaxel-induced nociceptive behavior and proinflammatory markers in a mouse model of chemotherapy-induced neuropathy (link to download–2018) http://jpet.aspetjournals.org/content/early/2018/03/14/jpet.117.245704

Cannabis for vismodegib-related muscle cramps in a patient with advanced basal cell carcinoma (1st page–2018) http://www.jpsmjournal.com/article/S0885-3924(18)30070-8/fulltext

Cannabinoids in Patients with Nausea and Vomiting Associated with Malignancy and Its Treatments (1st page–2018) https://www.amjmed.com/article/S0002-9343(18)30033-0/fulltext
Appraising the “entourage effect”: antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218302387

The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report (abst–2018) http://www.ejinme.com/article/S0953-6205(18)30003-7/fulltext

Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation (abst–2018) https://www.sciencedirect.com/science/article/pii/S0028390818303575?via%3Dihub

Therapeutic applications of cannabinoids (abst–2018) https://www.sciencedirect.com/science/article/pii/S0009279718307373?via%3Dihub

Safety and efficacy of nabilone for acute chemotherapy-induced vomiting prophylaxis in pediatric patients: A multicenter, retrospective review (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30051617

Cannabinoid pharmacology and therapy in gut disorders (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303186

Optimization Of A Preclinical Therapy Of Cannabinoids In Combination With Temozolomide Against Glioma (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303496

Effects of Δ9-tetrahydrocannabinol on irinotecan-induced clinical effects in rats (abst–2018) https://www.sciencedirect.com/science/article/pii/S0009279718308792?via%3Dihub

Targeting Glioma Initiating Cells With A Combined Therapy Of Cannabinoids And Temozolomide (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303897

Medical Marijuana Use in a Community Cancer Center (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30205775

Bortezomib And Endocannabinoid/Endovanilloid System: A Synergism In Osteosarcoma (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S1043661818310387

Medical Cannabis Use by Hodgkin Lymphoma Patients: Experience of a Single Center (abst–2018) https://www.karger.com/Article/Abstract/493567

Medicinal cannabis for chemotherapy-induced nausea and vomiting: prescribing with limited evidence (abst–2018) https://www.mja.com.au/journal/2018/210/1/medicinal-cannabis-chemotherapy-induced-nausea-and-vomiting-prescribing-limited

Cannabis-related cognitive impairment: a prospective evaluation of possible influences on patients with cancer during chemotherapy treatment as a pilot study (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30540595

Cannabis based drugs: how will they be used in practice? (abst–2018) https://www.bmj.com/content/363/bmj.k4665.long

Case Report: Clinical Outcome and Image Response of Two Patients With Secondary High-Grade Glioma Treated With Chemoradiation, PCV, and Cannabidiol (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345719/
Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study (full–2019) https://www.cambridge.org/core/journals/palliative-and-supportive-care/article/cannabis-treatment-in-hospitalized-patients-using-thesyqe-inhaler-results-of-a-pilot-openlabel-study/0C1940413E704A7EADCB949F5F49603A/core-reader

Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol (full–2019) https://onlinelibrary.wiley.com/doi/full/10.1002/jcsm.12426

Progress in cannabis research from a pharmaceutical chemist’s point of view (Germany) (abst in English & German–2019) https://link.springer.com/article/10.1007%2Fs00103-019-02964-4
Cannabis for cancer – illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30572744
Cannabinoids as a Potential New and Novel Treatment for Melanoma: A Pilot Study in a Murine Model (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30691796
Cannabinoids: the lows and the highs of chemotherapy-induced nausea and vomiting (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30720344
Patient Counseling Guidelines for the Use of Cannabis for the Treatment of Chemotherapy-Induced Nausea/Vomiting and Chronic Pain (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31070496
Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain (abst–2019) https://link.springer.com/article/10.1007%2Fs40265-019-01132-x
Opportunities for cannabis in supportive care in cancer (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31413731


CHEST PAIN-NON CARDIAC
A 4-Week Pilot Study With the Cannabinoid Receptor Agonist Dronabinol and Its Effect on Metabolic Parameters in a Randomized Trial (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26283236
Dronabinol increases pain threshold in patients with functional chest pain: a pilot doubleblind placebo-controlled trial (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26822791
Primary Causes of Hospitalizations and Procedures, Predictors of In-hospital Mortality, and Trends in Cardiovascular and Cerebrovascular Events Among Recreational Marijuana Users: A Five-year Nationwide Inpatient Assessment in the United States (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200442/


CHILD ABUSE/NEGLECT/BULLYING
The Association of Low Parental Monitoring With Early Substance Use in European
American and African American Adolescent Girls (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712655/
Gender minority social stress in adolescence: disparities in adolescent bullying and
substance use by gender identity (full–2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201643/
Inhibition of anandamide hydrolysis dampens the neuroendocrine response to stress in neonatal rats subjected to suboptimal rearing conditions (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26552023
Clearing the air: discrepant policy and practice concerning neonatal cannabinoid exposure (1st page–2016)
https://link.springer.com/article/10.1007/s12519-016-0050-x
Child maltreatment and cannabis use in young adulthood: A birth cohort study  (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27741369
A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis  (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415302943
Substantiated childhood maltreatment and young adulthood cannabis use disorders: A pre-birth cohort study (abst–2017) http://www.psy-journal.com/article/S0165-1781(16)31722-X/fulltext
Impulsivity as a mechanism linking child abuse and neglect with substance use in
adolescence and adulthood (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28606210
Associations of Bullying and Cyberbullying With Substance Use and Sexual Risk Taking in Young Adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28605163
Phenotypic and familial associations between childhood maltreatment and cannabis
initiation and problems in young adult European-American and African-American
women (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30373-3/fulltext
Genetic association analyses of the endocannabinoid system on anxious phenotype
(abst in English & Hungarian–2017)
http://www.mppt.hu/folyoirat/1/abstract/?vol=19&issue=4&elsooldal=177
Sexual orientation, minority stress, social norms, and substance use among racially
diverse adolescents (abst–2017) 
https://www.drugandalcoholdependence.com/article/S0376-8716(17)30254-5/fulltext
Social Stress and Substance Use Disparities by Sexual Orientation Among High School Students (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28826950
Serum profile changes in postpartum women with a history of childhood maltreatment: a combined metabolite and lipid fingerprinting study (full–2018)
https://www.nature.com/articles/s41598-018-21763-6
Adverse childhood experiences among patients with substance use disorders at a referral psychiatric hospital in Kenya (full–2018)
https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-018-1780-1

Risk Factors Associated With Gambling Involvement among a National Sample of African American and European American Young Adults (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233904/

The Continued Impact of Marijuana Legalization on Unintentional Pediatric Exposures in Colorado (1st page–2018) http://journals.sagepub.com/doi/abs/10.1177/0009922818805206?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed

Influence of the type of childhood violence on cannabis abuse and dependence among adolescents: a systematic review and meta-analysis (abst in English, link to abst in Spanish–2018) https://www.ncbi.nlm.nih.gov/pubmed/30627731
Childhood interpersonal violence and adult alcohol, cannabis, and tobacco use disorders: variation by race/ethnicity? (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29310741
Maternal separation increases alcohol-drinking behaviour and reduces endocannabinoid levels in the mouse striatum and prefrontal cortex (abst–2018)
http://www.europeanneuropsychopharmacology.com/article/S0924-977X(18)30044-0/fulltext
Altered hair endocannabinoid levels in mothers with childhood maltreatment and their newborns (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0301051118301972
Externalizing behavior problems are related to substance use in adolescents across six samples from Nordic countries (abst–2018)
https://link.springer.com/article/10.1007%2Fs00787-018-1148-6
Regular past year cannabis use in women veterans and associations with sexual trauma (abst–2018)  https://www.sciencedirect.com/science/article/abs/pii/S030646031830282X
The relationship between the level of exposure to stress factors and cannabis in recent onset psychosis (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29743139
Parental Divorce and Family History of Alcohol Disorder: Associations with Young
Adults’ Alcohol Problems, Marijuana Use, and Interpersonal Relations (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29693716
Childhood trauma- and cannabis-associated microstructural white matter changes in
patients with psychotic disorder: a longitudinal family-based diffusion imaging study (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29807550
An Examination of the Impact of Childhood Emotional Abuse and Gender on Cannabis Use Trajectories among Community Youth (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29930974
Women’s Cigarette and Marijuana Use in Pregnancy: Identifying the Role of Past Versus Recent Violence Exposure (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29936890
Tobacco and cannabis use in college students are predicted by sex-dimorphic interactions between MAOA genotype and child abuse (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29952131
Prevalence and Correlates of Substance Use in Homeless Youth and Young Adults  (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29505458
Bullying victimization and illicit drug use among students in Grades 7 to 12 in Manitoba, Canada: a cross-sectional analysis (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29981027

Posttraumatic Stress Symptoms and Emerging Adult Sexual Minority Men: Implications for Assessment and Treatment of Childhood Sexual Abuse (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30338584

The Influence of Online-Only Friends on the Substance Use of Young Adults with a History of Childhood Maltreatment (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30372360

Maltreatment, attachment, and substance use in adolescence: Direct and indirect pathways (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0306460318308724?via%3Dihub

Effects of victimization on mental health and substance use trajectories in young sexual minority men (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30585567

Substance Use and School Characteristics in Lesbian, Gay, Bisexual, and Heterosexual High School Students (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30637738

Genetic and Environmental Risk Factors for Cannabis Use: Preliminary Results for the Role of Parental Care Perception (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30663487
Adolescent Adversity and Concurrent Tobacco, Alcohol, and Marijuana Use (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30688644
Marijuana use motives mediate the association between experiences of childhood abuse and marijuana use outcomes among emerging adults (abst–2019) https://www.sciencedirect.com/science/article/abs/pii/S0306460318309456?via%3Dihub
Relationship Between Substance Use, Bullying, and Other Delinquent Behaviors Among High School Students: a Secondary Analysis of the Florida Youth Substance Abuse Survey (abst–2019) https://link.springer.com/article/10.1007%2Fs11414-019-09649-5
Mummy, daddy, and addiction: Implicit insecure attachment is associated with substance use in college students (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30855152
Adverse childhood experiences and MSM marijuana use (abst–2019) https://www.sciencedirect.com/science/article/pii/S0376871619300572?via%3Dihub
A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypes (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31382124
Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31422779


CHILDREN
The Cannabinoid Receptor 2 Q63R Variant Modulates the Relationship between Childhood Obesity and Age at Menarche (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140142
Medical marijuana’s public health lessons–implications for retail marijuana in Colorado (full–2015) http://www.nejm.org/doi/full/10.1056/NEJMp1500043
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318349/
Association between paracetamol use in infancy or childhood with body mass index (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/oby.21045/full
Use of paracetamol during pregnancy and child neurological development (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/dmcn.12745/full
Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700831/
Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/epi.13060/full
Urinary early kidney injury molecules in children with beta-thalassemia major (full–2015) http://www.tandfonline.com/doi/full/10.3109/0886022X.2015.1007871
Parental Separation and Early Substance Involvement: Results from Children of
Alcoholic and Cannabis Dependent Twins (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908916/
Perinatal asphyxia results in altered expression of the hippocampal  acylethanolamide / endocannabinoid signaling system associated to memory impairments in post weaned rats (full–2015)  http://journal.frontiersin.org/article/10.3389/fnana.2015.00141/full
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0149763415001244
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial (abst–2015) http://www.thelancet.com/journals/laneur/article/PIIS1474-4422%2815%2900379-8/abstract
The maternal deprivation animal model revisited (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25616179
Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25845492
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25935511
Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/25974389
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
The effect of WIN 55,212-2 suggests a cannabinoid-sensitive component in the early toxicity induced by organic acids accumulating in glutaric acidemia type I and in related disorders of propionate metabolism in rat brain synaptosomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26431622
top

Cannabidiol as potential treatment in refractory pediatric epilepsy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26567560
Hair analysis for Δ(9) -tetrahydrocannabinolic acid A (THCA-A) and Δ(9) –
tetrahydrocannabinol (THC) after handling cannabis plant material (abst–2015)
https://www.researchgate.net/publication/278895867_Hair_analysis_for_D9-tetrahydrocannabinolic_acid_A_THCA-A_and_D9-
tetrahydrocannabinol_THC_after_handling_cannabis_plant_material
Options for pharmacoresistant epilepsy in children: when medications don’t work (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25658218
Inhibition of anandamide hydrolysis dampens the neuroendocrine response to stress in neonatal rats subjected to suboptimal rearing conditions (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26552023
The Pharmacological Basis of Cannabis Therapy for Epilepsy (full–2016) http://jpet.aspetjournals.org/content/early/2016/01/19/jpet.115.230151.long
Cannabinoids for pediatric epilepsy? Up in smoke or real science? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729003/
Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/prp2.220/full
In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791143/
CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience (abst–2016) http://www.sciencedirect.com/science/article/pii/S1059131116000054
Genetic variation in the endocannabinoid system and response to Cognitive Behavior Therapy for child anxiety disorders (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/ajmg.b.32467/full
Is the medical use of cannabis a therapeutic option for children? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758425/
Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843434/
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood (full–2016) http://learnmem.cshlp.org/content/23/7/349.long
Acetaminophen Use for Fever in Children Associated with Autism Spectrum Disorder (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044872/
Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043219/
Declining Prevalence of Marijuana Use Disorders Among Adolescents in the United
States, 2002 to 2013 (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957692/
Cannabinoid receptor 2 as anti-obesity target: inflammation, fat storage and browning modulation (full-2016)  http://www.nature.com/tp/journal/v6/n11/full/tp2016225a.html?foxtrotcallback=true
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461973/
Disturbances of sleep and circadian rhythms: novel risk factors for obesity (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070789/
The hazards of bad sleep-Sleep duration and quality as predictors of adolescent alcohol and cannabis use (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086262/
Detecting biomarkers of secondhand marijuana smoke in young children (link to PDF–2016) http://www.nature.com/pr/journal/vaop/naam/abs/pr2016261a.html

Letter to the editor re Sredni et al.: spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system (letter–2016) http://link.springer.com/article/10.1007%2Fs00381-016-3333-6
Medicinal Use of Marijuana: What School Nurses Need to Know (abst–2016)  http://nas.sagepub.com/content/31/3/170.long
Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma (abst–2016) http://www.europeanneuropsychopharmacology.com/article/S0924-977X(16)00077-8/abstract
Childhood Maltreatment in the Migraine Patient (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27194425
Cannabinoid Poisoning by Hemp Seed Oil in a Child (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27299295
Marijuana Misadventures in Children: Exploration of a Dose-Response Relationship and Summary of Clinical Effects and Outcomes (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27050740
Pediatric oncology providers and use of medical marijuana in children with cancer (abst–2016) http://meetinglibrary.asco.org/content/170798-176
Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia (abst–2016) http://www.schres-journal.com/article/S0920-9964(16)30060-3/abstract
Childhood weight status and timing of first substance use in an ethnically diverse sample (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30111-9/abstract
Spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system (abst–2016) http://link.springer.com/article/10.1007%2Fs00381-016-3243-7
Child maltreatment and cannabis use in young adulthood: A birth cohort study (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27741369
Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27875353
The role of mifamurtide in chemotherapy-induced osteoporosis of children with osteosarcoma (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27993113
Experience with Gambling in Late Childhood and Early Adolescence: Implications for Substance Experimentation Behavior (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26836642
Effective treatment of spasticity using dronabinol in pediatric palliative care (abst–2016) https://www.ejpn-journal.com/article/S1090-3798(16)30127-1/fulltext
Using Medical Marijuana to Stop Childhood Seizures (news & abstract–2016) http://neurosciencenews.com/thc-cbd-childhood-seizures-3618/

Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults (full–2017) http://www.sciencedirect.com/science/article/pii/S221315821630170X
Anti-proliferative, pro-apoptotic and anti-invasive effect of EC/EV system in human
osteosarcoma (full–2017) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=17089&path%5B%5D=54691
Fine particles in homes of predominantly low-income families with children and
smokers: Key physical and behavioral determinants to inform indoor-air-quality
interventions (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0177718
Cannabinoids in Pediatrics (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473390/
Could Cannabidiol be a Treatment Option for Intractable Childhood and Adolescent
Epilepsy? (full–2017)
http://www.j-epilepsy.org/journal/view.php?year=2017&vol=7&page=16
An Australian nationwide survey on medicinal cannabis use for epilepsy: History of
antiepileptic drug treatment predicts medicinal cannabis use (full–2017)  http://www.epilepsybehavior.com/article/S1525-5050(17)30073-2/fulltext
What effects—if any—does marijuana use during pregnancy have on the fetus or child?  (full–2017) http://www.mdedge.com/jfponline/article/141775/pediatrics/what-effects-if-any-does-marijuana-use-during-pregnancy-have
The oxylipin and endocannabidome responses in acute phase Plasmodium falciparum malaria in children (full–2017)  https://malariajournal.biomedcentral.com/articles/10.1186/s12936-017-2001-y
Report from a Survey of Parents Regarding the Use of Cannabidiol (Medicinal cannabis) in Mexican Children with Refractory Epilepsy (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28392943
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last? (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767492/
The Unintended Consequences of Marijuana Legalization (full–2017)  http://www.jpeds.com/article/S0022-3476(17)31081-8/fulltext
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome (full–2017)
https://www.nejm.org/doi/10.1056/NEJMoa1611618?url_ver=Z39.88-
2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dwww.ncbi.nlm.nih.gov
Anti-proliferative, pro-apoptotic and anti-invasive effect of EC/EV system in human
osteosarcoma (full–2017) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589594/
The Role of Cannabinoids in the Treatment of Cancer in Pediatric Patients (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4044

Cannabinoids in treatment-resistant epilepsy: A review (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28188044
Caring for Young Children Exposed to Marijuana (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28141605
Social correlates of health status, quality of life, and mood states in patients treated with cannabidiol for epilepsy (abst–2017) http://www.epilepsybehavior.com/article/S1525-5050(16)30731-4/fulltext
A 10-year review of cannabis exposure in children under 3-years of age: do we need a more global approach? (abst–2017)  https://link.springer.com/article/10.1007%2Fs00431-017-2872-5
Substantiated childhood maltreatment and young adulthood cannabis use disorders: A pre-birth cohort study (abst–2017) http://www.psy-journal.com/article/S0165-1781(16)31722-X/fulltext
Impulsivity as a mechanism linking child abuse and neglect with substance use in
adolescence and adulthood (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28606210
Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in
developing rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28691158
Unintentional Cannabis Ingestion in Children: A Systematic Review (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28888560
Medical Cannabinoids in Children and Adolescents: A Systematic Review (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29061872
Role of Cannabinoid CB2 Receptor Gene (CNR2) Polymorphism in Children with
Immune Thrombocytopenic Purpura in Beni-Suef Governorate in Egypt (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29120578
Cannabis Intoxication Case Series: The Dangers of Edibles Containing  Tetrahydrocannabinol (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29103798
Efficacy and safety of cannabis for treating children with refractory epilepsy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29115760
Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center (full–2018) 
http://www.epilepsybehavior.com/article/S1525-5050(18)30009-X/fulltext
Plasma anandamide concentrations are lower in children with autism spectrum disorder (full–2018)    https://molecularautism.biomedcentral.com/articles/10.1186/s13229-018-0203-y
A brief validated screen to identify boys and girls at risk for early marijuana use  (full–2018) https://www.sciencedirect.com/science/article/pii/S1878929317300348?via%3Dihub
Trends in Cannabis and Cigarette Use Among Parents With Children at Home: 2002 to 2015 (full–2018)  http://pediatrics.aappublications.org/content/early/2018/05/10/peds.2017-3506.long
Effects of CB2 and TRPV1 receptors’ stimulation in pediatric acute T-lymphoblastic
leukemia (full–2018) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940388/
Multilevel population-based cross-sectional study examining school substance-misuse policy and the use of cannabis, mephedrone and novel psychoactive substances among students aged 11-16 years in schools in Wales (full–2018)
http://bmjopen.bmj.com/content/8/6/e020737.long
Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian
Community (full–2018) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033872/
Cannabis for pediatric epilepsy: protocol for a living systematic review (full–2018)
https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-018-0761-2

Cannabidiol for Treatment of Childhood Epilepsy-A Cross-Sectional Survey (full–2018) https://www.frontiersin.org/articles/10.3389/fneur.2018.00731/full

Maternal Cannabis Use During a Child’s Lifetime Associated With Earlier Initiation (full–2018) https://www.ajpmonline.org/article/S0749-3797(18)32092-0/fulltext

The effect of cannabis exposure on pubertal outcomes: a systematic review (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181473/

A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144444/

Efficacy of cannabinoids in paediatric epilepsy (full–2018) https://onlinelibrary.wiley.com/doi/full/10.1111/dmcn.14087

Marijuana and Tobacco Coexposure in Hospitalized Children (full–2018) http://pediatrics.aappublications.org/content/142/6/e20180820.long
Cannabis Oil in an Irish Children’s Critical Care Unit (full–2018) http://imj.ie/cannabis-oil-in-an-irish-childrens-critical-care-unit/
Endocannabinoid engagement of CB2 regulates RSV-induced immunity (link to PDF–2018) http://www.tandfonline.com/doi/abs/10.1080/21505594.2017.1421830

Maternal and paternal cannabis use during pregnancy and the risk of psychotic-like experiences in the offspring (link to PDF–2018) https://www.researchgate.net/publication/326224957_Maternal_and_paternal_cannabis_use_during_pregnancy_and_the_risk_of_psychotic-like_experiences_in_the_offspring

Practical considerations in medical cannabis administration and dosing (link to PDF–2018) https://www.researchgate.net/publication/322257368_Practical_considerations_in_medical_cannabis_administration_and_dosing

Cannabinoids: just like any other medication? (article–2018) https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31611-8/fulltext

Safety of cannabidiol prescribed for children with refractory epilepsy (letter–2018) https://www.mja.com.au/journal/2018/209/5/safety-cannabidiol-prescribed-children-refractory-epilepsy

The Continued Impact of Marijuana Legalization on Unintentional Pediatric Exposures in Colorado (1st page–2018) http://journals.sagepub.com/doi/abs/10.1177/0009922818805206?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed

Influence of the type of childhood violence on cannabis abuse and dependence among adolescents: a systematic review and meta-analysis (abst in English, link to abst in Spanish–2018) https://www.ncbi.nlm.nih.gov/pubmed/30627731

Childhood interpersonal violence and adult alcohol, cannabis, and tobacco use disorders: variation by race/ethnicity? (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29310741
Marijuana-Perinatal and Legal Issues With Use During Pregnancy (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29373417
Intoxication From Accidental Marijuana Ingestion in Pediatric Patients: What May Lie Ahead (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29406477
Maternal separation increases alcohol-drinking behaviour and reduces endocannabinoid levels in the mouse striatum and prefrontal cortex (abst–2018)
http://www.europeanneuropsychopharmacology.com/article/S0924-977X(18)30044-0/fulltext
Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in
children and adolescents – An observational, longitudinal study (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29674131
Childcare Providers’ Possession or Use of Marijuana, Tobacco, or Alcohol While Caring for Children: A Comparison of US State Regulations (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29672146
Parental Divorce and Family History of Alcohol Disorder: Associations with Young
Adults’ Alcohol Problems, Marijuana Use, and Interpersonal Relations (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29693716
Examining the relationships between life satisfaction and alcohol, tobacco and marijuana use among school-aged children (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29726950
Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders (abst–2018) http://journals.sagepub.com/doi/abs/10.1177/0883073818773028?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Finding treatable genetic obesity: strategies for success (abst-2018)
https://www.ncbi.nlm.nih.gov/pubmed/29771759
Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29807317

Safety and efficacy of nabilone for acute chemotherapy-induced vomiting prophylaxis in pediatric patients: A multicenter, retrospective review (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/30051617
Relationship of media exposure to substance use among adolescents in Saudi Arabia: Results from a national study (abst–2018) https://www.sciencedirect.com/science/article/pii/S037687161830142X

Cannabidiol as a suggested candidate for treatment of autism spectrum disorder (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30171992

Neuroprotective Action of the CB1/2 Receptor Agonist, WIN 55,212-2, against DMSO but Not Phenobarbital-Induced Neurotoxicity in Immature Rats (abst–2018) https://link.springer.com/article/10.1007%2Fs12640-018-9944-9

Anticonvulsant and Neuroprotective Effects of Cannabidiol During the Juvenile Period (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30169677

Resilience against marijuana use initiation in low-income African American youth (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0306460318304751

Early Risk Factors for Daily Cannabis Use in Young Adults (abst–2018) http://journals.sagepub.com/doi/abs/10.1177/0706743718804541?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=cpab
Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems—A Retrospective Feasibility Study (abst–2018) https://link.springer.com/article/10.1007%2Fs10803-018-3808-2

Cannabis for the treatment of paediatric epilepsy? An update for Canadian paediatricians (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30455572

Complementary and Alternative Medicine Use in Children With Inflammatory Bowel Disease (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30499887

Acute Marijuana Intoxication in Children (abst–2018) https://www.healio.com/pediatrics/journals/pedann/2018-12-47-12/%7Bdb05b271-b2c8-4d12-a528-d12dc70cc601%7D/acutemarijuana-intoxication-in-children

Unintentional Pediatric Marijuana Exposures at a Tertiary Care Children’s Hospital in Washington State: A Retrospective Review (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30601351

Substance use off and on school grounds: A California statewide comparison between different groups of homeless students and nonhomeless students (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0306460318307706?via%3Dihub

Cannabis-based products for pediatric epilepsy: A systematic review (full–2019) https://onlinelibrary.wiley.com/doi/full/10.1111/epi.14608

Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336869/

Emergency physicians and public health experts call for tight regulations on cannabis edibles and concentrates (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342695/

The Prevalence of Nonprescription Cannabinoid-Based Medicines in British Children’s Hospices: Results of a National Survey (full–2019) https://www.liebertpub.com/doi/full/10.1089/jpm.2018.0522?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed

Indoor cannabis smoke and children’s health (full–2019) https://www.sciencedirect.com/science/article/pii/S2211335519300385?via%3Dihub

Why I campaign for children like my son Alfie Dingley to be able to get medical cannabis (full–2019) https://www.bmj.com/content/365/bmj.l1921.long

Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy (full–2019) https://link.springer.com/article/10.1007%2Fs40263-019-00624-4

Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study (full–2019) https://www.frontiersin.org/articles/10.3389/fneur.2019.00716/full

The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study (full–2019) https://www.epilepsybehavior.com/article/S1525-5050(19)30305-1/fulltext
Endocannabinoid Metabolome Characterization of Milk from Guatemalan Women Living in the Western Highlands (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517780/

Metabolomics and Communication Skills Development in Children; Evidence from the Ages and Stages Questionnaire (full–2019) https://www.mdpi.com/2218-1989/9/3/42/htm

Cannabis Allergy in a Child with Asthma Chronically Exposed to Marijuana (link to download–2019) https://www.sciencedirect.com/science/article/pii/S2213219819306166?via%3Dihub

Smoke Exposure, Cytokine Levels, and Asthma Visits in Children Hospitalized for Bronchiolitis (abst–2019) http://hosppeds.aappublications.org/content/9/1/46.abstract

Epidiolex (Cannabidiol): A New Hope for Patients With Dravet or Lennox-Gastaut Syndromes (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30616501

Cannabinoid toxicity in pediatrics (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30694824

Cannabis for refractory epilepsy in children: A review focusing on CDKL5 Deficiency Disorder (abst–2019) https://www.sciencedirect.com/science/article/pii/S0920121118306107?via%3Dihub

Cannabis-related emergencies in children and teens (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30865027

Unintentional Pediatric Marijuana Exposures Prior to and After Legalization and Commercial Availability of Recreational Marijuana in Washington State (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30846215

Reclassifying cannabis based drugs has not made accessing them easier, MPs hear (abst–2019) https://www.bmj.com/content/364/bmj.l1302.long

Increased Testing and Health Care Costs for Pediatric Cannabis Exposures (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30998654

Cannabis-related emergencies in children and teens (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31090567

Disposition of oral delta-9 tetrahydrocannabinol (THC) in children receiving cannabis extracts for epilepsy (abst–2019) https://www.tandfonline.com/doi/abs/10.1080/15563650.2019.1616093?journalCode=ictx20
Medical Marijuana in the Pediatric Population With Epilepsy-What You Should Know (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31160106
Crossing the Line: Care of a Pediatric Patient with Intractable Seizures and Severe Neuropathic Pain in Absence of Access to Medical Marijuana (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31184974
Cannabis in homes with children: use and storage practices in a legalised state (Colorado) (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31371385A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypes (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31382124
Medical marijuana use for pediatric oncology patients: single institution experience (Israel) (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31424297


CHOLESTEROL*+
Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126839
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation (full–2015)  http://cardiovascres.oxfordjournals.org/content/early/2015/06/30/cvr.cvv179.long
Endogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments (full–2015)
http://www.nature.com/articles/srep15453
METABOLIC EFFECTS OF MARIJUANA USE AMONG BLACKS (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523241/
Protective effect of Xingnaojia formulation on rats with brain and liver damage caused by chronic alcoholism (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665616/
Orphan nuclear receptor oestrogen-related receptor γ (ERRγ) plays a key role in hepatic 
cannabinoid receptor type 1-mediated induction of CYP7A1 gene expression (full–2015) http://ajpendo.physiology.org/content/308/7/E583.long
Intake of farmed Atlantic salmon fed soybean oil increases hepatic levels of arachidonic acid-derived oxylipins and ceramides in mice (full–2015)  http://www.sciencedirect.com/science/article/pii/S0955286315000212
Transgenic ω-3 PUFA enrichment alters morphology and gene expression profile in
adipose tissue of obese mice: Potential role for protectins (full–2015)
http://www.metabolismjournal.com/article/S0026-0495(15)00036-0/fulltext
Participation of the endocannabinoid system (ECS) in the weight-gain and sensitization to LPS exposure in a maternal obesity model (article–2015)
http://www.placentajournal.org/article/S0143-4004%2815%2900526-3/fulltext
A potential role for cannabinoid receptors in the therapeutic action of fenofibrate  (download–2015) http://www.fasebj.org/content/29/4/1446.full.pdf+html
Polymorphism G1359A of the cannabinoid receptor gene (CNR1): allelic frequencies and influence on cardiovascular risk factors in a multicentre study of Castilla-Leon (abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/25682784
Association of G1359A polymorphism of the cannabinoid receptor gene (CNR1) with macronutrient intakes in obese females (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/jhn.12298/full
Beyond Lipoprotein Receptors: Learning from Receptor Knockouts Mouse Models about New Targets for Reduction of the Atherosclerotic Plaque (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26592248
Abstract 577: Medical Marijuana Use: Effect on Lipid Metabolism and Atherosclerosis (abst–2015) http://atvb.ahajournals.org/content/35/Suppl_1/A577
top
Metabolic Syndrome Among Marijuana Users in the United States: An Analysis of National Health and Nutrition Examination Survey Data (full–2016)
http://www.amjmed.com/article/S0002-9343(15)01024-4/fulltext
Modulation of Long-Term Potentiation of Cortico-Amygdala Synaptic Responses and Auditory Fear Memory by Dietary Polyunsaturated Fatty Acid (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993868/
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165432
Long-Term Effects of Prenatal Exposure to Undernutrition on Cannabinoid Receptor Related Behaviors: Sex and Tissue-Specific Alterations in the mRNA Expression of Cannabinoid Receptors and Lipid Metabolic Regulators (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00241/full
Effects of Different Levels of Hemp Seed (Cannabis Sativa L.) and Dextran Oligosaccharide on Growth Performance and Antibody Titer Response of Broiler Chickens (full–2016) http://www.tandfonline.com/doi/full/10.4081/ijas.2015.3473
Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408584/

Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo Controlled, Parallel Group Pilot Study (full–2016)
http://care.diabetesjournals.org/content/39/10/1777.long
Cyclooxygenase-2 contributes to the selective induction of cell death by the endocannabinoid 2-arachidonoyl glycerol in hepatic stellate cells (abst–2016) http://www.sciencedirect.com/science/article/pii/S0006291X16300833
Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27465665
Monoglyceride lipase deficiency affects hepatic cholesterol metabolism and lipid dependent gut transit in ApoE-/- mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464855/
Metabolic Syndrome Induced Bladder Cannabinoid Receptor Changes in the Fructose Fed Rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28386998
Inhibitory effect of trans-caryophyllene (TC) on leukocyte-endothelial attachment (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28624443
Endocannabinoids in Caenorhabditis elegans are essential for the mobilization of
cholesterol from internal reserves (full–2018)
https://www.nature.com/articles/s41598-018-24925-8
Gut Microbes and Health: A Focus on the Mechanisms Linking Microbes, Obesity, and Related Disorders (full–2018)  https://onlinelibrary.wiley.com/doi/full/10.1002/oby.22175
Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism (full–2018)  https://www.sciencedirect.com/science/article/pii/S2212877818303934?via%3Dihub
Effects of a Weight Loss Program on Metabolic Syndrome, Eating Disorders and
Psychological Outcomes: Mediation by Endocannabinoids (full–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981584/
Effects of cannabis use on body mass, fasting glucose and lipids during the first
12 months of treatment in schizophrenia spectrum disorders (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29519756
Stilbenoids and cannabinoids from the leaves of Cannabis sativa f. sativa with potential reverse cholesterol transport activity (abst–2018) https://pubs.rsc.org/en/Content/ArticleLanding/2018/FO/C8FO01896K#!divAbstract

Associations between cannabis use and cardiometabolic risk factors: A longitudinal study of men (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30589665

Effect of cannabis on weight and metabolism in first-episode non-affective psychosis: Results from a three-year longitudinal study (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30702972

Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high-fat high cholesterol diet via regulating NF-κB and NLRP3 inflammasome pathway (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31032942
24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderateto-Severe Alzheimer’s Disease: Analyses from a Clinical Trial with Nabilone (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31322567

The endocannabinoid system is affected by cholesterol dyshomeostasis: Insights from a murine model of Niemann Pick type C disease (abst–2019) https://www.sciencedirect.com/science/article/pii/S0969996119301998?via%3Dihub

Bioactive Lipids and the Gut-Brain Axis: Diet as a Modulator of Bioactivity and Diversity of Lipids in the Brain (abst–2019) https://link.springer.com/chapter/10.1007%2F978-3-030-11488-6_10


CHRONIC CEREBRAL HYPOPERFUSION
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling (abst–2016)  https://www.semanticscholar.org/paper/Cannabinoid-receptor-agonist-WIN55%2C212-2-and-fatty-SuWang/48314647099a3604c2a5334fec3328926703de88
Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats (abst–2018) https://link.springer.com/article/10.1007%2Fs12640-018-9972-5


CHRONIC FATIGUE SYNDROME/MYALGIC ENCEPHALOMYELITIS
Myalgic Encephalomyelitis by Anonymous (anecdotal–undated) http://www.rxmarijuana.com/shared_comments/Myalgic_Encephalomyelitis.htm
Cannabidiol as a Therapy for ASIA Syndrome? An Editorial on a Novel Study (link to PDF–2017)
https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4046


CHRONIC MOUNTAIN SICKNESS
Association Between Plasma N-Acylethanolamides and High Hemoglobin Concentration in Southern Peruvian Highlanders (click “PDF Research Gate” for PDF–2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Association+Between+Plasma+NAcylethanolamides+and+High+Hemoglobin+Concentration+in+Southern+Peruvian+Highlanders.&btnG=


CHRONIC TRAUMATIC ENCEPHALOPATHY/CTE
Inhibition of monoacylglycerol lipase prevents chronic traumatic encephalopathy-like neuropathology in a mouse model of repetitive mild closed head injury (full–2015) http://jcb.sagepub.com/content/35/3/443.long
Cannabis and the Health and Performance of the Elite Athlete (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116792/
Cannabis Therapeutics and the Future of Neurology (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200872/


CIDS/CNS INJURY-INDUCED IMMUNODEFICIENCY SYNDROME
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00264/full
Experimental Cannabinoid 2 Receptor Inhibition in CNS Injury-Induced Immunodeficiency Syndrome (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26999797


CIRCADIAN RHYTHM/CIRCANNUAL RHYTHM/BIORHYTHMS
Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-arachidonoylglycerol (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763355/
The effects of chronic marijuana use on circadian entrainment (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25801606
Evidence for a GPR18 Role in Diurnal Regulation of Intraocular Pressure (full–2016) http://iovs.arvojournals.org/article.aspx?articleid=2588572
Disturbances of sleep and circadian rhythms: novel risk factors for obesity (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070789/
Endocannabinoids and sleep (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0149763416302640
Signaling pathways to and from the hypophysial pars tuberalis, an important center for the control of seasonal rhythms (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/28511899
Daytime-Dependent Changes of Cannabinoid Receptor Type 1 and Type 2 Expression in Rat Liver (full–2017) http://www.mdpi.com/1422-0067/18/9/1844/htm
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28653665
The excitatory/inhibitory input to orexin/hypocretin neuron soma undergoes day/night reorganization (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28669028
The effects of anandamide and oleamide on cognition depend on diurnal variations  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28789932
Cannabidiol affects circadian clock core complex and its regulation in microglia cells (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30307084
Modulation of NMDA-Mediated Clock Resetting in the Suprachiasmatic Nuclei of mPer2 Luc Mouse by Endocannabinoids (full–2019) https://www.frontiersin.org/articles/10.3389/fphys.2019.00361/full
Several clock genes polymorphisms are meaningful risk factors in the development and severity of cannabis addiction (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30526093
Aging circadian rhythms and cannabinoids (abst–2019) https://www.sciencedirect.com/science/article/abs/pii/S0197458019300867?via%3Dihub
Anandamide modulation of circadian- and stress-dependent effects on rat short-term memory (abst–2019) https://www.sciencedirect.com/science/article/abs/pii/S0306453018312162?via%3Dihub


CLINICAL ENDOCANNABINOID DEFICIENCY THEORY
Fetal Syndrome of Endocannabinoid Deficiency (FSECD) In Maternal Obesity (full–2016) http://www.medical-hypotheses.com/article/S0306-9877(16)30280-8/fulltext
The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence From Two
Recent Genetic Endocannabinoid Deficiency Models (article–2016)  http://www.biologicalpsychiatryjournal.com/article/S0006-3223(15)00532-6/fulltext
Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are
associated with neurological phenotypes in humans (full–2017)  http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0187926
Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28745306
Plasma anandamide concentrations are lower in children with autism spectrum disorder (full–2018) https://molecularautism.biomedcentral.com/articles/10.1186/s13229-018-0203-y
Emerging Role of (Endo)Cannabinoids in Migraine (full–2018)
https://www.frontiersin.org/articles/10.3389/fphar.2018.00420/full
Cannabinoids in pain medicine (abst in German & English–2018)
https://link.springer.com/article/10.1007%2Fs00482-018-0299-1

Treatment of Fragile X Syndrome with Cannabidiol: A Case Series Study and Brief Review of the Literature (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446166/

Significance of the endocannabinoid system in migraine (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30962405


CNS/CENTRAL NERVOUS SYSTEM
Components of the endocannabinoid and dopamine systems are dysregulated in
Huntington’s disease: analysis of publicly available microarray datasets (full-2015)  http://onlinelibrary.wiley.com/doi/10.1002/prp2.104/full
cnrip1 is a regulator of eye and neural development in Xenopus laevis (full–2015)  http://onlinelibrary.wiley.com/doi/10.1111/gtc.12225/full
An Introduction to the Endogenous Cannabinoid System (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789136/
In vitro opioid receptor affinity and in vivo behavioral studies of Nelumbo nucifera
flower (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636954/
Gastric mucosal protection: from the periphery to the central nervous system (link to PDF–2015) http://www.jpp.krakow.pl/journal/archive/06_15/pdf/319_06_15_article.pdf
Cannabis, Cannabinoids, and Cerebral Metabolism: Potential Applications in Stroke and Disorders of the Central Nervous System (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26238742
Distribution of the Endocannabinoid System in the Central Nervous System (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_3
Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25819934
Localization and production of peptide endocannabinoids in the rodent CNS and adrenal medulla (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815001136
Peripherally Restricted Cannabinoids for the Treatment of Pain (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26497478
Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hippocampus (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26115586
Endocannabinoids drive the acquisition of an alternative phenotype in microglia (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26086345
The Endocannabinoid Signaling System in the CNS: A Primer (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26638763
Dual effects of the non-esterified fatty acid receptor ‘GPR40’ for human health (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25615413
The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/cns.12506/full
Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes—a Short Review (full–2016) http://link.springer.com/article/10.1007%2Fs12035-016-0313-5
A spider derived peptide, PnPP-19, induces central antinociception mediated by opioid and cannabinoid systems (full–2016) https://jvat.biomedcentral.com/articles/10.1186/s40409-016-0091-6
Phytocannabinoids and cannabimimetic drugs: recent patents in central nervous system disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27184693
Synthetic cannabinoid receptor agonists and antagonists: implication in CNS disorders. (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27193072
Experimental Cannabinoid 2 Receptor Inhibition in CNS Injury-Induced Immunodeficiency Syndrome (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26999797
Cannabinoid receptor ligand bias: implications in the central nervous system (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27835801
Advances in the Physiology of GPR55 in the Central Nervous (abst–2016)  http://www.eurekaselect.com/144395/article
The central cannabinoid receptor type-2 (CB2) and chronic pain (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27842450
Dangerous drugs: products containing synthetic chemicals (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26915246
The Central Nervous System and Bone Metabolism: An Evolving Story (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27501818
Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27334611
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in
Disease (full–2017) http://journal.frontiersin.org/article/10.3389/fncel.2016.00294/full
Altered striatal endocannabinoid signaling in a transgenic mouse model of
spinocerebellar ataxia type-3 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407801/
Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0181064
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid (full–2017) http://www.mdpi.com/1422-0067/18/8/1669/htm
Palmitoylethanolamide Modulates GPR55 Receptor Signaling in the Ventral Hippocampus to Regulate Mesolimbic Dopamine Activity, Social Interaction, and Memory Processing (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531370/
The role of the endocannabinoid system in the antihyperalgesic effect of Cedrus atlantica essential oil inhalation in a mouse model of postoperative pain (full–2017)  http://www.sciencedirect.com/science/article/pii/S0378874117320172?via%3Dihub
Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis
Pathophysiology? (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337874/
(-)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor
Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412277/
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric,  Movement and Neurodegenerative Disorders (full–2017)  http://www.cpn.or.kr/journal/view.html?volume=15&number=4&spage=301
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases (full–2017)  http://www.sciencedirect.com/science/article/pii/S0301008217300709?via%3Dihub
Dual Influence of Endocannabinoids on Long-Term Potentiation of Synaptic
Transmission (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742107/
CRIP1a inhibits endocytosis of G-protein coupled receptors activated by
endocannabinoids and glutamate by a common molecular mechanism (full–2017)
https://onlinelibrary.wiley.com/doi/full/10.1111/jnc.14021
Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor Independent Mechanisms (full–2017)  https://www.frontiersin.org/articles/10.3389/fphar.2017.00720/full
Characteristics and Treatment of Patients with Clinical Illness Due to Synthetic
Cannabinoid Inhalation Reported by Medical Toxicologists: A ToxIC Database Study  (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440319/
Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain (full–2017)  http://journals.sagepub.com/doi/full/10.1177/1744806917728227
Delirium and High Creatine Kinase and Myoglobin Levels Related to Synthetic

Cannabinoid Withdrawal (link to full–2017)  https://www.hindawi.com/journals/crim/2017/3894749/
CB1 Receptors Signaling in the Brain: Extracting Specificity from Ubiquity (link to PDF–2017) http://www.nature.com/npp/journal/vaop/naam/abs/npp2017206a.html?foxtrotcallback=true
Activation of CB2 receptor system restores cognitive capacity and hippocampal Sox2
expression in a transgenic mouse model of Alzheimer’s disease (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28551012
Chronic CB1 cannabinoid receptor antagonism persistently increases dendritic spine  densities in brain regions important to zebra finch vocal learning and production in an antidepressant-sensitive manner (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28743448
Chapter Eleven – Is the Cannabinoid CB2 Receptor a Major Regulator of the  Neuroinflammatory Axis of the Neurovascular Unit in Humans? (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1054358917300376?via%3Dihub
Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0014488617302212
Managing neuropathic pain in multiple sclerosis: Pharmacological interventions (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28875858
Elucidating opportunities and pitfalls in the treatment of experimental traumatic brain injury to optimize and facilitate clinical translation (abst–2017)  http://www.sciencedirect.com/science/article/pii/S014976341730088X
In vitro and in vivo pharmacological characterization of ASP8477: A novel highly
selective fatty acid amide hydrolase inhibitor (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29017758
Acute side effects after consumption of the new synthetic cannabinoids ABCHMINACA and MDMB-CHMICA (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29072524
Endocannabinoid-Mediated Potentiation of Non-Nociceptive Synapses Contributes to
Behavioral Sensitization (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29118192
Maternal Cannabinoid Use Alters Cannabinoid (CB1) and Endothelin (ETB) Receptor
Expression in the Brains of Dams but Not Their Offspring (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29131068
Enantiomer-specific positive allosteric modulation of CB1 signaling in autaptic  hippocampal neurons (abst–2017)  http://www.sciencedirect.com/science/article/pii/S104366181730871X?via%3Dihub
Neuroprotective effects of drug-induced therapeutic hypothermia in central nervous
system diseases (abst–2017) http://www.eurekaselect.com/152965/article
A Review of Adjunctive CNS Medications Used for the Treatment of Post-Surgical Pain  (abst–2017) https://link.springer.com/article/10.1007%2Fs40263-017-0440-1
Pharmacological inhibition of FAAH modulates TLR-induced neuroinflammation, but
not sickness behaviour: An effect partially mediated by central TRPV1 (abst–2017)
https://www.sciencedirect.com/science/article/pii/S0889159117300594?via%3Dihub
The endocannabinoid system in canine Steroid-Responsive Meningitis-Arteritis and
Intraspinal Spirocercosis (full–2018) 
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0187197
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System (full–2018) http://www.mdpi.com/1422-0067/19/3/833/htm
Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896684/
Canine NAPEPLD-associated models of human myelin disorders (full–2018)  https://www.nature.com/articles/s41598-018-23938-7
Pediatric Death Due to Myocarditis After Exposure to Cannabis (full–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965161/
An Inflammation-Centric View of Neurological Disease: Beyond the Neuron (full-2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871676/

Understanding the endocannabinoid system as a modulator of the trigeminal pain response to concussion (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122691/

Neuromodulation of Synaptic Transmission in the Main Olfactory Bulb (full–2018) https://www.mdpi.com/1660-4601/15/10/2194/htm

Cannabidiol’s Upregulation of N-acyl Ethanolamines in the Central Nervous System Requires N-acyl Phosphatidyl Ethanolamine-Specific Phospholipase D (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277981/

The Pharmacological Inhibition of Fatty Acid Amide Hydrolase Prevents Excitotoxic Damage in the Rat Striatum: Possible Involvement of CB1 Receptors Regulation (link to PDF–2018) https://www.researchgate.net/publication/325369339_The_Pharmacological_Inhibition_of_Fatty_Acid_Amide_Hydrolase_Prevents_Excitotoxic_Damage_in_the_Rat_Striatum_Possible_Involvement_of_CB1_Receptors_Regulation

Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels (link to PDF–2018) https://www.researchgate.net/publication/325611730_Antidepressantlike_effect_induced_by_Cannabidiol_is_dependent_on_brain_serotonin_levels

Cannabis cures the spine (article–2018) https://www.jtcvs.org/article/S0022-5223(18)32080-4/fulltext
Hunger, ghrelin and the gut (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0006899318300386
2-AG limits Theiler’s virus induced acute neuroinflammation by modulating microglia and promoting MDSCs (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29484707
N-Docosahexaenoylethanolamine: A neurotrophic and neuroprotective metabolite of
docosahexaenoic acid (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0098299718300244
Phyto and endocannabinoids exert complex actions on calcium and zinc signaling in
mouse cortical neurons (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0006295218301461
Positron emission tomography of type 2 cannabinoid receptors for detecting
inflammation in the central nervous system (abst–2018) https://www.semanticscholar.org/paper/Positron-emission-tomography-of-type-2-cannabinoid-NiMu/c9104245538a8ab64d6c26782a1dcfdb4e4d7e3b

Modulation of the Cannabinoid System: A New Perspective for the Treatment of the
Alzheimer’s Disease (abst–2018) 
https://www.ncbi.nlm.nih.gov/pubmed/29962346
Developmental and behavioral effects in neonatal and adult mice following prenatal
activation of endocannabinoid receptors by capsaicin (abst–2018)
https://www.nature.com/articles/s41401-018-0073-z
Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia (abst–2018) https://link.springer.com/article/10.1007%2Fs00213-018-4982-9

Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S000629521830337X

β-Amyrin, the cannabinoid receptors agonist, abrogates mice brain microglial cells inflammation induced by lipopolysaccharide/interferon-γ and regulates Mφ1/Mφ2 balances (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0753332217358201?via%3Dihub

Cannabis: From a Plant That Modulates Feeding Behaviors toward Developing Selective Inhibitors of the Peripheral Endocannabinoid System for the Treatment of Obesity and Metabolic Syndrome (full–2019) https://www.mdpi.com/2072-6651/11/5/275/htm

Contrasting Roles of Cannabidiol as an Insecticide and Rescuing Agent for Ethanol induced Death in the Tobacco Hornworm Manduca sexta (full–2019) https://www.nature.com/articles/s41598-019-47017-7

Elevated Levels of Arachidonic Acid-Derived Lipids Including Prostaglandins and Endocannabinoids Are Present Throughout ABHD12 Knockout Brains: Novel Insights Into the Neurodegenerative Phenotype (full–2019) https://www.frontiersin.org/articles/10.3389/fnmol.2019.00142/full
Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Targets (full–2019) https://www.frontiersin.org/articles/10.3389/fnmol.2019.00094/full
Endocannabinoid System and Alcohol Abuse Disorders (abst–2019) https://link.springer.com/chapter/10.1007%2F978-3-030-21737-2_6
A Cannabinoid Receptor-Mediated Mechanism Participates in the Neuroprotective Effects of Oleamide Against Excitotoxic Damage in Rat Brain Synaptosomes and Cortical Slices (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31286434
Role of the endocannabinoid system in neurological disorders (abst–2019) https://www.sciencedirect.com/science/article/abs/pii/S0736574818302995?via%3Dihub


COCAINE and the ENDOCANNABINOID SYSTEM
Cocaine-induced endocannabinoid release modulates behavioral and neurochemical
sensitization in mice (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913738/
Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area (full–2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2900926-2
CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in  rats (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703460/
Cannabidiol Rescues Acute Hepatic Toxicity and Seizure Induced by Cocaine (full–2015) http://www.hindawi.com/journals/mi/2015/523418/
Enhancement of endocannabinoid signalling protects against cocaine-induced  neurotoxicity (full–2015)  http://www.sciencedirect.com/science/article/pii/S0041008X15001556
Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits
potential of cannabinoids for crack-cocaine use (full–2015)  http://www.ijdp.org/article/S0955-3959(15)00300-X/fulltext
Cannabidiol, a Cannabis sativa constituent, inhibits cocaine-induced seizures in mice: Possible role of the mTOR pathway and reduction in glutamate release (abst–2015) http://www.sciencedirect.com/science/article/pii/S0161813X15001229
Comprehensive monitoring of the occurrence of 22 drugs of abuse and transformation products in airborne particulate matter in the city of Barcelona (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0048969715302254
Effects of Cannabinoid Exposure during Adolescence on the Conditioned Rewarding
Effects of WIN 55212-2 and Cocaine in Mice: Influence of the Novelty-Seeking Trait  (full–2016) http://www.hindawi.com/journals/np/2016/6481862/
Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid mediated disinhibition of dopaminergic neurons (full–2016)  http://www.nature.com/ncomms/2016/160722/ncomms12199/full/ncomms12199.html
Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via
Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats (full–2016) http://ijnp.oxfordjournals.org/content/early/2016/12/19/ijnp.pyw102.long
Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a  comprehensive review (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845302/
A role for the endocannabinoid 2-arachidonoyl-sn-glycerol for social and high-fat food reward in male mice (full-2016) http://www.ncbi.nlm.nih.gov/pubmed/26873082
Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats (full–2016)  http://journals.sagepub.com/doi/full/10.1177/0269881116667706
Opposite regulation of cannabinoid CB1 and CB2 receptors in the prefrontal cortex of rats treated with cocaine during adolescence (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/26797579
Estradiol impacts the endocannabinoid system in female rats to influence behavioral and structural responses to cocaine (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0028390816302428
Cocaine-induced behavioral sensitization decreases the expression of endocannabinoid  signaling-related proteins in the mouse hippocampus (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26811312
Influence of thermal hair straightening on cannabis and cocaine content in hair  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26826847
Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine
Withdrawal Symptoms in Adult Mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486147/
Psychostimulant Effect of the Synthetic Cannabinoid JWH-018 and AKB48: Behavioral, Neurochemical, and Dopamine Transporter Scan Imaging Studies in Mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543288/
CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ9-
Tetrahydrocannabinol (Δ9-THC)-Induced Aversive Effects in Mice (full–2017)  https://www.nature.com/articles/s41598-017-12399-z
The Epac-phospholipase Cε pathway regulates endocannabinoid signaling and cocaine induced disinhibition of VTA dopamine neurons (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354337/
Post-sensitization treatment with rimonabant blocks the expression of cocaine-induced 
behavioral sensitization and c-Fos protein in mice (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0091305717301995?via%3Dihub
Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28399488
Cannabis and cue-induced craving in cocaine-dependent individuals: A pilot study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28431292
Epigenetic mechanisms associated with addiction-related behavioural effects of nicotine and/or cocaine: implication of the endocannabinoid system (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28704272
Demographic and clinical characteristics of treatment seeking women with full and  subthreshold PTSD and concurrent cannabis and cocaine use disorders (abst–2017) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(17)30009-0/fulltext
17β-Estradiol Potentiates the Reinstatement of Cocaine Seeking in Female Rats: Role of the Prelimbic Prefrontal Cortex and Cannabinoid Type-1 Receptors (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28825421
Occurrence of illicit drugs in water and wastewater, and their removal during wastewater treatment (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0043135417306413
Stress Promotes Drug Seeking Through Glucocorticoid-Dependent Endocannabinoid
Mobilization in the Prelimbic Cortex (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29100630
Cannabinoid Modulation of Eukaryotic Initiation Factors (eIF2α and eIF2B1) and
Behavioral Cross-Sensitization to Cocaine in Adolescent Rats (full–2018)
http://www.cell.com/cell-reports/fulltext/S2211-1247(18)30259-6
Effects of Cocaine Self-Administration and Its Extinction on the Rat Brain Cannabinoid CB1 and CB2 Receptors (full–2018)
https://link.springer.com/article/10.1007%2Fs12640-018-9910-6
Unique treatment potential of cannabidiol for the prevention of relapse to drug use:
preclinical proof of principle (full-2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098033/

Psychoactive substances and violent offences: A retrospective analysis of presentations to an urban emergency department in Switzerland (full–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875877/
Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross sensitization without affecting the escalation of cocaine self-administration in adulthood (full–2018) https://www.nature.com/articles/s41598-018-31921-5
Does perception of drug-related harm change with age? A cross-sectional online survey of young and older people (full–2018) https://bmjopen.bmj.com/content/8/11/e021109.long
Drug Use during Pregnancy and its Consequences: A Nested Case Control Study on
Severe Maternal Morbidity (full in English, abst in Portuguese–2018)
https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0038-1667291

Drug Use during Pregnancy and its Consequences: A Nested Case Control Study on Severe Maternal Morbidity (full in English, abst in Portuguese–2018) https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0038-1667291

Toxoplasma gondii seropositivity and substance use in US adults (link to full–2018) http://folia.paru.cas.cz/artkey/fol-201801-0011_toxoplasma_gondii_seropositivity_and_substance_use_in_us_adults.php

Influence of substance use and cognitive impairment on adherence to antiretroviral therapy in HIV+ patients (abst in English, link to abst in Spanish–2018) https://www.ncbi.nlm.nih.gov/pubmed/30627722
Fatty acid binding protein deletion prevents stress-induced preference for cocaine and dampens stress-induced corticosterone levels (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29457656
Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the
Growth and Development of Their Offspring in Early Childhood (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29694295

Loren Parsons’ contribution to addiction neurobiology (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29949237
The Use of Psychoactive Substances and Illegal Drugs in the Albanian Society (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30070180
Racial disparities in discontinuation of long-term opioid therapy following illicit drug use among black and white patients (abst–2018) https://www.sciencedirect.com/science/article/pii/S0376871618303855
Opposing roles of type-1 and type-2 cannabinoid receptors in cocaine stimulant and rewarding effects (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30101419
FAAH variant Pro129Thr modulates subjective effects produced by cocaine administration (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30126012

Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus (abst–2018) https://www.sciencedirect.com/science/article/pii/S0028390818307135?via%3Dihub

A fully automated approach for the analysis of 37 psychoactive substances in raw wastewater based on on-line solid phase extraction-liquid chromatography-tandem mass spectrometry (abst–2018) https://www.sciencedirect.com/science/article/pii/S0021967318311890?via%3Dihub

Marijuana, tobacco, alcohol and cocaine use during pregnancy in 2013 and 2016. A self report study in Montevideo, Uruguay (links to PDF in English & Spanish–2019) http://adicciones.es/index.php/adicciones/article/view/1107
Wastewater-based monitoring of illicit drug consumption in Istanbul: Preliminary results from two districts (abst–2019) https://www.sciencedirect.com/science/article/pii/S0048969718347016?via%3Dihub
Differential Impact According to Mission’s Operational Intensity on Psychoactive Substance Use: A Retrospective Cohort of French Male Army Service Members (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30648459
Correspondence between Oral Fluid Drug Test Results and Self-Reported Illicit Drug Use among Music Festival Attendees (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30860932
Substance use is independently associated with pneumonia severity in persons living with the human immunodeficiency virus (HIV) (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30883265
Medical marijuana laws are associated with increases in substance use treatment admissions by pregnant women (abst–2019) https://onlinelibrary.wiley.com/doi/abs/10.1111/add.14661
Distinct inflammatory profiles in HIV-infected individuals under ART using cannabis, cocaine or cannabis plus cocaine (Brazil) (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31259759


COHORT/LARGE STUDIES
A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676097/
METABOLIC EFFECTS OF MARIJUANA USE AMONG BLACKS (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523241/
Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH) (full–2015)
http://cid.oxfordjournals.org/content/61/1/40.long
K2 and Spice use among a cohort of college students in southeast region of the USA (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526379/
Adolescent cannabis and tobacco use and educational outcomes at age 16: birth cohort study (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405050/
Prevalence of Marijuana and Other Substance Use Before and After Washington State’s Change from Legal Medical Marijuana to Legal Medical and Non-Medical Marijuana: Cohort Comparisons in a Sample of Adolescents (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744815/
Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the  California Men’s Health Study (full–2015) http://www.goldjournal.net/article/S0090-4295(14)01206-0/fulltext
Who receives cannabis use offers: A general population study of adolescents (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26433564
Association between marijuana use and adverse obstetrical and neonatal outcomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26401751
Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26233612
Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis
Spasticity in Italy: First Data from a Large Observational Study (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26571097
Marijuana use and pregnancy: prevalence, associated characteristics, and birth  outcomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25895138
Maternal marijuana use and neonatal morbidity (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26026918
Assessing the overlap between tobacco and marijuana: Trends in patterns of co-use of tobacco and marijuana in adults from 2003-2012 (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26036666
top
Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study (full–2016) http://jop.sagepub.com/content/early/2016/01/06/0269881115622241.full
Trends in cannabis use disorders among racial/ethnic population groups in the United States (full–2016) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30147-8/fulltext
Cannabis Use as Risk or Protection for Type 2 Diabetes: A Longitudinal Study of 18 000 Swedish Men and Women (full–2016) https://www.hindawi.com/journals/jdr/2016/6278709/
Assessment of rates of recanting and hair testing as a biological measure of drug use in a general population sample of young people (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/add.13645/full
Cannabis, Tobacco, Alcohol Use, and the Risk of Early Stroke: A Population-Based Cohort Study of 45 000 Swedish Men (full–2016)  http://stroke.ahajournals.org/content/48/2/265.long
Identifying HIV care enrollees at-risk for cannabis use disorder (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573588/
Marijuana users do not have increased healthcare utilization: A National Health and

Nutrition Examination Survey (NHANES) study (1st page–2016)  http://www.ejinme.com/article/S0953-6205(16)30231-X/fulltext
The old open question of marijuana and healthcare: Flares from NANHES (1st page–2016) http://www.ejinme.com/article/S0953-6205(16)30256-4/fulltext
Child maltreatment and cannabis use in young adulthood: A birth cohort study (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27741369
Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015 (abst–2016)  http://www.drugandalcoholdependence.com/article/S0376-8716(16)30215-0/fulltext
Changing perspectives on marijuana use during early adolescence and young adulthood: Evidence from a panel of cross-sectional surveys (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27750184
Prior Cannabis Use Is Associated with Outcome after Intracerebral Hemorrhage (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26820826
A longitudinal examination of the relationship between cannabis use and cognitive
function in mid-life adults (abst–2016) 
https://www.drugandalcoholdependence.com/article/S0376-8716(16)30966-8/fulltext
Childhood academic ability in relation to cigarette, alcohol and cannabis use from  adolescence into early adulthood: Longitudinal Study of Young People in England  (LSYPE) (full–2017) http://bmjopen.bmj.com/content/7/2/e012989.long

Cannabis and intractable chronic pain: an explorative retrospective analysis of Italian cohort of 614 patients (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449133/
Patterns of cannabis use during adolescence and their association with harmful substance use behaviour: findings from a UK birth cohort (full–2017)  http://jech.bmj.com/content/71/8/764
Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana (full–2017) http://pediatrics.aappublications.org/content/139/4/e20162675.long
Associations between Cannabis Use and Physical Health Problems in Early Midlife: A
Longitudinal Comparison of Persistent Cannabis versus Tobacco Users (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936934/
Synthetic Cannabinoid Use Among High School Seniors (full–2017)  http://pediatrics.aappublications.org/content/early/2017/09/07/peds.2017-1330.long
Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0176416
Cannabis, alcohol and fatal road accidents (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678710/
Frequency of Cannabis Use Among Primary Care Patients in Washington State (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769869/
Recreational Marijuana Use and Acute Myocardial Infarction: Insights from Nationwide Inpatient Sample in the United States (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752226/
Evidence for Sex Convergence in Prevalence of Cannabis Use: A Systematic Review and Meta-Regression (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440360/
Cognitive Functioning of Adolescent and Young Adult Cannabis Users in the
Philadelphia Neurodevelopmental Cohort (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468477/
Is recovery from cannabis use problems different from alcohol and other drugs? Results from a national probability-based sample of the United States adult population (full–2017) https://www.ijdp.org/article/S0955-3959(17)30363-8/fulltext
Cannabis Use and Disorder From Childhood to Adulthood in a Longitudinal Community Sample With American Indians (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564181/
Patterns of simultaneous and concurrent alcohol and marijuana use among adolescents (full–2017) https://www.tandfonline.com/doi/full/10.1080/00952990.2017.1402335
Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders  (1st page–2017) http://jamanetwork.com/journals/jama/article-abstract/2610319

Modelling possible causality in the associations between unemployment, cannabis use, and alcohol misuse (abst–2017) http://www.sciencedirect.com/science/article/pii/S0277953617300011
Whole genome sequence study of cannabis dependence in two independent cohorts  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28111843
Cannabis use and the course and outcome of major depressive disorder: A population  based longitudinal study (abst–2017) http://www.psy-journal.com/article/S0165-1781(16)31187-8/abstract
Cannabis use and mental health-related quality of life among individuals with depressive disorders (abst–2017) http://www.psy-journal.com/article/S0165-1781(15)30306-1/fulltext
Marijuana Use and Self-reported Quality of Eyesight (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28422803
Early cannabis initiation and educational attainment: is the association causal? Data from the French TEMPO study (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28520946
Examination of cumulative effects of early adolescent depression on cannabis and  alcohol use disorder in late adolescence in a community-based cohort (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28600897
Substantiated childhood maltreatment and young adulthood cannabis use disorders: A pre-birth cohort study (abst–2017) http://www.psy-journal.com/article/S0165-1781(16)31722-X/fulltext
Associations between Adolescent Cannabis Use and Neuropsychological Decline: A

Longitudinal Co-Twin Control Study (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28734078
Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015 (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28421836
Marijuana and tobacco co-use among a nationally representative sample of US pregnant and non-pregnant women: 2005-2014 National Survey on Drug Use and Health findings (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28599211
Predicting Persistent, Limited, and Delayed Problematic Cannabis Use in Early  Adulthood: Findings From a Longitudinal Study (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29096779
Marijuana use during pregnancy: A comparison of trends and correlates among married and unmarried pregnant women (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30531-8/fulltext
Association Between Marijuana Use and Sexual Frequency in the United States: A  Population-Based Study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29110804
Associations between medical cannabis and other drug use among unstably housed
women (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29227883
Social Stress and Substance Use Disparities by Sexual Orientation Among High School Students (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28826950
Changes and specificities in health behaviors among healthcare students over an 8-year period (full–2018) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0194188
Nineteen and Up study (19Up): understanding pathways to mental health disorders in young Australian twins (full–2018)  http://bmjopen.bmj.com/content/8/3/e018959.long
Plasma anandamide concentrations are lower in children with autism spectrum disorder (full–2018) https://molecularautism.biomedcentral.com/articles/10.1186/s13229-018-0203-y
Job exposure to the public in relation with alcohol, tobacco and cannabis use: Findings from the CONSTANCES cohort study (full–2018)
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0196330
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort (full–2018) https://link.springer.com/article/10.1186/s10194-018-0862-2
The Belfast Youth Development Study (BYDS): A prospective cohort study of the
initiation, persistence and desistance of substance use from adolescence to adulthood in Northern Ireland (full–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965826/
Recreational marijuana legalization and prescription opioids received by Medicaid enrollees (full–2018) https://www.sciencedirect.com/science/article/pii/S0376871618307567
Past-month cannabis use among U.S. individuals from 2002–2015: An age-period-cohort analysis (full–2018) https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S0376871618307415?returnurl=null&referrer=null
Comorbidity of Symptoms of Alcohol and Cannabis Use Disorders among a Population Based Sample of Simultaneous Users. Insight from a Network Perspective (full–2018) https://www.mdpi.com/1660-4601/15/12/2893/htm
Prevalence and Sociodemographic Correlates of Adolescent Use and Polyuse of Combustible, Vaporized, and Edible Cannabis Products (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324616/
Increased Levels of Circulating Fatty Acids Are Associated with Protective Effects against Future Cardiovascular Events in Nondiabetics (link to PDF–2018) https://www.researchgate.net/publication/321784276_Increased_Levels_of_Circulating_Fatty_Acids_Are_Associated_with_Protective_Effects_against_Future_Cardiovascular_Events_in_Nondiabetics
Trends in and correlates of medical marijuana use among adults in the United States (link to PDF–2018) https://www.researchgate.net/publication/323763594_Trends_in_and_correlates_of_medical_marijuana_use_among_adults_in_the_United_States
Marijuana is not associated with progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis (link to PDF–2018) https://www.researchgate.net/publication/327798677_Marijuana_is_not_associated_with_progression_of_hepatic_fibrosis_in_liver_disease_a_systematic_review_and_meta-analysis

Relation of Cannabis Use and Atrial Fibrillation Among Patients Hospitalized for Heart Failure (link to PDF–2018) https://www.researchgate.net/publication/324061333_Relation_of_Cannabis_Use_and_Atrial_Fibrillation_Among_Patients_Hospitalized_for_Heart_Failure
Association of Marijuana Use With Psychosocial and Quality of Life Outcomes Among Patients With Head and Neck Cancer (download–2018) https://www.sativaisticated.com/wp-content/uploads/2018/08/Association-of-Marijuana-Use-With-Psychosocial-and-Quality-of-Life-Outcomes-Among-Patients-With-Head-and-Neck-Cancer-Medical-Cannabis-Medical-Marijuana-Research-Study-for-Head-and-Neck-Cancer.pdf
Alcohol and Drug Use among Deaf and Hard-of-Hearing Individuals: A Secondary Analysis of NHANES 2013-2014 (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29452067
The impact of cohort substance use upon likelihood of transitioning through stages of alcohol and cannabis use and use disorder: Findings from the Australian National Survey on Mental Health and Wellbeing (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29505682
Population-level predictions from cannabis risk perceptions to active cannabis use prevalence in the United States, 1991-2014 (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0306460318300959
The association between lifetime cannabis use and dysthymia across six birth decades (abst–2018) http://www.jad-journal.com/article/S0165-0327(17)32436-9/fulltext
Gender- and age-varying associations of sensation seeking and substance use across young adulthood (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0306460318304453
Self-Reported Tobacco, Alcohol, and Illicit Drug Use and Progression of Chronic Kidney Disease (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29880471
Additive drug-specific and sex-specific risks associated with co-use of marijuana and
tobacco during pregnancy: Evidence from 3 recent developmental cohorts (2003-2015) (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0892036218300266?via%3Dihub
The Initiation of Cannabis Use in Adolescence is Predicted by Sex-Specific Psychosocial and Neurobiological Features (abst–2018) https://www.researchgate.net/publication/325702973_The_Initiation_of_Cannabis_Use_in_Adolescence_is_Predicted_by_SexSpecific_Psychosocial_and_Neurobiological_Features
Genome-wide association meta-analysis of age at first cannabis use (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30003630
Genetic vulnerability to schizophrenia is associated with cannabis use patterns during adolescence (abst–2018)  https://www.drugandalcoholdependence.com/article/S0376-8716(18)30339-9/fulltext
Early Cannabis Use and Neurocognitive Risk: A Prospective Functional Neuroimaging Study (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30033100
Trends in cannabis use disorder by cigarette smoking status in the United States, 2002–2016 (abst–2018) https://www.sciencedirect.com/science/article/pii/S0376871618303776
Cigarette and Cannabis Use in Young Swiss Men: Examination of the Bidirectional, Longitudinal Associations Between Frequency of Use and Descriptive Norms (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30079874
The end of convergence in developmental patterns of frequent marijuana use from ages 18 to 30: An analysis of cohort change from 1976-2016 (abst–2018) https://www.sciencedirect.com/science/article/pii/S0376871618304241
Relative influence of perceived peer and family substance use on adolescent alcohol, cigarette, and marijuana use across middle and high school (abst–2018) https://www.sciencedirect.com/science/article/pii/S0306460318306014?via%3Dihub
Trends and correlates of cannabis use in pregnancy: a population-based study in Ontario, Canada from 2012 to 2017 (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30387034
Factors associated with cannabis use change in youth: Evidence from the COMPASS study (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0306460318310207?via%3Dihub
Associations between cannabis use and cardiometabolic risk factors: A longitudinal study of men (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30589665
Exploring associations between early substance use and longitudinal socio-occupational functioning in young people engaged in a mental health service (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336340/
Prelegalisation patterns and trends of cannabis use among Canadian youth: results from the COMPASS prospective cohort study (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475172/
Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution TherapyData From the German Hepatitis C-Registry (DHC-R) (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440029/
Perceived Racial Discrimination and Marijuana Use a Decade Later; Gender Differences Among Black Youth (full–2019) https://www.frontiersin.org/articles/10.3389/fped.2019.00078/full
In-hospital outcomes of inflammatory bowel disease in cannabis users: a nationwide propensity-matched analysis in the United States (full–2019) http://atm.amegroups.com/article/view/25637/24217
Smoke Exposure, Cytokine Levels, and Asthma Visits in Children Hospitalized for Bronchiolitis (abst–2019) http://hosppeds.aappublications.org/content/9/1/46.abstract
No influence of cannabis use on liver stiffness in HIV-HCV co-infected patients (ANRS CO13 HEPAVIH cohort study) (abst–2019) https://insights.ovid.com/pubmed?pmid=30575641
Young adult longitudinal patterns of marijuana use among US National samples of 12th grade frequent marijuana users: a repeated-measures latent class analysis (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30614105Associations Between Cannabis Use, Sexual Behavior, and Sexually Transmitted Infections/Human Immunodeficiency Virus in a Cohort of Young Men Who Have Sex With Men (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30640212
Not getting high with a little help from your friends: Social versus drug network correlates of marijuana use among YMSM (abst–2019) https://www.sciencedirect.com/science/article/abs/pii/S0306460318308244?via%3Dihub
Differential Impact According to Mission’s Operational Intensity on Psychoactive Substance Use: A Retrospective Cohort of French Male Army Service Members (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30648459
The role of energy drink consumption in the intention to initiate marijuana use among adolescents (abst–2019) https://www.sciencedirect.com/science/article/abs/pii/S0306460319301285?via%3Dihub
Age, period and cohort effects in frequent cannabis use among US students: 1991-2018 (abst–2019) https://onlinelibrary.wiley.com/doi/abs/10.1111/add.14665
Medical Cannabis: Effects on Opioid and Benzodiazepine Requirements for Pain Control (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31129977
Cannabis Use Preferences and Decision-making Among a Cross-sectional Cohort of Medical Cannabis Patients with Chronic Pain (abst–2019) https://www.jpain.org/article/S1526-5900(19)30067-7/fulltext
Surveys of pharmacy students and pharmacy educators regarding medical marijuana (abst–2019) https://www.sciencedirect.com/science/article/abs/pii/S1877129718302594?via%3Dihub
Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population-based cohort study (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31240747
Cessation of cannabis use: A retrospective cohort study (abst–2019) https://www.sciencedirect.com/science/article/abs/pii/S0165178119307590?via%3Dihub


COLITIS*+
GPR55 – a putative “type 3” cannabinoid receptor in inflammation (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0080/jbcpp-2015-0080.xml
Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556478/
The GPR55 antagonist CID16020046 protects against intestinal inflammation (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587547/
Gastric mucosal protection: from the periphery to the central nervous system (link to PDF–2015) http://www.jpp.krakow.pl/journal/archive/06_15/pdf/319_06_15_article.pdf
top
Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25699149
Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment (full–2016) http://journal-inflammation.biomedcentral.com/articles/10.1186/s12950-016-0129-0
Endocannabinoids in the Gut (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940133/
The CB2 receptor and its role as a regulator of inflammation (full–2016) http://link.springer.com/article/10.1007%2Fs00018-016-2300-4
Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK (full–2016) http://www.wjgnet.com/1007-9327/full/v22/i43/9515.htm
An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse (full-2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047908/
Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017608/
Therapeutic Use of Cannabis in Inflammatory Bowel Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193087/
Role of cannabinoids in gastrointestinal mucosal defense and inflammation (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333598/
Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154806/

Cannabis in Inflammatory Bowel Diseases: from Anecdotal Use to Medicalization? (link to PDF–2016) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4045
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn’s Disease and Ulcerative Colitis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26561079 Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27875353
Application of carbon nanotubes as the carriers of the cannabinoid, 2- arachidonoylglycerol: Towards a novel treatment strategy in colitis (abst–2016) http://www.sciencedirect.com/science/article/pii/S002432051630666X
The Anti-Inflammatory Effect and Intestinal Barrier Protection of HU210 Differentially Depend on TLR4 Signaling in Dextran Sulfate Sodium-Induced Murine Colitis (abst–2016) http://link.springer.com/article/10.1007%2Fs10620-016-4404-y
We are not alone: a case for the human microbiome in extra intestinal diseases (full–2017) https://gutpathogens.biomedcentral.com/articles/10.1186/s13099-017-0163-3
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells (full–2017)  http://journals.sagepub.com/doi/full/10.1177/2050640617698622
Host-probiotic interaction: new insight into the role of the endocannabinoid system by in vivo and ex vivo approaches (full–2017)  https://www.nature.com/articles/s41598-017-01322-1
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we  go? (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388177/
Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-
Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis
Extracts (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627671/
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721977/
Elevation of arachidonoylethanolamide levels by activation of the endocannabinoid  system protects against colitis and ameliorates remote organ lesions in mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740744/
G protein-coupled receptor 55 (GPR55) expresses differently in patients with Crohn’s  disease and ulcerative colitis (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/00365521.2017.1298834?journalCode=igas20
The Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111500/
Intestinal P-glycoprotein exports endocannabinoids to prevent inflammation and maintain homeostasis (full–2018) https://www.jci.org/articles/view/96817
Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease? (full–2018) https://academic.oup.com/ibdjournal/advance-article-abstract/doi/10.1093/ibd/izy230/5055343?redirectedFrom=fulltext
Cannabis, cannabinoids and the endocannabinoid system – is there therapeutic potential for inflammatory bowel disease? (full–2018) https://academic.oup.com/ecco-jcc/advance-article/doi/10.1093/ecco-jcc/jjy185/5173479
Cannabis for the treatment of ulcerative colitis (summary in English & Spanish–2018) https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012954.pub2/full
The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29562280
The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information: Commissioned by the Crohn’s and Colitis Foundation (abst–2018) https://academic.oup.com/ibdjournal/advance-article-abstract/doi/10.1093/ibd/izy319/5144402?redirectedFrom=fulltext
In-hospital outcomes of inflammatory bowel disease in cannabis users: a nationwide propensity-matched analysis in the United States (full–2019) http://atm.amegroups.com/article/view/25637/24217
Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer (full–2019) https://www.nature.com/articles/s41598-019-38865-4
Use of Medical Cannabis in Patients With Inflammatory Bowel Disease (interview–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366240/
Association between cannabis use and complications related to ulcerative colitis in hospitalized patients: A propensity matched retrospective cohort study (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31393356


CONCUSSIONS 
Abnormalities in Dynamic Brain Activity Caused by Mild Traumatic Brain Injury Are Partially Rescued by the Cannabinoid Type-2 Receptor Inverse Agonist SMM-189 (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562300/
Review of the neurological benefits of phytocannabinoids (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938896/
Cannabis and the Health and Performance of the Elite Athlete (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116792/
Understanding the endocannabinoid system as a modulator of the trigeminal pain response to concussion (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122691/


CONSTIPATION+
Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of  constipation (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459026/
Uncovering the Mechanisms of Chinese Herbal Medicine (MaZiRenWan) for Functional Constipation by Focused Network Pharmacology Approach (full–2018)
https://www.frontiersin.org/articles/10.3389/fphar.2018.00270/full

Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase synergize with the opioid analgesic morphine to suppress chemotherapy-induced neuropathic nociception without enhancing effects of morphine on gastrointestinal transit (link to PDF–2018) http://jpet.aspetjournals.org/content/early/2018/10/01/jpet.118.252288.long

Cannabinoids and gastrointestinal motility: Pharmacology, clinical effects, and potential therapeutics in humans (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29745439

Cannabinoid pharmacology and therapy in gut disorders (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303186

Using Twitter to Understand the Human Bowel Disease Community: Exploratory Analysis of Key Topics (full–2019) https://www.jmir.org/2019/8/e12610/


COPD/CHRONIC OBSTRUCTIVE PULMONARY DISEASE*+
Cannabis, tobacco smoking, and lung function: a cross-sectional observational study in a general practice population (full–2015) http://bjgp.org/content/65/631/e89
top

Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup  (full-2015)  http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough (full–2015)  http://jpet.aspetjournals.org/content/353/1/169.long
How beneficial is vaping cannabis to respiratory health compared to smoking? (article-2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13075/full
Editorial: Lung macrophages high on cannabinoids: jamming PAMs and taming TAMs? (full–2016) http://www.jleukbio.org/content/99/4/518.full
The Endogenous Cannabinoid Anandamide Increases Human Airway Epithelial Cell Permeability through an Arachidonic Acid Metabolite (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26808080
Cannabis and lung. What we know and everything we don’t know yet (abst in English & French-2017) http://www.em-consulte.com/article/1173971/alertePM
Marijuana Use Associations with Pulmonary Symptoms and Function in Tobacco
Smokers Enrolled in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) (full–2018) 
https://journal.copdfoundation.org/jcopdf/id/1177/Marijuana-Use-Associations-with-Pulmonary-Symptoms-and-Function-in-TobaccoSmokers-Enrolled-in-the-Subpopulations-and-Intermediate-Outcome-Measures-in-COPD-Study-SPIROMICS
Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise Endurance in Advanced COPD: A Randomized Controlled Trial (full–2018)  https://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201803-198OC


CORNEAL KERATITIS
Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00304/full


COUGH+
The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough (full–2015)  http://jpet.aspetjournals.org/content/353/1/169.long
Effects of quitting cannabis on respiratory symptoms (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780250/
Endocannabinoid Inhibition Of Airway Sensory Nerve Depolarisation (abst–2015)  http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4114
Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28931663
Marijuana Use, Respiratory Symptoms, and Pulmonary Function: A Systematic Review and Meta-analysis (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29971337


COWPOX
Possible Immunosuppressive Effects of Drug Exposure and Environmental and Nutritional Effects on Infection and Vaccination (full–2015)
http://www.hindawi.com/journals/mi/2015/349176/ 


CREATIVITY and CANNABIS
Inspired by Mary Jane? Mechanisms underlying enhanced creativity in cannabis users  (abst–2017)  https://www.sciencedirect.com/science/article/pii/S1053810017303744?via%3Dihub
A Qualitative Study on the Effects of Psychoactive Substance use upon Artistic
Creativity (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29185845
Substance Use and Psychological Disorders Among Art and Non-art University Students: an Empirical Self-Report Survey (full–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814514/
Neuropsychopharmacological aesthetics: A theoretical consideration of pharmacological approaches to causative brain study in aesthetics and art (link to PDF–2018) https://www.researchgate.net/publication/325062447_Neuropsychopharmacological_aesthetics_A_theoretical_consideration_of_pharmacological_approaches_to_causative_brain_study_in_aesthetics_and_art


CRIME and CANNABIS
Drugs and Crime Facts (full–2015) http://www.bjs.gov/content/dcf/ptrpa.cfm
Cannabis Withdrawal Among Detained Adolescents: Exploring the Impact of Nicotine and Race (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331066/
Mitigation of Marijuana-Related Legal Harms to Youth in California (full–2016) https://www.semanticscholar.org/paper/Mitigation-of-Marijuana-Related-Legal-Harms-to-in-Banys/12a393eb29b1adfe8923f1bc463f8125d06349ed
Use of marijuana for medical purposes (link to PDF–2016) http://www.aaem.pl/Use-of-marijuana-for-medical-purposes,72462,0,2.html http://www.ncbi.nlm.nih.gov/pubmed/27660881

Multidimensional Family Therapy Reduces Self-Reported Criminality Among
Adolescents With a Cannabis Use Disorder (download–2017) http://www.mdft.org/mdft/media/files/Publications/van-der-Pol-et-al-%282017%29-MDFT-reduces-self-criminality-among-adolescents-with-a-cannabis-use-disorder.pdf 
Acceptability and effectiveness of a web-based psychosocial intervention among criminal justice involved adults (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346353/
Illicit drug policy in Spain: the opinion of health and legal professionals (abst in Spanish, link to PDF in English-2017)  http://www.adicciones.es/index.php/adicciones/article/view/810

Prohibition, regulation or laissez faire: The policy trade-offs of cannabis policy (full–2018) https://www.ijdp.org/article/S0955-3959(18)30094-X/fulltext
Effects of cannabis on eyewitness memory: A field study (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055797/ https://www.ncbi.nlm.nih.gov/pubmed/30069079
Risk Factors Associated With Gambling Involvement among a National Sample of African American and European American Young Adults (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233904/
High on Crime? Exploring the Effects of Marijuana Dispensary Laws on Crime in
California Counties (link to PDF–2018)
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3193321
Substance Use Outcomes for Hispanic Emerging Adults Exposed to Incarceration of a Household Member during Childhood (click “researchgate” for download–2018) https://scholar.google.com/scholar?q=Substance+Use+Outcomes+for+Hispanic+Emerging+Adults+Exposed+to+Incarceration+of+a+Household+Member+during+Childhood.&hl=en&as_sdt=0&as_vis=1&oi=scholart
ANNALS EXPRESS: Analytical evidence to show letters impregnated with novel
psychoactive substances (NPS) are a means of getting drugs to inmates within the UK
prison service (abst–2018) 
http://journals.sagepub.com/doi/abs/10.1177/0004563218767462
Religiosity, Crime, and Drug Use Among Juvenile Offenders: A Test of Reciprocal
Relationships Over Time (abst–2018) 
https://www.ncbi.nlm.nih.gov/pubmed/29749264
The Impact of the Urban Neighborhood Environment on Marijuana Trajectories During Emerging Adulthood (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29845401
Risk of criminal justice system involvement among people with co-occurring severe
mental illness and substance use disorder (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29852999
Attention deficit hyperactivity disorder and arrest history: Differential association of
clinical characteristics by sex (abst–2018) 
https://www.ncbi.nlm.nih.gov/pubmed/29853005
Characteristics of Pregnant Women Reporting Cannabis Use Disorder at Substance Use Treatment Entry (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29864087
Effects of cannabis on eyewitness memory: A field study (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/30069079
Adolescent arrestees detained in police cells: an observational study in the Paris, France, area (abst–2018) https://link.springer.com/article/10.1007%2Fs00414-018-1942-1

Trajectories of alcohol and marijuana use among primary versus secondary psychopathy variants within an adjudicated adolescent male sample (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30080061

Factors Associated With Marijuana Use Among Treatment-seeking Adult Cigarette Smokers in the Criminal Justice Population (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30394995
Synthetic cannabinoid use among a sample of individuals enrolled in community-based recovery programs: Are synthetic cannabinoids actually preferred to other drugs? (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30457960
Changes over time in marijuana use, deviant behavior and preference for risky behavior among U.S. adolescents from 2002-2014: Testing the moderating effect of gender and age (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30461115
Incarceration history, social network composition, and substance use among homeless youth in Los Angeles (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30592248
Poly-use of cannabis and other substances among juvenile-justice involved youth: variations in psychological and substance-related problems by typology (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30620228
Associations Between Cannabis Use, Sexual Behavior, and Sexually Transmitted Infections / Human Immunodeficiency Virus in a Cohort of Young Men Who Have Sex With Men (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30640212
Relationship Between Substance Use, Bullying, and Other Delinquent Behaviors Among High School Students: a Secondary Analysis of the Florida Youth Substance Abuse Survey (abst–2019) https://link.springer.com/article/10.1007%2Fs11414-019-09649-5
Long-term medical cannabis use and risk factors for diversion: report on physician’s guidance and patients’ behaviour (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31190678


CROHN’S DISEASE*+
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015) http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Monoglyceride lipase-deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity (full–2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556478/
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally-restricted manner (full–2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403103/
In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat (full–2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918633/

Gastric mucosal protection: from the periphery to the central nervous system (link to PDF–2015) http://www.jpp.krakow.pl/journal/archive/06_15/pdf/319_06_15_article.pdf
Marijuana, Reconsidered: Dr. Lester Grinspoon On 45 Years Of Cannabis Science  (interview–2015) http://www.mintpressnews.com/MyMPN/marijuana-reconsidered-an-interview-with-doctor-lestergrinspoon/
Cannabis – therapy for the future? (abst in English–2015) http://www.ncbi.nlm.nih.gov/pubmed/26375695 (abst in Czech) https://www.prolekare.cz/casopisy/vnitrni-lekarstvi/2015-7-8/konopi-lecba-budoucnosti-55723?hl=cs
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26422462
Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK (full–2016) http://www.wjgnet.com/1007-9327/full/v22/i43/9515.htm
Therapeutic Use of Cannabis in Inflammatory Bowel Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193087/
top
Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154806/
Cannabis in Inflammatory Bowel Diseases: from Anecdotal Use to Medicalization? (link to PDF–2016) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4045

Efficacy, tolerability, and safety of cannabinoids in gastroenterology : A systematic review (abst in German & English-2016)
https://link.springer.com/article/10.1007%2Fs00482-015-0087-0
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn’s Disease and Ulcerative Colitis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26561079 Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27875353
Host-probiotic interaction: new insight into the role of the endocannabinoid system by in vivo and ex vivo approaches (full–2017)  https://www.nature.com/articles/s41598-017-01322-1
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go? (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388177/
Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-
Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis
Extracts (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627671/
Cannabinoid Receptor-2 Ameliorates Inflammation in Murine Model of Crohn’s Disease (full–2017) https://academic.oup.com/ecco-jcc/article/11/11/1369/3977952
G protein-coupled receptor 55 (GPR55) expresses differently in patients with Crohn’s

disease and ulcerative colitis (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/00365521.2017.1298834?journalCode=igas20
Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn’s Disease, a Randomized Controlled Trial (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28349233
Role of cannabis in digestive disorders (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/27792038
Systematic review: interventions for abdominal pain management in inflammatory bowel disease (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28470846

The Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111500/

Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease? (full–2018) https://academic.oup.com/ibdjournal/advance-article-abstract/doi/10.1093/ibd/izy230/5055343?redirectedFrom=fulltext
Cannabis, cannabinoids and the endocannabinoid system – is there therapeutic potential for inflammatory bowel disease? (full–2018) https://academic.oup.com/ecco-jcc/advance-article/doi/10.1093/ecco-jcc/jjy185/5173479
Use of Medical Cannabis in Patients With Inflammatory Bowel Disease (interview–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366240/
Cannabis for the treatment of Crohn’s disease (abst + summary in English & Spanish–2018) https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012853.pub2/full
The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information: Commissioned by the Crohn’s and Colitis Foundation (abst–2018) https://academic.oup.com/ibdjournal/advance-article-abstract/doi/10.1093/ibd/izy319/5144402?redirectedFrom=fulltext
Profiles of Patients Who Use Marijuana for Inflammatory Bowel Disease (abst–2018) https://link.springer.com/article/10.1007%2Fs10620-018-5040-5
Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study (full–2019) https://www.cambridge.org/core/journals/palliative-and-supportive-care/article/cannabis-treatment-in-hospitalized-patients-using-thesyqe-inhaler-results-of-a-pilot-openlabel-study/0C1940413E704A7EADCB949F5F49603A/core-reader
Nabilone administration in refractory chronic diarrhea: a case series (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593541/Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic Disorders (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507278/
In-hospital outcomes of inflammatory bowel disease in cannabis users: a nationwide propensity-matched analysis in the United States (full–2019) http://atm.amegroups.com/article/view/25637/24217
Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer (full–2019) https://www.nature.com/articles/s41598-019-38865-4
Association Between Cannabis Use and Complications Related to Crohn’s Disease: A Retrospective Cohort Study (abst–2019) https://link.springer.com/article/10.1007%2Fs10620-019-05556-z


CRPS/RSD-COMPLEX REGIONAL PAIN SYNDROME/REFLEX SYMPATHETIC DYSTROPHY/CAUSALGIA+
Palmitoylethanolamide (PeaPure®) as Treatment for Chronic Regional Pain Syndrome (article–link to download–2016) https://www.worksafebc.com/en/resources/health-care-providers/guides/ebpg-rapidreview-palmitoylethanolamide-peapure-as-treatment-for-chronic-regional-pain-syndrome?lang=en
Activation of Cannabinoid Receptor 2 Attenuates Mechanical Allodynia and Neuroinflammatory Responses in a Chronic Post-Ischemic Pain Model of Complex Regional Pain Syndrome Type I in Rats (abst–2016) https://www.semanticscholar.org/paper/Activation-of-cannabinoid-receptor-2-attenuates-and-XuTang/b76958bc75f9e27fdf6bad7f451661111189e311
Medical Marijuana for Chronic Pain (full–2018) https://www.nejm.org/doi/10.1056/NEJMclde1808149?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dwww.ncbi.nlm.nih.gov
FDA Grants Orphan Drug Designation to Cannabis Pellet (article–2018) https://www.practicalpainmanagement.com/treatments/pharmacological/fda-grants-orphan-drug-designation-cannabis-pellet


CULTIVATION
The globalisation of cannabis cultivation: A growing challenge (full–2015) http://www.ijdp.org/article/S0955-3959%2815%2900003-1/fulltext
Intrusive growth of primary and secondary phloem fibres in hemp stem determines fibre bundle formation and structure (full–2015) http://aobpla.oxfordjournals.org/content/early/2015/05/27/aobpla.plv061.long
Global patterns of domestic cannabis cultivation: Sample characteristics and patterns of growing across eleven countries (full–2015) http://www.ijdp.org/article/S0955-3959%2814%2900363-6/fulltext
The Genetic Structure of Marijuana and Hemp (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0133292
Comparative genomics of a cannabis pathogen reveals insight into the evolution of pathogenicity in Xanthomonas (full–2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468381/
Impacts of surface water diversions for marijuana cultivation on aquatic habitat in four northwestern California watersheds (full–2015)
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0120016
The globalisation of cannabis cultivation: A growing challenge (full–2015) http://www.ijdp.org/article/S0955-3959%2815%2900003-1/fulltext
Are Moroccan cannabis growers able to adapt to recent European market trend? (full–2015) http://www.ijdp.org/article/S0955-3959%2814%2900336-3/fulltext
Cannabinoids Production by Hairy Root Cultures of Cannabis sativa L. (full–2015) http://file.scirp.org/Html/21-2601738_58491.htm
Levels of selected metals in leaves of Cannabis sativa L. cultivated in Ethiopia (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503701/
Patterns of Natural and Human-Caused Mortality Factors of a Rare Forest Carnivore, the Fisher (Pekania pennanti) in California (full–2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633177/
CONTROLLED SUBSTANCES CHAOS: THE DEPARTMENT OF JUSTICE’S NEW POLICY POSITION ON MARIJUANA AND WHAT IT MEANS FOR INDUSTRIAL HEMP FARMING IN NORTH DAKOTA (PDF-2015)  https://law.und.edu/_files/docs/ndlr/pdf/issues/90/3/90ndlr599.pdf
Assessing the harms of cannabis cultivation in Belgium (abst–2015)  http://www.ijdp.org/article/S0955-3959(14)00359-4/fulltext
Seized cannabis seeds cultivated in greenhouse: A chemical study by gas chromatography–mass spectrometry and chemometric analysis (full–2015)

http://www.scienceandjusticejournal.com/article/S1355-0306%2815%2900111-2/fulltext
top

Cannabis cultivation in Quebec: Between space-time hotspots and coldspots (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25620750
“Should I Buy or Should I Grow?” How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25655217
Effect of induced polyploidy on some biochemical parameters in Cannabis sativa L (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25492688
Evaluation of elemental profiling methods, including laser-induced breakdown spectroscopy (LIBS), for the differentiation of Cannabis plant material grown in different nutrient solutions (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25898182
In Vitro Propagation of Cannabis sativa L. Using meta-Topolin (abst-2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1545167
Legal issues for German-speaking cannabis growers. Results from an online survey (abst–2015) http://www.ijdp.org/article/S0955-3959%2815%2900315-1/abstract
Size matters: evolution of large drug-secreting resin glands in elite pharmaceutical strains of Cannabis sativa (marijuana) (abst–2015) http://link.springer.com/article/10.1007/s10722-015-0254-2
Molecular cytogenetic analysis of monoecious hemp (Cannabis sativa L) cultivars reveals its karyotype variations and sex chromosomes constitution (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26149370
Expansion of female sex organs in response to prolonged virginity in Cannabis sativa (marijuana) (abst–2015) http://www.agr.gc.ca/eng/abstract/?id=35387000000564
Tyler Markwart: The Case For GMO Cannabis (interview–2015) http://www.ganjapreneur.com/tyler-markwart-gmo-marijuana/
DIY test to find high CBD plants grown from seeds (forum post–2015)
http://forum.grasscity.com/medical-marijuana-usage-applications/1368614-diy-test-find-high-cbd-plants-grown-seeds.html
Cannabis sativa
: The Plant of the Thousand and One Molecules (full–2016) http://journal.frontiersin.org/article/10.3389/fpls.2016.00019/full

High Time for Conservation: Adding the Environment to the Debate on Marijuana Liberalization (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776720/
Studying Secondary Growth and Bast Fiber Development: The Hemp Hypocotyl Peeks behind the Wall (full–2016) http://journal.frontiersin.org/article/10.3389/fpls.2016.01733/full
A Belated Green Revolution for Cannabis: Virtual Genetic Resources to Fast-Track Cultivar Development (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965456/
Monitoring Metabolite Profiles of Cannabis sativa L. Trichomes during Flowering Period Using 1H NMR-Based Metabolomics and Real-Time PCR (full–2016)  https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0042-108058
Transcriptome differences between fiber-type and seed-type Cannabis sativa variety
exposed to salinity (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120038/
What Should We Tell Our Patients About Marijuana (Cannabis indica and Cannabis
sativa)? (full–2016) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312838/
Greening the black market: understanding and learning from the diversification of
cannabis supply laws (full–2016) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446799/
Abnormal Meiosis in Tetraploid (4x) Cannabis sativa from Lahaul-spiti (Cold Desert

High Altitude Himalayas)-A Neglected But Important Herb (download–2016)  http://www.eresearchco.com/jbcc-pdf/6%20VKS%20JBCC%202_1_.pdf
Applications To Become Registered Under the Controlled Substances Act To Manufacture Marijuana To Supply Researchers in the United States. Policy statement (click “Link out” for download–2016) http://www.ncbi.nlm.nih.gov/pubmed/27529905
DEA Announces Actions Related to Marijuana and Industrial Hemp (article–2016)  https://www.dea.gov/divisions/hq/2016/hq081116.shtml
Farming medical ganja in Jamaica (1st page–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27296757
Hashish in Morocco and Lebanon: A comparative study (abst–2016) http://www.ijdp.org/article/S0955-3959(16)30056-1/abstract
Medical use of cannabis products : Lessons to be learned from Israel and Canada (abst in English & German–2016) https://link.springer.com/article/10.1007%2Fs00482-015-0083-4
Chapter 1 – The Botany of Cannabis sativa L (abst–2016) http://www.sciencedirect.com/science/article/pii/B9780128046463000011
Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jnatprod.5b00949
The influences of cultivation setting on inflorescence lipid distributions, concentrations, and carbon isotope ratios of Cannabis sp. (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27045381
In Vitro Propagation of Cannabis sativa L. and Evaluation of Regenerated Plants for Genetic Fidelity and Cannabinoids Content for Quality Assurance (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27108324
Phytotoxic Effect of Fiber Hemp Essential Oil on Germination of Some Weeds and Crops (abst–2016) http://www.tandfonline.com/doi/abs/10.1080/0972060X.2015.1137236? journalCode=teop20
Use of Embryos Extracted from Individual Cannabis sativa Seeds for Genetic Studies and Forensic Applications (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/27404624
Cannabis clubs in Uruguay: The challenges of regulation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27475713

Cannabis cultivation in Spain: A profile of plantations, growers and production systems (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27619556
Near infrared spectroscopy combined with chemometrics for growth stage classification of cannabis cultivated in a greenhouse from seized seeds (abst–2016) http://www.sciencedirect.com/science/article/pii/S1386142516305583
Estimating the production, consumption and export of cannabis: The Dutch case (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27048853
High Time to Assess the Environmental Impacts of Cannabis Cultivation (full–2017) http://pubs.acs.org/doi/full/10.1021/acs.est.6b06343
Challenges towards Revitalizing Hemp: A Multifaceted Crop (full–2017)  http://www.cell.com/trends/plant-science/fulltext/S1360-1385(17)30177-2
The three betrayals of the medical cannabis growing activist: From multiple victimhood to reconstruction, redemption and activism (full–2017)
https://www.ijdp.org/article/S0955-3959(17)30360-2/fulltext
Endogenous synthesis of pyrethrins by cannabis (not all strains, just medihaze, so far) (link to PDF-2017) http://www.biorxiv.org/content/early/2017/07/28/169417

A new neglected crop: cannabis (summary–full is free with registration-2017)  http://science.sciencemag.org/content/356/6335/232
Pesticide Use on Cannabis (link to article–2017)  https://www.technologynetworks.com/tn/white-papers/pesticide-use-on-cannabis-288143
Uruguay’s middle-ground approach to cannabis legalization (1st page–2017)  http://www.ijdp.org/article/S0955-3959(17)30055-5/fulltext
Cannabis cultivation: Methodological issues for obtaining medical-grade product (abst–2017) http://www.epilepsybehavior.com/article/S1525-5050(16)30588-1/fulltext
Cannabis cultivation within a religious context: A case study of Ghomara in the Rif
Mountain (Northern Morocco) (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28375809
Support for marijuana legalization in the US state of Washington has continued to
increase through 2016 (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30171-0/fulltext
Why is it so difficult to determine the yield of indoor cannabis plantations? A case study from the Netherlands (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28502714
The use of pesticides in Belgian illicit indoor cannabis plantations (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0379073817301871
U.S. cannabis legalization and use of vaping and edible products among youth (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30184-9/fulltext
Molecular characterization, vector identification and sources of phytoplasmas associated with brinjal little leaf disease in India (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385184/
Community-level policy responses to state marijuana legalization in Washington State (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473373/
Optimal Rate of Organic Fertilizer during the Vegetative-stage for Cannabis Grown in

Two Coir-based Substrates (abst–2017)  http://hortsci.ashspublications.org/content/52/9/1307.abstract?sid=bfe42f6d-f2ae-42d8-8291-c13f8a327d67
Legal cannabis laws, home cultivation, and use of edible cannabis products: A growing relationship? (abst–2017) http://www.ijdp.org/article/S0955-3959(17)30292-X/fulltext
Pharmacological Foundations of Cannabis Chemovars (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29161743
Into the void: Regulating pesticide use in Colorado’s commercial cannabis markets (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28173984
The application of plant in vitro cultures in cannabinoid production (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29249063
Regulating Hemp and Cannabis-Based Products (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29095577
Grass is not always greener: rodenticide exposure of a threatened species near marijuana growing operations (full–2018) https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-018-3206-z
Notes from the Field: Occupational Hazards Associated with Harvesting and Processing Cannabis — Washington, 2015–2016 (full–2018)
https://www.cdc.gov/mmwr/volumes/67/wr/mm6708a7.htm?s_cid=mm6708a7_w
Water- and Nitrogen-Use Efficiencies of Hemp (Cannabis sativa L.) Based on WholeCanopy Measurements and Modeling (full–2018)   https://www.frontiersin.org/articles/10.3389/fpls.2018.00951/full
Accumulation of bioactive metabolites in cultivated medical Cannabis (full–2018)
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0201119
Chemometric Analysis of Cannabinoids: Chemotaxonomy and Domestication Syndrome (full–2018) https://www.nature.com/articles/s41598-018-31120-2
Cannabis, from Plant to Pill (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29701252
Developmental Plasticity of the Major Alkyl Cannabinoid Chemotypes in a Diverse Cannabis Genetic Resource Collection (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206272/
Chromatographic Analyses, In Vitro Biological Activities, and Cytotoxicity of Cannabis sativa L. Essential Oil: A Multidisciplinary Study (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320915/Latitudinal Adaptation and Genetic Insights Into the Origins of Cannabis sativa L. (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309158/
Genome-Wide Expression Profiles of Hemp (Cannabis sativa L.) in Response to Drought Stress (link to full–2018) https://www.hindawi.com/journals/ijg/2018/3057272/
Endophytes of industrial hemp (Cannabis sativa L.) cultivars: identification of culturable bacteria and fungi in leaves, petioles, and seeds (download–2018) https://tspace.library.utoronto.ca/bitstream/1807/89161/1/cjm-2018-0108.pdf
Healthy and Concentrated Cannabis Plants: How to Use Acronyms to Optimize Production (link to download–2018) https://www.ingentaconnect.com/content/aoac/jaoac/pre-prints/content-jaoac_180205;jsessionid=18xjnorbe71aw.x-ic-live-02#
Microbial hazards during harvesting and processing at an outdoor United States cannabis farm (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29370578
How Close to the “Honeypot?” A Comparative Analysis of Cannabis Markets Under Two Different Policies Toward Personal Cultivation (abst–2018) http://journals.sagepub.com/doi/full/10.1177/1057567717744857
An analysis of Belgian Cannabis Social Clubs’ supply practices: A shapeshifting model? (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0955395918300975
“The difference is in the tomato at the end”: Understanding the motivations and practices of cannabis growers operating within Belgian Cannabis Social Clubs (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0955395917303808
Consumer agency in cannabis supply – Exploring auto-regulatory documents of the cannabis social clubs in Spain (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29367012
Agricultural innovations in Morocco’s cannabis industry (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29885594
Genome of Serratia nematodiphila MB307 offers unique insights into its diverse traits (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29957088
Jasmonic acid to boost secondary growth in hemp hypocotyl (abst–2018) https://www.semanticscholar.org/paper/Jasmonic-acid-to-boost-secondary-growth-in-hemp-BehrLutts/a77969940e3f5e791e2d81f65052f5667c710008
Growing practices and the use of potentially harmful chemical additives among a sample of small-scale cannabis growers in three countries (abst–2018) https://www.sciencedirect.com/science/article/pii/S0376871618305490
Phenotypic plasticity influences the success of clonal propagation in industrial pharmaceutical Cannabis sativa (full-2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422331/
An Update on Plant Photobiology and Implications for Cannabis Production (full–2019) https://www.frontiersin.org/articles/10.3389/fpls.2019.00296/full
Architecture and Florogenesis in Female Cannabis sativa Plants (full–2019) https://www.ncbi.nlm.nih.gov/pubmed/31001293
Into the Weeds: Regulating Pesticides in Cannabis (full–2019) https://ehp.niehs.nih.gov/doi/full/10.1289/EHP5265?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Inner Workings: Genomics blazes a trail to improved cannabis cultivation (full–2019) https://www.pnas.org/content/116/18/8638.long
Decriminalisation of recreational cannabis in South Africa (full–2019) https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)30011-X/fulltext
Closing the Yield Gap for Cannabis: A Meta-Analysis of Factors Determining Cannabis Yield (full–2019) https://www.frontiersin.org/articles/10.3389/fpls.2019.00495/full
Impact of N, P, K, and Humic Acid Supplementation on the Chemical Profile of Medical Cannabis (Cannabis sativa L) (full–2019) https://www.frontiersin.org/articles/10.3389/fpls.2019.00736/full
Polyploidization for the Genetic Improvement of Cannabis sativa (full–2019) https://www.frontiersin.org/articles/10.3389/fpls.2019.00476/full
Protein Changes in Response to Lead Stress of Lead-Tolerant and Lead-Sensitive Industrial Hemp Using SWATH Technology (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562531/
The Complex Interactions Between Flowering Behavior and Fiber Quality in Hemp (full–2019) https://www.frontiersin.org/articles/10.3389/fpls.2019.00614/full
Legal and Regulatory Issues Governing Cannabis and Cannabis-Derived Products in the United States (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590107/
Contrasting Roles of Cannabidiol as an Insecticide and Rescuing Agent for Ethanol induced Death in the Tobacco Hornworm Manduca sexta (full–2019) https://www.nature.com/articles/s41598-019-47017-7
Gender differences among cannabis self-cultivators in Spain (link to PDFs in English & Spanish–2019) http://adicciones.es/index.php/adicciones/article/view/1107
African Roots of Marijuana (partial preview–2019) https://books.google.com/books?id=QRSXDwAAQBAJ&printsec=frontcover&dq=african+roots+of+marijuana&hl=en&sa=X&ved=0ahUKEwiwsfP-59riAhVZwMQHHdOTA9AQ6AEIKDAA#v=onepage&q=african%20roots%20of%20marijuana&f=false
Hemp hemp hooray for cannabis research (letter–2019) https://www.sciencemagazinedigital.org/sciencemagazine/15_february_2019/MobilePagedArticle.action?articleId=1464203#articleId1464203
Overview of “home” cultivation policies and the case for community-based cannabis supply (abst–2019) https://www.sciencedirect.com/science/article/abs/pii/S0955395919301434?via%3Dihub
Comprehensive Determination of Unregulated Pesticide Residues in Oregon Cannabis Flower by LC-MS/MS and GC-MS/MS (abst–2019) https://pubs.acs.org/doi/10.1021/acs.jafc.9b01559
Back to the roots: protocol for the photoautotrophic micropropagation of medicinal Cannabis (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31404230


CYCLIC VOMITING SYNDROME
Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome. (link to PDF–2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Cannabinoid+Receptor+Type+1+and+muOpioid+Receptor+Polymorphisms+Are+Associated+With+Cyclic+Vomiting+Syndrome.&btnG=
Recent Trends in Cyclic Vomiting Syndrome – Associated Hospitalizations with Liberalization of Cannabis Use in the State of Colorado (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30426628
Patterns of Cannabis Use In Patients With Cyclic Vomiting Syndrome (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31352091


CYSTIC FIBROSIS*+
Ajulemic acid: potential treatment for chronic inflammation (full–2018)
https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1002/prp2.394
False-positive cannabinoid screens in adult cystic fibrosis patients treated with lumacaftor / ivacaftor (full–2018) https://www.cysticfibrosisjournal.com/article/S1569-1993(18)30754-9/fulltext


CYSTITIS+
Intrathecal cannabinoid-1 receptor agonist prevents referred hyperalgesia in acute acrolein-induced cystitis in rats (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446380/
Endocannabinoids and the Digestive Tract and Bladder in Health and Disease (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_14
Potential of Endocannabinoids to Control Bladder Pain (full–2018) https://www.frontiersin.org/articles/10.3389/fnsys.2018.00017/full


Updated 28 September 2019